id	sid	tid	token	lemma	pos
aiua-12869	1	1	stesura	stesura	PROPN
aiua-12869	1	2	seveso	seveso	PROPN
aiua-12869	1	3	archivio	archivio	PROPN
aiua-12869	1	4	italiano	italiano	X
aiua-12869	1	5	di	di	X
aiua-12869	1	6	urologia	urologia	PROPN
aiua-12869	1	7	e	e	PROPN
aiua-12869	1	8	andrologia	andrologia	NOUN
aiua-12869	1	9	2024	2024	NUM
aiua-12869	1	10	;	;	PUNCT
aiua-12869	1	11	96(3):12869	96(3):12869	NUM
aiua-12869	1	12	1	1	NUM
aiua-12869	1	13	original	original	ADJ
aiua-12869	1	14	paper	paper	NOUN
aiua-12869	1	15	introduction	introduction	NOUN
aiua-12869	1	16	benign	benign	ADJ
aiua-12869	1	17	prostatic	prostatic	ADJ
aiua-12869	1	18	hyperplasia	hyperplasia	NOUN
aiua-12869	1	19	(	(	PUNCT
aiua-12869	1	20	bph	bph	NOUN
aiua-12869	1	21	)	)	PUNCT
aiua-12869	1	22	is	be	AUX
aiua-12869	1	23	a	a	DET
aiua-12869	1	24	common	common	ADJ
aiua-12869	1	25	urological	urological	ADJ
aiua-12869	1	26	disease	disease	NOUN
aiua-12869	1	27	among	among	ADP
aiua-12869	1	28	older	old	ADJ
aiua-12869	1	29	men	man	NOUN
aiua-12869	1	30	.	.	PUNCT
aiua-12869	2	1	it	it	PRON
aiua-12869	2	2	consists	consist	VERB
aiua-12869	2	3	of	of	ADP
aiua-12869	2	4	a	a	DET
aiua-12869	2	5	progressive	progressive	ADJ
aiua-12869	2	6	enlargement	enlargement	NOUN
aiua-12869	2	7	of	of	ADP
aiua-12869	2	8	the	the	DET
aiua-12869	2	9	prostatic	prostatic	ADJ
aiua-12869	2	10	tissue	tissue	NOUN
aiua-12869	2	11	,	,	PUNCT
aiua-12869	2	12	especially	especially	ADV
aiua-12869	2	13	its	its	PRON
aiua-12869	2	14	central	central	ADJ
aiua-12869	2	15	portion	portion	NOUN
aiua-12869	2	16	.	.	PUNCT
aiua-12869	3	1	the	the	DET
aiua-12869	3	2	resulting	result	VERB
aiua-12869	3	3	bladder	bladder	NOUN
aiua-12869	3	4	outlet	outlet	NOUN
aiua-12869	3	5	obstruction	obstruction	NOUN
aiua-12869	3	6	,	,	PUNCT
aiua-12869	3	7	coupled	couple	VERB
aiua-12869	3	8	with	with	ADP
aiua-12869	3	9	increased	increase	VERB
aiua-12869	3	10	muscle	muscle	NOUN
aiua-12869	3	11	tone	tone	NOUN
aiua-12869	3	12	of	of	ADP
aiua-12869	3	13	the	the	DET
aiua-12869	3	14	bladder	bladder	NOUN
aiua-12869	3	15	and	and	CCONJ
aiua-12869	3	16	secondary	secondary	ADJ
aiua-12869	3	17	dysfunction	dysfunction	NOUN
aiua-12869	3	18	of	of	ADP
aiua-12869	3	19	the	the	DET
aiua-12869	3	20	detrusor	detrusor	NOUN
aiua-12869	3	21	,	,	PUNCT
aiua-12869	3	22	produce	produce	VERB
aiua-12869	3	23	lower	low	ADJ
aiua-12869	3	24	urinary	urinary	ADJ
aiua-12869	3	25	tract	tract	NOUN
aiua-12869	3	26	symptoms	symptom	NOUN
aiua-12869	3	27	(	(	PUNCT
aiua-12869	3	28	1	1	NUM
aiua-12869	3	29	)	)	PUNCT
aiua-12869	3	30	.	.	PUNCT
aiua-12869	4	1	medical	medical	ADJ
aiua-12869	4	2	treatment	treatment	NOUN
aiua-12869	4	3	is	be	AUX
aiua-12869	4	4	the	the	DET
aiua-12869	4	5	first	first	ADJ
aiua-12869	4	6	-	-	PUNCT
aiua-12869	4	7	line	line	NOUN
aiua-12869	4	8	therapeutical	therapeutical	ADJ
aiua-12869	4	9	option	option	NOUN
aiua-12869	4	10	for	for	ADP
aiua-12869	4	11	this	this	DET
aiua-12869	4	12	condition	condition	NOUN
aiua-12869	4	13	.	.	PUNCT
aiua-12869	5	1	commonly	commonly	ADV
aiua-12869	5	2	administered	administer	VERB
aiua-12869	5	3	drugs	drug	NOUN
aiua-12869	5	4	are	be	AUX
aiua-12869	5	5	alphablockers	alphablocker	NOUN
aiua-12869	5	6	,	,	PUNCT
aiua-12869	5	7	5	5	NUM
aiua-12869	5	8	-	-	PUNCT
aiua-12869	5	9	alpha	alpha	ADJ
aiua-12869	5	10	reductase	reductase	NOUN
aiua-12869	5	11	inhibitors	inhibitor	NOUN
aiua-12869	5	12	(	(	PUNCT
aiua-12869	5	13	5	5	NUM
aiua-12869	5	14	-	-	PUNCT
aiua-12869	5	15	aris	aris	ADJ
aiua-12869	5	16	)	)	PUNCT
aiua-12869	5	17	and	and	CCONJ
aiua-12869	5	18	phosphodiesterase	phosphodiesterase	NOUN
aiua-12869	5	19	5	5	NUM
aiua-12869	5	20	-	-	PUNCT
aiua-12869	5	21	inhibitors	inhibitor	NOUN
aiua-12869	5	22	(	(	PUNCT
aiua-12869	5	23	pde5	pde5	NOUN
aiua-12869	5	24	-	-	PUNCT
aiua-12869	5	25	i	i	PROPN
aiua-12869	5	26	)	)	PUNCT
aiua-12869	5	27	.	.	PUNCT
aiua-12869	6	1	if	if	SCONJ
aiua-12869	6	2	men	man	NOUN
aiua-12869	6	3	have	have	VERB
aiua-12869	6	4	persistent	persistent	ADJ
aiua-12869	6	5	irritative	irritative	ADJ
aiua-12869	6	6	storage	storage	NOUN
aiua-12869	6	7	symptoms	symptom	NOUN
aiua-12869	6	8	after	after	SCONJ
aiua-12869	6	9	first	first	ADJ
aiua-12869	6	10	line	line	NOUN
aiua-12869	6	11	bph	bph	NOUN
aiua-12869	6	12	therapy	therapy	NOUN
aiua-12869	6	13	then	then	ADV
aiua-12869	6	14	overactive	overactive	ADJ
aiua-12869	6	15	bladder	bladder	NOUN
aiua-12869	6	16	(	(	PUNCT
aiua-12869	6	17	oab	oab	PROPN
aiua-12869	6	18	)	)	PUNCT
aiua-12869	6	19	medications	medication	NOUN
aiua-12869	6	20	can	can	AUX
aiua-12869	6	21	be	be	AUX
aiua-12869	6	22	added	add	VERB
aiua-12869	6	23	or	or	CCONJ
aiua-12869	6	24	used	use	VERB
aiua-12869	6	25	as	as	ADP
aiua-12869	6	26	a	a	DET
aiua-12869	6	27	replacement	replacement	NOUN
aiua-12869	6	28	.	.	PUNCT
aiua-12869	7	1	combination	combination	NOUN
aiua-12869	7	2	therapies	therapy	NOUN
aiua-12869	7	3	usually	usually	ADV
aiua-12869	7	4	allow	allow	VERB
aiua-12869	7	5	to	to	PART
aiua-12869	7	6	increase	increase	VERB
aiua-12869	7	7	the	the	DET
aiua-12869	7	8	efficacy	efficacy	NOUN
aiua-12869	7	9	of	of	ADP
aiua-12869	7	10	medical	medical	ADJ
aiua-12869	7	11	treatments	treatment	NOUN
aiua-12869	7	12	and	and	CCONJ
aiua-12869	7	13	delay	delay	VERB
aiua-12869	7	14	the	the	DET
aiua-12869	7	15	need	need	NOUN
aiua-12869	7	16	for	for	ADP
aiua-12869	7	17	corrective	corrective	ADJ
aiua-12869	7	18	surgery	surgery	NOUN
aiua-12869	7	19	(	(	PUNCT
aiua-12869	7	20	2	2	NUM
aiua-12869	7	21	,	,	PUNCT
aiua-12869	7	22	3	3	NUM
aiua-12869	7	23	)	)	PUNCT
aiua-12869	7	24	.	.	PUNCT
aiua-12869	8	1	most	most	ADJ
aiua-12869	8	2	said	say	VERB
aiua-12869	8	3	drugs	drug	NOUN
aiua-12869	8	4	,	,	PUNCT
aiua-12869	8	5	however	however	ADV
aiua-12869	8	6	,	,	PUNCT
aiua-12869	8	7	show	show	VERB
aiua-12869	8	8	a	a	DET
aiua-12869	8	9	consistent	consistent	ADJ
aiua-12869	8	10	rate	rate	NOUN
aiua-12869	8	11	of	of	ADP
aiua-12869	8	12	side	side	NOUN
aiua-12869	8	13	effects	effect	NOUN
aiua-12869	8	14	in	in	ADP
aiua-12869	8	15	those	those	PRON
aiua-12869	8	16	who	who	PRON
aiua-12869	8	17	use	use	VERB
aiua-12869	8	18	them	they	PRON
aiua-12869	8	19	.	.	PUNCT
aiua-12869	9	1	this	this	PRON
aiua-12869	9	2	is	be	AUX
aiua-12869	9	3	why	why	SCONJ
aiua-12869	9	4	there	there	PRON
aiua-12869	9	5	is	be	VERB
aiua-12869	9	6	a	a	DET
aiua-12869	9	7	massive	massive	ADJ
aiua-12869	9	8	increase	increase	NOUN
aiua-12869	9	9	of	of	ADP
aiua-12869	9	10	interest	interest	NOUN
aiua-12869	9	11	for	for	ADP
aiua-12869	9	12	herbal	herbal	ADJ
aiua-12869	9	13	and	and	CCONJ
aiua-12869	9	14	nutraceutical	nutraceutical	ADJ
aiua-12869	9	15	treatments	treatment	NOUN
aiua-12869	9	16	.	.	PUNCT
aiua-12869	10	1	serenoa	serenoa	ADJ
aiua-12869	10	2	repens	repen	NOUN
aiua-12869	10	3	,	,	PUNCT
aiua-12869	10	4	for	for	ADP
aiua-12869	10	5	instance	instance	NOUN
aiua-12869	10	6	,	,	PUNCT
aiua-12869	10	7	is	be	AUX
aiua-12869	10	8	one	one	NUM
aiua-12869	10	9	of	of	ADP
aiua-12869	10	10	the	the	DET
aiua-12869	10	11	oldest	old	ADJ
aiua-12869	10	12	and	and	CCONJ
aiua-12869	10	13	most	most	ADV
aiua-12869	10	14	effective	effective	ADJ
aiua-12869	10	15	nutraceutical	nutraceutical	ADJ
aiua-12869	10	16	drugs	drug	NOUN
aiua-12869	10	17	used	use	VERB
aiua-12869	10	18	to	to	PART
aiua-12869	10	19	treat	treat	VERB
aiua-12869	10	20	bph	bph	NOUN
aiua-12869	10	21	-	-	PUNCT
aiua-12869	10	22	related	relate	VERB
aiua-12869	10	23	symptoms	symptom	NOUN
aiua-12869	10	24	.	.	PUNCT
aiua-12869	11	1	in	in	ADP
aiua-12869	11	2	vitro	vitro	X
aiua-12869	11	3	,	,	PUNCT
aiua-12869	11	4	serenoa	serenoa	ADJ
aiua-12869	11	5	repens	repen	NOUN
aiua-12869	11	6	extract	extract	NOUN
aiua-12869	11	7	(	(	PUNCT
aiua-12869	11	8	320	320	NUM
aiua-12869	11	9	mg	mg	NOUN
aiua-12869	11	10	once	once	ADV
aiua-12869	11	11	a	a	DET
aiua-12869	11	12	day	day	NOUN
aiua-12869	11	13	)	)	PUNCT
aiua-12869	11	14	has	have	AUX
aiua-12869	11	15	demonstrated	demonstrate	VERB
aiua-12869	11	16	anti	anti	ADJ
aiua-12869	11	17	-	-	ADJ
aiua-12869	11	18	inflammatory	inflammatory	ADJ
aiua-12869	11	19	,	,	PUNCT
aiua-12869	11	20	antiandrogenic	antiandrogenic	ADJ
aiua-12869	11	21	,	,	PUNCT
aiua-12869	11	22	and	and	CCONJ
aiua-12869	11	23	estrogenic	estrogenic	ADJ
aiua-12869	11	24	effects	effect	NOUN
aiua-12869	11	25	along	along	ADP
aiua-12869	11	26	with	with	ADP
aiua-12869	11	27	a	a	DET
aiua-12869	11	28	decrease	decrease	NOUN
aiua-12869	11	29	in	in	ADP
aiua-12869	11	30	sexual	sexual	ADJ
aiua-12869	11	31	hormone	hormone	NOUN
aiua-12869	11	32	-	-	PUNCT
aiua-12869	11	33	binding	bind	VERB
aiua-12869	11	34	globulin	globulin	NOUN
aiua-12869	11	35	;	;	PUNCT
aiua-12869	11	36	inhibition	inhibition	NOUN
aiua-12869	11	37	of	of	ADP
aiua-12869	11	38	5α	5α	ADJ
aiua-12869	11	39	-	-	PUNCT
aiua-12869	11	40	reductase	reductase	NOUN
aiua-12869	11	41	,	,	PUNCT
aiua-12869	11	42	muscarinic	muscarinic	ADJ
aiua-12869	11	43	cholinoreceptors	cholinoreceptor	NOUN
aiua-12869	11	44	,	,	PUNCT
aiua-12869	11	45	dihydropyridine	dihydropyridine	NOUN
aiua-12869	11	46	receptors	receptor	NOUN
aiua-12869	11	47	,	,	PUNCT
aiua-12869	11	48	and	and	CCONJ
aiua-12869	11	49	vanilloid	vanilloid	NOUN
aiua-12869	11	50	receptors	receptor	NOUN
aiua-12869	11	51	;	;	PUNCT
aiua-12869	11	52	neutralization	neutralization	NOUN
aiua-12869	11	53	of	of	ADP
aiua-12869	11	54	free	free	ADJ
aiua-12869	11	55	radicals	radical	NOUN
aiua-12869	11	56	.	.	PUNCT
aiua-12869	12	1	as	as	ADP
aiua-12869	12	2	of	of	ADP
aiua-12869	12	3	today	today	NOUN
aiua-12869	12	4	,	,	PUNCT
aiua-12869	12	5	serenoa	serenoa	ADJ
aiua-12869	12	6	repens	repen	NOUN
aiua-12869	12	7	is	be	AUX
aiua-12869	12	8	considered	consider	VERB
aiua-12869	12	9	introduction	introduction	NOUN
aiua-12869	12	10	:	:	PUNCT
aiua-12869	12	11	the	the	DET
aiua-12869	12	12	aim	aim	NOUN
aiua-12869	12	13	of	of	ADP
aiua-12869	12	14	our	our	PRON
aiua-12869	12	15	study	study	NOUN
aiua-12869	12	16	was	be	AUX
aiua-12869	12	17	to	to	PART
aiua-12869	12	18	treat	treat	VERB
aiua-12869	12	19	2	2	NUM
aiua-12869	12	20	similar	similar	ADJ
aiua-12869	12	21	groups	group	NOUN
aiua-12869	12	22	of	of	ADP
aiua-12869	12	23	patients	patient	NOUN
aiua-12869	12	24	suffering	suffer	VERB
aiua-12869	12	25	from	from	ADP
aiua-12869	12	26	benign	benign	ADJ
aiua-12869	12	27	prostatic	prostatic	ADJ
aiua-12869	12	28	hyperplasia	hyperplasia	NOUN
aiua-12869	12	29	(	(	PUNCT
aiua-12869	12	30	bph	bph	NOUN
aiua-12869	12	31	):	):	PUNCT
aiua-12869	12	32	one	one	NUM
aiua-12869	12	33	group	group	NOUN
aiua-12869	12	34	with	with	ADP
aiua-12869	12	35	a	a	DET
aiua-12869	12	36	complex	complex	NOUN
aiua-12869	12	37	of	of	ADP
aiua-12869	12	38	phytochemicals	phytochemical	NOUN
aiua-12869	12	39	based	base	VERB
aiua-12869	12	40	on	on	ADP
aiua-12869	12	41	phycocyanin	phycocyanin	ADV
aiua-12869	12	42	,	,	PUNCT
aiua-12869	12	43	palmitoylethanolamide	palmitoylethanolamide	ADJ
aiua-12869	12	44	(	(	PUNCT
aiua-12869	12	45	pea	pea	NOUN
aiua-12869	12	46	)	)	PUNCT
aiua-12869	12	47	and	and	CCONJ
aiua-12869	12	48	selenium	selenium	NOUN
aiua-12869	12	49	;	;	PUNCT
aiua-12869	12	50	the	the	DET
aiua-12869	12	51	other	other	ADJ
aiua-12869	12	52	group	group	NOUN
aiua-12869	12	53	with	with	ADP
aiua-12869	12	54	dutasteride	dutasteride	PROPN
aiua-12869	12	55	.	.	PUNCT
aiua-12869	13	1	the	the	DET
aiua-12869	13	2	effectiveness	effectiveness	NOUN
aiua-12869	13	3	of	of	ADP
aiua-12869	13	4	these	these	DET
aiua-12869	13	5	treatments	treatment	NOUN
aiua-12869	13	6	was	be	AUX
aiua-12869	13	7	checked	check	VERB
aiua-12869	13	8	,	,	PUNCT
aiua-12869	13	9	especially	especially	ADV
aiua-12869	13	10	regarding	regard	VERB
aiua-12869	13	11	the	the	DET
aiua-12869	13	12	improvement	improvement	NOUN
aiua-12869	13	13	of	of	ADP
aiua-12869	13	14	lower	low	ADJ
aiua-12869	13	15	urinary	urinary	ADJ
aiua-12869	13	16	tract	tract	NOUN
aiua-12869	13	17	symptoms	symptom	NOUN
aiua-12869	13	18	(	(	PUNCT
aiua-12869	13	19	luts	luts	PROPN
aiua-12869	13	20	)	)	PUNCT
aiua-12869	13	21	and	and	CCONJ
aiua-12869	13	22	the	the	DET
aiua-12869	13	23	reduction	reduction	NOUN
aiua-12869	13	24	of	of	ADP
aiua-12869	13	25	prostatic	prostatic	ADJ
aiua-12869	13	26	specific	specific	ADJ
aiua-12869	13	27	antigen	antigen	NOUN
aiua-12869	13	28	(	(	PUNCT
aiua-12869	13	29	psa	psa	NOUN
aiua-12869	13	30	)	)	PUNCT
aiua-12869	13	31	and	and	CCONJ
aiua-12869	13	32	prostate	prostate	NOUN
aiua-12869	13	33	volume	volume	NOUN
aiua-12869	13	34	.	.	PUNCT
aiua-12869	14	1	materials	material	NOUN
aiua-12869	14	2	and	and	CCONJ
aiua-12869	14	3	methods	method	NOUN
aiua-12869	14	4	:	:	PUNCT
aiua-12869	14	5	we	we	PRON
aiua-12869	14	6	included	include	VERB
aiua-12869	14	7	104	104	NUM
aiua-12869	14	8	patients	patient	NOUN
aiua-12869	14	9	in	in	ADP
aiua-12869	14	10	the	the	DET
aiua-12869	14	11	study	study	NOUN
aiua-12869	14	12	.	.	PUNCT
aiua-12869	15	1	all	all	DET
aiua-12869	15	2	patients	patient	NOUN
aiua-12869	15	3	were	be	AUX
aiua-12869	15	4	aged	age	VERB
aiua-12869	15	5	between	between	ADP
aiua-12869	15	6	50	50	NUM
aiua-12869	15	7	and	and	CCONJ
aiua-12869	15	8	70	70	NUM
aiua-12869	15	9	years	year	NOUN
aiua-12869	15	10	,	,	PUNCT
aiua-12869	15	11	with	with	ADP
aiua-12869	15	12	psa	psa	NOUN
aiua-12869	15	13	values	value	NOUN
aiua-12869	15	14	between	between	ADP
aiua-12869	15	15	4	4	NUM
aiua-12869	15	16	and	and	CCONJ
aiua-12869	15	17	10	10	NUM
aiua-12869	15	18	ng	ng	PROPN
aiua-12869	15	19	/	/	SYM
aiua-12869	15	20	ml	ml	PROPN
aiua-12869	15	21	,	,	PUNCT
aiua-12869	15	22	prostate	prostate	NOUN
aiua-12869	15	23	volume	volume	NOUN
aiua-12869	15	24	,	,	PUNCT
aiua-12869	15	25	as	as	SCONJ
aiua-12869	15	26	calculated	calculate	VERB
aiua-12869	15	27	by	by	ADP
aiua-12869	15	28	transrectal	transrectal	ADJ
aiua-12869	15	29	ultrasound	ultrasound	NOUN
aiua-12869	15	30	between	between	ADP
aiua-12869	15	31	50	50	NUM
aiua-12869	15	32	and	and	CCONJ
aiua-12869	15	33	70	70	NUM
aiua-12869	15	34	cc	cc	NOUN
aiua-12869	15	35	,	,	PUNCT
aiua-12869	15	36	maximum	maximum	ADJ
aiua-12869	15	37	flow	flow	NOUN
aiua-12869	15	38	value	value	NOUN
aiua-12869	15	39	greater	great	ADJ
aiua-12869	15	40	than	than	ADP
aiua-12869	15	41	or	or	CCONJ
aiua-12869	15	42	equal	equal	ADJ
aiua-12869	15	43	to	to	ADP
aiua-12869	15	44	10	10	NUM
aiua-12869	15	45	ml	ml	NOUN
aiua-12869	15	46	/	/	SYM
aiua-12869	15	47	s	s	NOUN
aiua-12869	15	48	at	at	ADP
aiua-12869	15	49	flowmetry	flowmetry	NOUN
aiua-12869	15	50	,	,	PUNCT
aiua-12869	15	51	no	no	DET
aiua-12869	15	52	suspicious	suspicious	ADJ
aiua-12869	15	53	nodules	nodule	NOUN
aiua-12869	15	54	on	on	ADP
aiua-12869	15	55	difital	difital	ADJ
aiua-12869	15	56	rectal	rectal	ADJ
aiua-12869	15	57	examination	examination	NOUN
aiua-12869	15	58	(	(	PUNCT
aiua-12869	15	59	dre	dre	PROPN
aiua-12869	15	60	)	)	PUNCT
aiua-12869	15	61	,	,	PUNCT
aiua-12869	15	62	no	no	DET
aiua-12869	15	63	suspicious	suspicious	ADJ
aiua-12869	15	64	lesions	lesion	NOUN
aiua-12869	15	65	on	on	ADP
aiua-12869	15	66	magnetic	magnetic	ADJ
aiua-12869	15	67	resonance	resonance	NOUN
aiua-12869	15	68	imaging	imaging	NOUN
aiua-12869	15	69	mri	mri	NOUN
aiua-12869	15	70	(	(	PUNCT
aiua-12869	15	71	pi	pi	NOUN
aiua-12869	15	72	-	-	PUNCT
aiua-12869	15	73	rads	rad	NOUN
aiua-12869	15	74	1	1	NUM
aiua-12869	15	75	-	-	SYM
aiua-12869	15	76	2	2	NUM
aiua-12869	15	77	)	)	PUNCT
aiua-12869	15	78	,	,	PUNCT
aiua-12869	15	79	negative	negative	ADJ
aiua-12869	15	80	previous	previous	ADJ
aiua-12869	15	81	prostatic	prostatic	ADJ
aiua-12869	15	82	biopsies	biopsy	NOUN
aiua-12869	15	83	or	or	CCONJ
aiua-12869	15	84	never	never	ADV
aiua-12869	15	85	biopsied	biopsie	VERB
aiua-12869	15	86	,	,	PUNCT
aiua-12869	15	87	moreover	moreover	ADP
aiua-12869	15	88	absence	absence	NOUN
aiua-12869	15	89	of	of	ADP
aiua-12869	15	90	diabetes	diabetes	NOUN
aiua-12869	15	91	mellitus	mellitus	NOUN
aiua-12869	15	92	or	or	CCONJ
aiua-12869	15	93	chronic	chronic	ADJ
aiua-12869	15	94	renal	renal	ADJ
aiua-12869	15	95	failure	failure	NOUN
aiua-12869	15	96	(	(	PUNCT
aiua-12869	15	97	blood	blood	NOUN
aiua-12869	15	98	creatinine	creatinine	NOUN
aiua-12869	15	99	>	>	X
aiua-12869	15	100	2	2	NUM
aiua-12869	15	101	mg	mg	PROPN
aiua-12869	15	102	/	/	SYM
aiua-12869	15	103	dl	dl	NOUN
aiua-12869	15	104	)	)	PUNCT
aiua-12869	15	105	.	.	PUNCT
aiua-12869	16	1	we	we	PRON
aiua-12869	16	2	considered	consider	VERB
aiua-12869	16	3	:	:	PUNCT
aiua-12869	16	4	group	group	NOUN
aiua-12869	16	5	a	a	PRON
aiua-12869	16	6	of	of	ADP
aiua-12869	16	7	54	54	NUM
aiua-12869	16	8	men	man	NOUN
aiua-12869	16	9	who	who	PRON
aiua-12869	16	10	used	use	VERB
aiua-12869	16	11	the	the	DET
aiua-12869	16	12	complex	complex	NOUN
aiua-12869	16	13	of	of	ADP
aiua-12869	16	14	phytochemicals	phytochemical	NOUN
aiua-12869	16	15	;	;	PUNCT
aiua-12869	16	16	group	group	NOUN
aiua-12869	16	17	b	b	PROPN
aiua-12869	16	18	of	of	ADP
aiua-12869	16	19	50	50	NUM
aiua-12869	16	20	patients	patient	NOUN
aiua-12869	16	21	treated	treat	VERB
aiua-12869	16	22	with	with	ADP
aiua-12869	16	23	dutasteride	dutasteride	PROPN
aiua-12869	16	24	.	.	PUNCT
aiua-12869	17	1	we	we	PRON
aiua-12869	17	2	followed	follow	VERB
aiua-12869	17	3	all	all	DET
aiua-12869	17	4	the	the	DET
aiua-12869	17	5	patients	patient	NOUN
aiua-12869	17	6	for	for	ADP
aiua-12869	17	7	6	6	NUM
aiua-12869	17	8	months	month	NOUN
aiua-12869	17	9	after	after	ADP
aiua-12869	17	10	starting	start	VERB
aiua-12869	17	11	therapy	therapy	NOUN
aiua-12869	17	12	,	,	PUNCT
aiua-12869	17	13	considering	consider	VERB
aiua-12869	17	14	the	the	DET
aiua-12869	17	15	following	follow	VERB
aiua-12869	17	16	parameters	parameter	NOUN
aiua-12869	17	17	:	:	PUNCT
aiua-12869	17	18	psa	psa	NOUN
aiua-12869	17	19	,	,	PUNCT
aiua-12869	17	20	prostate	prostate	NOUN
aiua-12869	17	21	volume	volume	NOUN
aiua-12869	17	22	,	,	PUNCT
aiua-12869	17	23	and	and	CCONJ
aiua-12869	17	24	flowmetry	flowmetry	NOUN
aiua-12869	17	25	.	.	PUNCT
aiua-12869	18	1	results	result	NOUN
aiua-12869	18	2	:	:	PUNCT
aiua-12869	18	3	our	our	PRON
aiua-12869	18	4	results	result	NOUN
aiua-12869	18	5	showed	show	VERB
aiua-12869	18	6	that	that	SCONJ
aiua-12869	18	7	both	both	CCONJ
aiua-12869	18	8	dutasteride	dutasteride	NOUN
aiua-12869	18	9	and	and	CCONJ
aiua-12869	18	10	the	the	DET
aiua-12869	18	11	phytochemicals	phytochemical	NOUN
aiua-12869	18	12	complex	complex	NOUN
aiua-12869	18	13	decreased	decrease	VERB
aiua-12869	18	14	psa	psa	NOUN
aiua-12869	18	15	levels	level	NOUN
aiua-12869	18	16	(	(	PUNCT
aiua-12869	18	17	p	p	X
aiua-12869	18	18	<	<	X
aiua-12869	18	19	0.0001	0.0001	NUM
aiua-12869	18	20	for	for	ADP
aiua-12869	18	21	both	both	PRON
aiua-12869	18	22	)	)	PUNCT
aiua-12869	18	23	,	,	PUNCT
aiua-12869	18	24	with	with	ADP
aiua-12869	18	25	a	a	DET
aiua-12869	18	26	more	more	ADV
aiua-12869	18	27	significant	significant	ADJ
aiua-12869	18	28	effect	effect	NOUN
aiua-12869	18	29	of	of	ADP
aiua-12869	18	30	dutasteride	dutasteride	NOUN
aiua-12869	18	31	(	(	PUNCT
aiua-12869	18	32	mean	mean	INTJ
aiua-12869	18	33	decrease	decrease	NOUN
aiua-12869	18	34	of	of	ADP
aiua-12869	18	35	-2.743	-2.743	PRON
aiua-12869	18	36	ng	ng	PROPN
aiua-12869	18	37	/	/	SYM
aiua-12869	18	38	ml	ml	PROPN
aiua-12869	18	39	vs	vs	ADP
aiua-12869	18	40	-0.971	-0.971	ADJ
aiua-12869	18	41	ng	ng	PROPN
aiua-12869	18	42	/	/	SYM
aiua-12869	18	43	ml	ml	PROPN
aiua-12869	18	44	)	)	PUNCT
aiua-12869	18	45	.	.	PUNCT
aiua-12869	19	1	uroflowmetry	uroflowmetry	NOUN
aiua-12869	19	2	also	also	ADV
aiua-12869	19	3	improved	improve	VERB
aiua-12869	19	4	in	in	ADP
aiua-12869	19	5	both	both	DET
aiua-12869	19	6	groups	group	NOUN
aiua-12869	19	7	(	(	PUNCT
aiua-12869	19	8	p	p	X
aiua-12869	19	9	<	<	X
aiua-12869	19	10	0.0001	0.0001	NUM
aiua-12869	19	11	)	)	PUNCT
aiua-12869	19	12	with	with	ADP
aiua-12869	19	13	a	a	DET
aiua-12869	19	14	mean	mean	ADJ
aiua-12869	19	15	increase	increase	NOUN
aiua-12869	19	16	in	in	ADP
aiua-12869	19	17	maximum	maximum	ADJ
aiua-12869	19	18	flow	flow	NOUN
aiua-12869	19	19	of	of	ADP
aiua-12869	19	20	urine	urine	NOUN
aiua-12869	19	21	of	of	ADP
aiua-12869	19	22	+	+	X
aiua-12869	19	23	3.03	3.03	NUM
aiua-12869	19	24	ml	ml	NOUN
aiua-12869	19	25	/	/	SYM
aiua-12869	19	26	min	min	NOUN
aiua-12869	19	27	for	for	ADP
aiua-12869	19	28	the	the	DET
aiua-12869	19	29	dutasteride	dutasteride	PROPN
aiua-12869	19	30	group	group	NOUN
aiua-12869	19	31	and	and	CCONJ
aiua-12869	19	32	+	+	NOUN
aiua-12869	19	33	13.02	13.02	NUM
aiua-12869	19	34	ml	ml	NOUN
aiua-12869	19	35	/	/	SYM
aiua-12869	19	36	min	min	NOUN
aiua-12869	19	37	for	for	ADP
aiua-12869	19	38	phytochemicals	phytochemical	NOUN
aiua-12869	19	39	complex	complex	ADJ
aiua-12869	19	40	group	group	NOUN
aiua-12869	19	41	.	.	PUNCT
aiua-12869	20	1	lastly	lastly	ADV
aiua-12869	20	2	,	,	PUNCT
aiua-12869	20	3	dutasteride	dutasteride	PROPN
aiua-12869	20	4	proved	prove	VERB
aiua-12869	20	5	to	to	PART
aiua-12869	20	6	be	be	AUX
aiua-12869	20	7	highly	highly	ADV
aiua-12869	20	8	effective	effective	ADJ
aiua-12869	20	9	on	on	ADP
aiua-12869	20	10	reducing	reduce	VERB
aiua-12869	20	11	the	the	DET
aiua-12869	20	12	prostate	prostate	NOUN
aiua-12869	20	13	volume	volume	NOUN
aiua-12869	20	14	on	on	ADP
aiua-12869	20	15	transrectal	transrectal	ADJ
aiua-12869	20	16	ultrasound	ultrasound	NOUN
aiua-12869	20	17	(	(	PUNCT
aiua-12869	20	18	trus	trus	NOUN
aiua-12869	20	19	)	)	PUNCT
aiua-12869	20	20	(	(	PUNCT
aiua-12869	20	21	-22.14	-22.14	PROPN
aiua-12869	20	22	ml	ml	PROPN
aiua-12869	20	23	,	,	PUNCT
aiua-12869	20	24	p	p	X
aiua-12869	20	25	<	<	X
aiua-12869	20	26	0.0001	0.0001	NUM
aiua-12869	20	27	)	)	PUNCT
aiua-12869	20	28	compared	compare	VERB
aiua-12869	20	29	to	to	ADP
aiua-12869	20	30	the	the	DET
aiua-12869	20	31	complex	complex	NOUN
aiua-12869	20	32	of	of	ADP
aiua-12869	20	33	phytochemicals	phytochemical	NOUN
aiua-12869	20	34	,	,	PUNCT
aiua-12869	20	35	which	which	PRON
aiua-12869	20	36	showed	show	VERB
aiua-12869	20	37	a	a	DET
aiua-12869	20	38	mean	mean	ADJ
aiua-12869	20	39	decrease	decrease	NOUN
aiua-12869	20	40	of	of	ADP
aiua-12869	20	41	-10.04	-10.04	PROPN
aiua-12869	20	42	ml	ml	X
aiua-12869	20	43	(	(	PUNCT
aiua-12869	20	44	p	p	X
aiua-12869	20	45	<	<	X
aiua-12869	20	46	0.0001	0.0001	NUM
aiua-12869	20	47	)	)	PUNCT
aiua-12869	20	48	.	.	PUNCT
aiua-12869	21	1	moreover	moreover	ADV
aiua-12869	21	2	,	,	PUNCT
aiua-12869	21	3	the	the	DET
aiua-12869	21	4	reduction	reduction	NOUN
aiua-12869	21	5	in	in	ADP
aiua-12869	21	6	prostate	prostate	NOUN
aiua-12869	21	7	volume	volume	NOUN
aiua-12869	21	8	obtained	obtain	VERB
aiua-12869	21	9	through	through	ADP
aiua-12869	21	10	the	the	DET
aiua-12869	21	11	use	use	NOUN
aiua-12869	21	12	of	of	ADP
aiua-12869	21	13	dutasteride	dutasteride	NOUN
aiua-12869	21	14	proved	prove	VERB
aiua-12869	21	15	to	to	PART
aiua-12869	21	16	be	be	AUX
aiua-12869	21	17	more	more	ADV
aiua-12869	21	18	consistent	consistent	ADJ
aiua-12869	21	19	than	than	ADP
aiua-12869	21	20	the	the	DET
aiua-12869	21	21	one	one	NOUN
aiua-12869	21	22	obtained	obtain	VERB
aiua-12869	21	23	by	by	ADP
aiua-12869	21	24	using	use	VERB
aiua-12869	21	25	the	the	DET
aiua-12869	21	26	complex	complex	NOUN
aiua-12869	21	27	of	of	ADP
aiua-12869	21	28	phytochemicals	phytochemical	NOUN
aiua-12869	21	29	even	even	ADV
aiua-12869	21	30	at	at	ADP
aiua-12869	21	31	statistical	statistical	ADJ
aiua-12869	21	32	analysis	analysis	NOUN
aiua-12869	21	33	(	(	PUNCT
aiua-12869	21	34	p	p	X
aiua-12869	21	35	<	<	X
aiua-12869	21	36	0.0001	0.0001	NUM
aiua-12869	21	37	)	)	PUNCT
aiua-12869	21	38	.	.	PUNCT
aiua-12869	22	1	conclusions	conclusion	NOUN
aiua-12869	22	2	:	:	PUNCT
aiua-12869	22	3	both	both	CCONJ
aiua-12869	22	4	the	the	DET
aiua-12869	22	5	complex	complex	NOUN
aiua-12869	22	6	of	of	ADP
aiua-12869	22	7	phytochemicals	phytochemical	NOUN
aiua-12869	22	8	and	and	CCONJ
aiua-12869	22	9	dutasteride	dutasteride	NOUN
aiua-12869	22	10	showed	show	VERB
aiua-12869	22	11	reduction	reduction	NOUN
aiua-12869	22	12	of	of	ADP
aiua-12869	22	13	psa	psa	NOUN
aiua-12869	22	14	values	value	NOUN
aiua-12869	22	15	after	after	ADP
aiua-12869	22	16	6	6	NUM
aiua-12869	22	17	months	month	NOUN
aiua-12869	22	18	of	of	ADP
aiua-12869	22	19	treatment	treatment	NOUN
aiua-12869	22	20	.	.	PUNCT
aiua-12869	23	1	the	the	DET
aiua-12869	23	2	complex	complex	NOUN
aiua-12869	23	3	based	base	VERB
aiua-12869	23	4	on	on	ADP
aiua-12869	23	5	phycocyanin	phycocyanin	ADV
aiua-12869	23	6	,	,	PUNCT
aiua-12869	23	7	pea	pea	NOUN
aiua-12869	23	8	and	and	CCONJ
aiua-12869	23	9	selenium	selenium	NOUN
aiua-12869	23	10	showed	show	VERB
aiua-12869	23	11	a	a	DET
aiua-12869	23	12	statistically	statistically	ADV
aiua-12869	23	13	significant	significant	ADJ
aiua-12869	23	14	improvement	improvement	NOUN
aiua-12869	23	15	in	in	ADP
aiua-12869	23	16	urinary	urinary	ADJ
aiua-12869	23	17	flow	flow	NOUN
aiua-12869	23	18	,	,	PUNCT
aiua-12869	23	19	while	while	SCONJ
aiua-12869	23	20	dutasteride	dutasteride	NOUN
aiua-12869	23	21	acted	act	VERB
aiua-12869	23	22	more	more	ADV
aiua-12869	23	23	on	on	ADP
aiua-12869	23	24	the	the	DET
aiua-12869	23	25	volume	volume	NOUN
aiua-12869	23	26	of	of	ADP
aiua-12869	23	27	the	the	DET
aiua-12869	23	28	prostate	prostate	NOUN
aiua-12869	23	29	.	.	PUNCT
aiua-12869	24	1	prospective	prospective	ADJ
aiua-12869	24	2	observational	observational	ADJ
aiua-12869	24	3	study	study	NOUN
aiua-12869	24	4	on	on	ADP
aiua-12869	24	5	the	the	DET
aiua-12869	24	6	efficacy	efficacy	NOUN
aiua-12869	24	7	and	and	CCONJ
aiua-12869	24	8	tolerability	tolerability	NOUN
aiua-12869	24	9	of	of	ADP
aiua-12869	24	10	a	a	DET
aiua-12869	24	11	complex	complex	NOUN
aiua-12869	24	12	of	of	ADP
aiua-12869	24	13	phytochemicals	phytochemical	NOUN
aiua-12869	24	14	versus	versus	ADP
aiua-12869	24	15	dutasteride	dutasteride	NOUN
aiua-12869	24	16	in	in	ADP
aiua-12869	24	17	the	the	DET
aiua-12869	24	18	treatment	treatment	NOUN
aiua-12869	24	19	of	of	ADP
aiua-12869	24	20	lower	low	ADJ
aiua-12869	24	21	urinary	urinary	ADJ
aiua-12869	24	22	tract	tract	NOUN
aiua-12869	24	23	symptomps	symptomp	NOUN
aiua-12869	24	24	due	due	ADJ
aiua-12869	24	25	to	to	ADP
aiua-12869	24	26	benign	benign	ADJ
aiua-12869	24	27	prostatic	prostatic	ADJ
aiua-12869	24	28	hyperplasia	hyperplasia	NOUN
aiua-12869	24	29	giuseppe	giuseppe	PROPN
aiua-12869	24	30	saitta	saitta	PROPN
aiua-12869	24	31	1	1	NUM
aiua-12869	24	32	,	,	PUNCT
aiua-12869	24	33	franco	franco	PROPN
aiua-12869	24	34	a.	a.	PROPN
aiua-12869	24	35	mantovani	mantovani	PROPN
aiua-12869	24	36	1	1	NUM
aiua-12869	24	37	,	,	PUNCT
aiua-12869	24	38	benedetto	benedetto	PROPN
aiua-12869	24	39	calabrese	calabrese	PROPN
aiua-12869	24	40	1	1	NUM
aiua-12869	24	41	,	,	PUNCT
aiua-12869	24	42	2	2	NUM
aiua-12869	24	43	,	,	PUNCT
aiua-12869	24	44	camilla	camilla	NOUN
aiua-12869	24	45	aliboni	aliboni	NOUN
aiua-12869	24	46	1	1	NUM
aiua-12869	24	47	,	,	PUNCT
aiua-12869	24	48	2	2	NUM
aiua-12869	24	49	,	,	PUNCT
aiua-12869	24	50	giuseppe	giuseppe	PROPN
aiua-12869	24	51	di	di	PROPN
aiua-12869	24	52	paola	paola	PROPN
aiua-12869	24	53	1	1	NUM
aiua-12869	24	54	,	,	PUNCT
aiua-12869	24	55	attilio	attilio	PROPN
aiua-12869	24	56	l.	l.	PROPN
aiua-12869	24	57	meazza	meazza	PROPN
aiua-12869	24	58	1	1	NUM
aiua-12869	24	59	,	,	PUNCT
aiua-12869	24	60	mauro	mauro	PROPN
aiua-12869	24	61	seveso	seveso	VERB
aiua-12869	24	62	1	1	NUM
aiua-12869	24	63	1	1	NUM
aiua-12869	24	64	iccs	iccs	VERB
aiua-12869	24	65	istituto	istituto	PROPN
aiua-12869	24	66	clinico	clinico	PROPN
aiua-12869	24	67	città	città	PROPN
aiua-12869	24	68	studi	studi	PROPN
aiua-12869	24	69	,	,	PUNCT
aiua-12869	24	70	milan	milan	PROPN
aiua-12869	24	71	,	,	PUNCT
aiua-12869	24	72	italy	italy	PROPN
aiua-12869	24	73	;	;	PUNCT
aiua-12869	24	74	2	2	NUM
aiua-12869	24	75	humanitas	humanitas	NOUN
aiua-12869	24	76	university	university	NOUN
aiua-12869	24	77	,	,	PUNCT
aiua-12869	24	78	pieve	pieve	PROPN
aiua-12869	24	79	emanuele	emanuele	PROPN
aiua-12869	24	80	,	,	PUNCT
aiua-12869	24	81	milan	milan	PROPN
aiua-12869	24	82	,	,	PUNCT
aiua-12869	24	83	italy	italy	PROPN
aiua-12869	24	84	.	.	PUNCT
aiua-12869	25	1	doi	doi	PROPN
aiua-12869	25	2	:	:	PUNCT
aiua-12869	25	3	10.4081	10.4081	NUM
aiua-12869	25	4	/	/	SYM
aiua-12869	25	5	aiua.2024.12869	aiua.2024.12869	PROPN
aiua-12869	25	6	summary	summary	NOUN
aiua-12869	25	7	however	however	ADV
aiua-12869	25	8	,	,	PUNCT
aiua-12869	25	9	the	the	DET
aiua-12869	25	10	natural	natural	ADJ
aiua-12869	25	11	complex	complex	NOUN
aiua-12869	25	12	is	be	AUX
aiua-12869	25	13	a	a	DET
aiua-12869	25	14	product	product	NOUN
aiua-12869	25	15	with	with	ADP
aiua-12869	25	16	good	good	ADJ
aiua-12869	25	17	efficacy	efficacy	NOUN
aiua-12869	25	18	on	on	ADP
aiua-12869	25	19	the	the	DET
aiua-12869	25	20	phlogistic	phlogistic	ADJ
aiua-12869	25	21	component	component	NOUN
aiua-12869	25	22	and	and	CCONJ
aiua-12869	25	23	does	do	AUX
aiua-12869	25	24	not	not	PART
aiua-12869	25	25	have	have	VERB
aiua-12869	25	26	the	the	DET
aiua-12869	25	27	side	side	NOUN
aiua-12869	25	28	effects	effect	NOUN
aiua-12869	25	29	of	of	ADP
aiua-12869	25	30	dutasteride	dutasteride	NOUN
aiua-12869	25	31	(	(	PUNCT
aiua-12869	25	32	eg	eg	NOUN
aiua-12869	25	33	gynecomastia	gynecomastia	PROPN
aiua-12869	25	34	,	,	PUNCT
aiua-12869	25	35	reduced	reduce	VERB
aiua-12869	25	36	libido	libido	NOUN
aiua-12869	25	37	)	)	PUNCT
aiua-12869	25	38	.	.	PUNCT
aiua-12869	26	1	therefore	therefore	ADV
aiua-12869	26	2	,	,	PUNCT
aiua-12869	26	3	we	we	PRON
aiua-12869	26	4	believe	believe	VERB
aiua-12869	26	5	it	it	PRON
aiua-12869	26	6	can	can	AUX
aiua-12869	26	7	be	be	AUX
aiua-12869	26	8	used	use	VERB
aiua-12869	26	9	by	by	ADP
aiua-12869	26	10	a	a	DET
aiua-12869	26	11	large	large	ADJ
aiua-12869	26	12	part	part	NOUN
aiua-12869	26	13	of	of	ADP
aiua-12869	26	14	the	the	DET
aiua-12869	26	15	population	population	NOUN
aiua-12869	26	16	with	with	ADP
aiua-12869	26	17	bph	bph	NOUN
aiua-12869	26	18	,	,	PUNCT
aiua-12869	26	19	in	in	ADP
aiua-12869	26	20	order	order	NOUN
aiua-12869	26	21	to	to	PART
aiua-12869	26	22	reduce	reduce	VERB
aiua-12869	26	23	luts	luts	PROPN
aiua-12869	26	24	and	and	CCONJ
aiua-12869	26	25	psa	psa	VERB
aiua-12869	26	26	and	and	CCONJ
aiua-12869	26	27	improve	improve	VERB
aiua-12869	26	28	urinary	urinary	ADJ
aiua-12869	26	29	flow	flow	NOUN
aiua-12869	26	30	,	,	PUNCT
aiua-12869	26	31	without	without	ADP
aiua-12869	26	32	side	side	NOUN
aiua-12869	26	33	effects	effect	NOUN
aiua-12869	26	34	.	.	PUNCT
aiua-12869	27	1	key	key	ADJ
aiua-12869	27	2	words	word	NOUN
aiua-12869	27	3	:	:	PUNCT
aiua-12869	27	4	benign	benign	ADJ
aiua-12869	27	5	prostatic	prostatic	ADJ
aiua-12869	27	6	hyperplasia	hyperplasia	NOUN
aiua-12869	27	7	;	;	PUNCT
aiua-12869	27	8	lower	low	ADJ
aiua-12869	27	9	urinary	urinary	ADJ
aiua-12869	27	10	tract	tract	NOUN
aiua-12869	27	11	symptoms	symptom	NOUN
aiua-12869	27	12	;	;	PUNCT
aiua-12869	27	13	prostate	prostate	NOUN
aiua-12869	27	14	specific	specific	ADJ
aiua-12869	27	15	antigen	antigen	NOUN
aiua-12869	27	16	;	;	PUNCT
aiua-12869	27	17	prostate	prostate	NOUN
aiua-12869	27	18	volume	volume	NOUN
aiua-12869	27	19	;	;	PUNCT
aiua-12869	27	20	urinary	urinary	ADJ
aiua-12869	27	21	flow	flow	NOUN
aiua-12869	27	22	.	.	PUNCT
aiua-12869	27	23	submitted	submit	VERB
aiua-12869	27	24	5	5	NUM
aiua-12869	27	25	august	august	PROPN
aiua-12869	27	26	2024	2024	NUM
aiua-12869	27	27	;	;	PUNCT
aiua-12869	27	28	accepted	accept	VERB
aiua-12869	27	29	12	12	NUM
aiua-12869	27	30	september	september	PROPN
aiua-12869	27	31	2024	2024	NUM
aiua-12869	27	32	archivio	archivio	NOUN
aiua-12869	27	33	italiano	italiano	NOUN
aiua-12869	27	34	di	di	X
aiua-12869	27	35	urologia	urologia	PROPN
aiua-12869	27	36	e	e	PROPN
aiua-12869	27	37	andrologia	andrologia	NOUN
aiua-12869	27	38	2024	2024	NUM
aiua-12869	27	39	;	;	PUNCT
aiua-12869	27	40	96(3):12869	96(3):12869	NUM
aiua-12869	27	41	g.	g.	NOUN
aiua-12869	27	42	saitta	saitta	PROPN
aiua-12869	27	43	,	,	PUNCT
aiua-12869	27	44	f.a	f.a	PROPN
aiua-12869	27	45	.	.	PROPN
aiua-12869	27	46	mantovani	mantovani	PROPN
aiua-12869	27	47	,	,	PUNCT
aiua-12869	27	48	b.	b.	PROPN
aiua-12869	27	49	calabrese	calabrese	PROPN
aiua-12869	27	50	,	,	PUNCT
aiua-12869	27	51	et	et	PROPN
aiua-12869	27	52	al	al	PROPN
aiua-12869	27	53	.	.	PROPN
aiua-12869	27	54	2	2	NUM
aiua-12869	27	55	equally	equally	ADV
aiua-12869	27	56	effective	effective	ADJ
aiua-12869	27	57	compared	compare	VERB
aiua-12869	27	58	to	to	ADP
aiua-12869	27	59	the	the	DET
aiua-12869	27	60	alphablocker	alphablocker	ADJ
aiua-12869	27	61	tamsulosin	tamsulosin	NOUN
aiua-12869	27	62	for	for	ADP
aiua-12869	27	63	what	what	PRON
aiua-12869	27	64	concerns	concern	VERB
aiua-12869	27	65	the	the	DET
aiua-12869	27	66	improvements	improvement	NOUN
aiua-12869	27	67	on	on	ADP
aiua-12869	27	68	international	international	ADJ
aiua-12869	27	69	prostate	prostate	NOUN
aiua-12869	27	70	symptom	symptom	NOUN
aiua-12869	27	71	score	score	NOUN
aiua-12869	27	72	(	(	PUNCT
aiua-12869	27	73	ipss	ipss	PROPN
aiua-12869	27	74	)	)	PUNCT
aiua-12869	27	75	,	,	PUNCT
aiua-12869	27	76	quality	quality	NOUN
aiua-12869	27	77	of	of	ADP
aiua-12869	27	78	life	life	NOUN
aiua-12869	27	79	(	(	PUNCT
aiua-12869	27	80	qol	qol	NOUN
aiua-12869	27	81	)	)	PUNCT
aiua-12869	27	82	,	,	PUNCT
aiua-12869	27	83	maximum	maximum	ADJ
aiua-12869	27	84	urinary	urinary	ADJ
aiua-12869	27	85	flow	flow	NOUN
aiua-12869	27	86	rate	rate	NOUN
aiua-12869	27	87	,	,	PUNCT
aiua-12869	27	88	postvoid	postvoid	VERB
aiua-12869	27	89	residual	residual	ADJ
aiua-12869	27	90	volume	volume	NOUN
aiua-12869	27	91	and	and	CCONJ
aiua-12869	27	92	prostate	prostate	NOUN
aiua-12869	27	93	specific	specific	ADJ
aiua-12869	27	94	antigen	antigen	NOUN
aiua-12869	27	95	(	(	PUNCT
aiua-12869	27	96	psa	psa	NOUN
aiua-12869	27	97	)	)	PUNCT
aiua-12869	27	98	levels	level	NOUN
aiua-12869	27	99	(	(	PUNCT
aiua-12869	27	100	4	4	NUM
aiua-12869	27	101	,	,	PUNCT
aiua-12869	27	102	5	5	NUM
aiua-12869	27	103	)	)	PUNCT
aiua-12869	27	104	.	.	PUNCT
aiua-12869	28	1	combination	combination	NOUN
aiua-12869	28	2	therapy	therapy	NOUN
aiua-12869	28	3	of	of	ADP
aiua-12869	28	4	alpha	alpha	NOUN
aiua-12869	28	5	-	-	PUNCT
aiua-12869	28	6	blockers	blocker	NOUN
aiua-12869	28	7	and	and	CCONJ
aiua-12869	28	8	serenoa	serenoa	ADJ
aiua-12869	28	9	repens	repen	NOUN
aiua-12869	28	10	,	,	PUNCT
aiua-12869	28	11	furthermore	furthermore	ADV
aiua-12869	28	12	,	,	PUNCT
aiua-12869	28	13	proved	prove	VERB
aiua-12869	28	14	even	even	ADV
aiua-12869	28	15	more	more	ADV
aiua-12869	28	16	effective	effective	ADJ
aiua-12869	28	17	than	than	ADP
aiua-12869	28	18	monotherapy	monotherapy	NOUN
aiua-12869	28	19	(	(	PUNCT
aiua-12869	28	20	6	6	NUM
aiua-12869	28	21	)	)	PUNCT
aiua-12869	28	22	.	.	PUNCT
aiua-12869	29	1	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-12869	29	2	(	(	PUNCT
aiua-12869	29	3	pea	pea	NOUN
aiua-12869	29	4	)	)	PUNCT
aiua-12869	29	5	is	be	AUX
aiua-12869	29	6	an	an	DET
aiua-12869	29	7	endogenous	endogenous	ADJ
aiua-12869	29	8	fatty	fatty	NOUN
aiua-12869	29	9	acid	acid	NOUN
aiua-12869	29	10	amide	amide	NOUN
aiua-12869	29	11	-	-	PUNCT
aiua-12869	29	12	signaling	signal	VERB
aiua-12869	29	13	molecule	molecule	NOUN
aiua-12869	29	14	with	with	ADP
aiua-12869	29	15	anti	anti	ADJ
aiua-12869	29	16	-	-	ADJ
aiua-12869	29	17	inflammatory	inflammatory	ADJ
aiua-12869	29	18	and	and	CCONJ
aiua-12869	29	19	neuroprotective	neuroprotective	ADJ
aiua-12869	29	20	effects	effect	NOUN
aiua-12869	29	21	that	that	PRON
aiua-12869	29	22	has	have	VERB
aiua-12869	29	23	an	an	DET
aiua-12869	29	24	interesting	interesting	ADJ
aiua-12869	29	25	role	role	NOUN
aiua-12869	29	26	in	in	ADP
aiua-12869	29	27	the	the	DET
aiua-12869	29	28	management	management	NOUN
aiua-12869	29	29	of	of	ADP
aiua-12869	29	30	chronic	chronic	ADJ
aiua-12869	29	31	pelvic	pelvic	ADJ
aiua-12869	29	32	pain	pain	NOUN
aiua-12869	29	33	syndrome	syndrome	NOUN
aiua-12869	29	34	and	and	CCONJ
aiua-12869	29	35	chronic	chronic	ADJ
aiua-12869	29	36	urological	urological	ADJ
aiua-12869	29	37	pain	pain	NOUN
aiua-12869	29	38	(	(	PUNCT
aiua-12869	29	39	7	7	NUM
aiua-12869	29	40	)	)	PUNCT
aiua-12869	29	41	.	.	PUNCT
aiua-12869	30	1	pea	pea	NOUN
aiua-12869	30	2	exerts	exert	VERB
aiua-12869	30	3	its	its	PRON
aiua-12869	30	4	clinical	clinical	ADJ
aiua-12869	30	5	effects	effect	NOUN
aiua-12869	30	6	through	through	ADP
aiua-12869	30	7	different	different	ADJ
aiua-12869	30	8	mechanisms	mechanism	NOUN
aiua-12869	30	9	:	:	PUNCT
aiua-12869	30	10	the	the	DET
aiua-12869	30	11	down	down	ADJ
aiua-12869	30	12	-	-	PUNCT
aiua-12869	30	13	regulation	regulation	NOUN
aiua-12869	30	14	of	of	ADP
aiua-12869	30	15	mast	mast	NOUN
aiua-12869	30	16	cell	cell	NOUN
aiua-12869	30	17	activation	activation	NOUN
aiua-12869	30	18	;	;	PUNCT
aiua-12869	30	19	the	the	DET
aiua-12869	30	20	direct	direct	ADJ
aiua-12869	30	21	activation	activation	NOUN
aiua-12869	30	22	at	at	ADP
aiua-12869	30	23	least	least	ADV
aiua-12869	30	24	two	two	NUM
aiua-12869	30	25	different	different	ADJ
aiua-12869	30	26	receptors	receptor	NOUN
aiua-12869	30	27	:	:	PUNCT
aiua-12869	30	28	the	the	DET
aiua-12869	30	29	peroxisome	peroxisome	PROPN
aiua-12869	30	30	proliferator	proliferator	NOUN
aiua-12869	30	31	-	-	PUNCT
aiua-12869	30	32	activated	activate	VERB
aiua-12869	30	33	receptors	receptor	NOUN
aiua-12869	30	34	-	-	PUNCT
aiua-12869	30	35	alfa	alfa	NOUN
aiua-12869	30	36	(	(	PUNCT
aiua-12869	30	37	ppar	ppar	NOUN
aiua-12869	30	38	-	-	PUNCT
aiua-12869	30	39	α	α	NOUN
aiua-12869	30	40	)	)	PUNCT
aiua-12869	30	41	and	and	CCONJ
aiua-12869	30	42	the	the	DET
aiua-12869	30	43	orphan	orphan	NOUN
aiua-12869	30	44	g	g	NOUN
aiua-12869	30	45	-	-	PUNCT
aiua-12869	30	46	protein	protein	NOUN
aiua-12869	30	47	coupled	couple	VERB
aiua-12869	30	48	receptors	receptor	NOUN
aiua-12869	30	49	55	55	NUM
aiua-12869	30	50	(	(	PUNCT
aiua-12869	30	51	gpcr	gpcr	ADJ
aiua-12869	30	52	55	55	NUM
aiua-12869	30	53	):	):	PUNCT
aiua-12869	30	54	gpr55	gpr55	PROPN
aiua-12869	30	55	;	;	PUNCT
aiua-12869	30	56	more	more	ADV
aiua-12869	30	57	recently	recently	ADV
aiua-12869	30	58	,	,	PUNCT
aiua-12869	30	59	it	it	PRON
aiua-12869	30	60	has	have	AUX
aiua-12869	30	61	also	also	ADV
aiua-12869	30	62	been	be	AUX
aiua-12869	30	63	demonstrated	demonstrate	VERB
aiua-12869	30	64	that	that	SCONJ
aiua-12869	30	65	pea	pea	NOUN
aiua-12869	30	66	can	can	AUX
aiua-12869	30	67	activate	activate	VERB
aiua-12869	30	68	transient	transient	ADJ
aiua-12869	30	69	receptor	receptor	NOUN
aiua-12869	30	70	potential	potential	ADJ
aiua-12869	30	71	vanilloid	vanilloid	NOUN
aiua-12869	30	72	1	1	NUM
aiua-12869	30	73	(	(	PUNCT
aiua-12869	30	74	trpv1	trpv1	NOUN
aiua-12869	30	75	)	)	PUNCT
aiua-12869	30	76	channels	channel	NOUN
aiua-12869	30	77	or	or	CCONJ
aiua-12869	30	78	increase	increase	VERB
aiua-12869	30	79	the	the	DET
aiua-12869	30	80	expression	expression	NOUN
aiua-12869	30	81	of	of	ADP
aiua-12869	30	82	cannabinoid	cannabinoid	NOUN
aiua-12869	30	83	receptor	receptor	NOUN
aiua-12869	30	84	2	2	NUM
aiua-12869	30	85	(	(	PUNCT
aiua-12869	30	86	cb2	cb2	NOUN
aiua-12869	30	87	)	)	PUNCT
aiua-12869	30	88	receptors	receptor	NOUN
aiua-12869	30	89	,	,	PUNCT
aiua-12869	30	90	of	of	ADP
aiua-12869	30	91	which	which	PRON
aiua-12869	30	92	pea	pea	NOUN
aiua-12869	30	93	has	have	AUX
aiua-12869	30	94	been	be	AUX
aiua-12869	30	95	demonstrated	demonstrate	VERB
aiua-12869	30	96	to	to	PART
aiua-12869	30	97	be	be	AUX
aiua-12869	30	98	a	a	DET
aiua-12869	30	99	weak	weak	ADJ
aiua-12869	30	100	agonist	agonist	NOUN
aiua-12869	30	101	,	,	PUNCT
aiua-12869	30	102	via	via	ADP
aiua-12869	30	103	ppar	ppar	NOUN
aiua-12869	30	104	-	-	PUNCT
aiua-12869	30	105	α	α	NOUN
aiua-12869	30	106	receptors	receptor	NOUN
aiua-12869	30	107	.	.	PUNCT
aiua-12869	31	1	this	this	PRON
aiua-12869	31	2	results	result	VERB
aiua-12869	31	3	in	in	ADP
aiua-12869	31	4	a	a	DET
aiua-12869	31	5	neuroprotective	neuroprotective	ADJ
aiua-12869	31	6	and	and	CCONJ
aiua-12869	31	7	anti	anti	ADJ
aiua-12869	31	8	-	-	ADJ
aiua-12869	31	9	nociceptive	nociceptive	ADJ
aiua-12869	31	10	effect	effect	NOUN
aiua-12869	31	11	of	of	ADP
aiua-12869	31	12	pea	pea	NOUN
aiua-12869	31	13	,	,	PUNCT
aiua-12869	31	14	decreasing	decrease	VERB
aiua-12869	31	15	hyperalgesic	hyperalgesic	ADJ
aiua-12869	31	16	responses	response	NOUN
aiua-12869	31	17	in	in	ADP
aiua-12869	31	18	the	the	DET
aiua-12869	31	19	chronic	chronic	ADJ
aiua-12869	31	20	constriction	constriction	NOUN
aiua-12869	31	21	injury	injury	NOUN
aiua-12869	31	22	(	(	PUNCT
aiua-12869	31	23	cci	cci	NOUN
aiua-12869	31	24	)	)	PUNCT
aiua-12869	31	25	model	model	NOUN
aiua-12869	31	26	of	of	ADP
aiua-12869	31	27	neuropathic	neuropathic	ADJ
aiua-12869	31	28	pain	pain	NOUN
aiua-12869	31	29	(	(	PUNCT
aiua-12869	31	30	8	8	NUM
aiua-12869	31	31	,	,	PUNCT
aiua-12869	31	32	9	9	NUM
aiua-12869	31	33	)	)	PUNCT
aiua-12869	31	34	.	.	PUNCT
aiua-12869	32	1	in	in	ADP
aiua-12869	32	2	a	a	DET
aiua-12869	32	3	female	female	ADJ
aiua-12869	32	4	rat	rat	NOUN
aiua-12869	32	5	model	model	NOUN
aiua-12869	32	6	of	of	ADP
aiua-12869	32	7	cyclophosphamideinduced	cyclophosphamideinduced	ADJ
aiua-12869	32	8	cystitis	cystitis	NOUN
aiua-12869	32	9	,	,	PUNCT
aiua-12869	32	10	it	it	PRON
aiua-12869	32	11	has	have	AUX
aiua-12869	32	12	been	be	AUX
aiua-12869	32	13	reported	report	VERB
aiua-12869	32	14	that	that	SCONJ
aiua-12869	32	15	pain	pain	NOUN
aiua-12869	32	16	behavior	behavior	NOUN
aiua-12869	32	17	,	,	PUNCT
aiua-12869	32	18	bladder	bladder	NOUN
aiua-12869	32	19	inflammation	inflammation	NOUN
aiua-12869	32	20	and	and	CCONJ
aiua-12869	32	21	voiding	void	VERB
aiua-12869	32	22	dysfunction	dysfunction	NOUN
aiua-12869	32	23	were	be	AUX
aiua-12869	32	24	associated	associate	VERB
aiua-12869	32	25	with	with	ADP
aiua-12869	32	26	increased	increase	VERB
aiua-12869	32	27	bladder	bladder	NOUN
aiua-12869	32	28	levels	level	NOUN
aiua-12869	32	29	of	of	ADP
aiua-12869	32	30	pea	pea	NOUN
aiua-12869	32	31	,	,	PUNCT
aiua-12869	32	32	up	up	NOUN
aiua-12869	32	33	-	-	PUNCT
aiua-12869	32	34	regulation	regulation	NOUN
aiua-12869	32	35	of	of	ADP
aiua-12869	32	36	cannabinoid	cannabinoid	NOUN
aiua-12869	32	37	receptor	receptor	NOUN
aiua-12869	32	38	1	1	NUM
aiua-12869	32	39	(	(	PUNCT
aiua-12869	32	40	cb1	cb1	NOUN
aiua-12869	32	41	)	)	PUNCT
aiua-12869	32	42	receptor	receptor	NOUN
aiua-12869	32	43	expression	expression	NOUN
aiua-12869	32	44	and	and	CCONJ
aiua-12869	32	45	down	down	ADP
aiua-12869	32	46	-	-	PUNCT
aiua-12869	32	47	regulation	regulation	NOUN
aiua-12869	32	48	of	of	ADP
aiua-12869	32	49	ppar	ppar	NOUN
aiua-12869	32	50	-	-	PUNCT
aiua-12869	32	51	α	α	NOUN
aiua-12869	32	52	expression	expression	NOUN
aiua-12869	32	53	.	.	PUNCT
aiua-12869	33	1	oral	oral	ADJ
aiua-12869	33	2	administration	administration	NOUN
aiua-12869	33	3	of	of	ADP
aiua-12869	33	4	ultra	ultra	ADJ
aiua-12869	33	5	micronized	micronized	ADJ
aiua-12869	33	6	pea	pea	NOUN
aiua-12869	33	7	produced	produce	VERB
aiua-12869	33	8	both	both	CCONJ
aiua-12869	33	9	anti	anti	ADJ
aiua-12869	33	10	-	-	ADJ
aiua-12869	33	11	inflammatory	inflammatory	ADJ
aiua-12869	33	12	and	and	CCONJ
aiua-12869	33	13	analgesic	analgesic	ADJ
aiua-12869	33	14	effects	effect	NOUN
aiua-12869	33	15	(	(	PUNCT
aiua-12869	33	16	10	10	NUM
aiua-12869	33	17	)	)	PUNCT
aiua-12869	33	18	.	.	PUNCT
aiua-12869	34	1	such	such	ADJ
aiua-12869	34	2	results	result	NOUN
aiua-12869	34	3	suggest	suggest	VERB
aiua-12869	34	4	that	that	SCONJ
aiua-12869	34	5	pea	pea	NOUN
aiua-12869	34	6	could	could	AUX
aiua-12869	34	7	also	also	ADV
aiua-12869	34	8	be	be	AUX
aiua-12869	34	9	used	use	VERB
aiua-12869	34	10	in	in	ADP
aiua-12869	34	11	bph	bph	NOUN
aiua-12869	34	12	-	-	PUNCT
aiua-12869	34	13	related	relate	VERB
aiua-12869	34	14	voiding	void	VERB
aiua-12869	34	15	dysfunctions	dysfunction	NOUN
aiua-12869	34	16	and	and	CCONJ
aiua-12869	34	17	irritative	irritative	ADJ
aiua-12869	34	18	lower	low	ADJ
aiua-12869	34	19	urinary	urinary	ADJ
aiua-12869	34	20	tract	tract	NOUN
aiua-12869	34	21	symptoms	symptom	NOUN
aiua-12869	34	22	(	(	PUNCT
aiua-12869	34	23	luts	luts	PROPN
aiua-12869	34	24	)	)	PUNCT
aiua-12869	34	25	.	.	PUNCT
aiua-12869	35	1	in	in	ADP
aiua-12869	35	2	fact	fact	NOUN
aiua-12869	35	3	,	,	PUNCT
aiua-12869	35	4	d’amico	d’amico	PROPN
aiua-12869	35	5	et	et	PROPN
aiua-12869	35	6	al	al	PROPN
aiua-12869	35	7	.	.	PROPN
aiua-12869	35	8	demonstrated	demonstrate	VERB
aiua-12869	35	9	that	that	SCONJ
aiua-12869	35	10	daily	daily	ADJ
aiua-12869	35	11	administration	administration	NOUN
aiua-12869	35	12	of	of	ADP
aiua-12869	35	13	pea	pea	NOUN
aiua-12869	35	14	in	in	ADP
aiua-12869	35	15	bph	bph	NOUN
aiua-12869	35	16	-	-	PUNCT
aiua-12869	35	17	affected	affect	VERB
aiua-12869	35	18	rats	rat	NOUN
aiua-12869	35	19	considerably	considerably	ADV
aiua-12869	35	20	reduced	reduce	VERB
aiua-12869	35	21	the	the	DET
aiua-12869	35	22	levels	level	NOUN
aiua-12869	35	23	of	of	ADP
aiua-12869	35	24	testosterone	testosterone	NOUN
aiua-12869	35	25	and	and	CCONJ
aiua-12869	35	26	dihydroetestosterone	dihydroetestosterone	NOUN
aiua-12869	35	27	(	(	PUNCT
aiua-12869	35	28	dht	dht	NOUN
aiua-12869	35	29	)	)	PUNCT
aiua-12869	35	30	,	,	PUNCT
aiua-12869	35	31	main	main	ADJ
aiua-12869	35	32	characters	character	NOUN
aiua-12869	35	33	of	of	ADP
aiua-12869	35	34	bph	bph	NOUN
aiua-12869	35	35	.	.	PUNCT
aiua-12869	36	1	also	also	ADV
aiua-12869	36	2	,	,	PUNCT
aiua-12869	36	3	it	it	PRON
aiua-12869	36	4	substantially	substantially	ADV
aiua-12869	36	5	reduced	reduce	VERB
aiua-12869	36	6	5α	5α	NUM
aiua-12869	36	7	-	-	PUNCT
aiua-12869	36	8	reductase-2	reductase-2	NUM
aiua-12869	36	9	expression	expression	NOUN
aiua-12869	36	10	and	and	CCONJ
aiua-12869	36	11	obtained	obtain	VERB
aiua-12869	36	12	a	a	DET
aiua-12869	36	13	significant	significant	ADJ
aiua-12869	36	14	decrease	decrease	NOUN
aiua-12869	36	15	in	in	ADP
aiua-12869	36	16	tumor	tumor	NOUN
aiua-12869	36	17	growth	growth	NOUN
aiua-12869	36	18	factor	factor	NOUN
aiua-12869	36	19	-	-	PUNCT
aiua-12869	36	20	beta	beta	NOUN
aiua-12869	36	21	(	(	PUNCT
aiua-12869	36	22	tgf	tgf	PROPN
aiua-12869	36	23	-	-	PUNCT
aiua-12869	36	24	b	b	NOUN
aiua-12869	36	25	)	)	PUNCT
aiua-12869	36	26	expression	expression	NOUN
aiua-12869	36	27	,	,	PUNCT
aiua-12869	36	28	leading	lead	VERB
aiua-12869	36	29	to	to	ADP
aiua-12869	36	30	a	a	DET
aiua-12869	36	31	better	well	ADJ
aiua-12869	36	32	cellular	cellular	ADJ
aiua-12869	36	33	growth	growth	NOUN
aiua-12869	36	34	/	/	SYM
aiua-12869	36	35	apoptosis	apoptosis	NOUN
aiua-12869	36	36	ratio	ratio	NOUN
aiua-12869	36	37	(	(	PUNCT
aiua-12869	36	38	11	11	NUM
aiua-12869	36	39	)	)	PUNCT
aiua-12869	36	40	.	.	PUNCT
aiua-12869	37	1	phycocyanin	phycocyanin	INTJ
aiua-12869	37	2	(	(	PUNCT
aiua-12869	37	3	pc	pc	NOUN
aiua-12869	37	4	)	)	PUNCT
aiua-12869	37	5	is	be	AUX
aiua-12869	37	6	a	a	DET
aiua-12869	37	7	protein	protein	NOUN
aiua-12869	37	8	that	that	PRON
aiua-12869	37	9	derives	derive	VERB
aiua-12869	37	10	from	from	ADP
aiua-12869	37	11	spirulina	spirulina	NOUN
aiua-12869	37	12	.	.	PUNCT
aiua-12869	38	1	it	it	PRON
aiua-12869	38	2	has	have	AUX
aiua-12869	38	3	been	be	AUX
aiua-12869	38	4	widely	widely	ADV
aiua-12869	38	5	demonstrated	demonstrate	VERB
aiua-12869	38	6	that	that	SCONJ
aiua-12869	38	7	pc	pc	NOUN
aiua-12869	38	8	exerts	exert	VERB
aiua-12869	38	9	its	its	PRON
aiua-12869	38	10	antiinflammatory	antiinflammatory	NOUN
aiua-12869	38	11	and	and	CCONJ
aiua-12869	38	12	antioxidant	antioxidant	ADJ
aiua-12869	38	13	activity	activity	NOUN
aiua-12869	38	14	through	through	ADP
aiua-12869	38	15	the	the	DET
aiua-12869	38	16	inhibition	inhibition	NOUN
aiua-12869	38	17	of	of	ADP
aiua-12869	38	18	cyclooxygenase-2	cyclooxygenase-2	NUM
aiua-12869	38	19	(	(	PUNCT
aiua-12869	38	20	cox-2	cox-2	NOUN
aiua-12869	38	21	)	)	PUNCT
aiua-12869	38	22	enzymatic	enzymatic	ADJ
aiua-12869	38	23	activity	activity	NOUN
aiua-12869	38	24	.	.	PUNCT
aiua-12869	39	1	the	the	DET
aiua-12869	39	2	same	same	ADJ
aiua-12869	39	3	inhibitory	inhibitory	ADJ
aiua-12869	39	4	effect	effect	NOUN
aiua-12869	39	5	of	of	ADP
aiua-12869	39	6	cox-2	cox-2	NUM
aiua-12869	39	7	was	be	AUX
aiua-12869	39	8	observed	observe	VERB
aiua-12869	39	9	in	in	ADP
aiua-12869	39	10	the	the	DET
aiua-12869	39	11	model	model	NOUN
aiua-12869	39	12	of	of	ADP
aiua-12869	39	13	human	human	ADJ
aiua-12869	39	14	prostate	prostate	NOUN
aiua-12869	39	15	epithelial	epithelial	ADJ
aiua-12869	39	16	cells	cell	NOUN
aiua-12869	39	17	,	,	PUNCT
aiua-12869	39	18	in	in	ADP
aiua-12869	39	19	which	which	PRON
aiua-12869	39	20	pc	pc	NOUN
aiua-12869	39	21	also	also	ADV
aiua-12869	39	22	showed	show	VERB
aiua-12869	39	23	a	a	DET
aiua-12869	39	24	synergic	synergic	ADJ
aiua-12869	39	25	effect	effect	NOUN
aiua-12869	39	26	with	with	ADP
aiua-12869	39	27	pea	pea	NOUN
aiua-12869	39	28	by	by	ADP
aiua-12869	39	29	abating	abate	VERB
aiua-12869	39	30	the	the	DET
aiua-12869	39	31	synthesis	synthesis	NOUN
aiua-12869	39	32	of	of	ADP
aiua-12869	39	33	prostaglandin	prostaglandin	NOUN
aiua-12869	39	34	e2	e2	PROPN
aiua-12869	39	35	(	(	PUNCT
aiua-12869	39	36	pge2	pge2	PROPN
aiua-12869	39	37	)	)	PUNCT
aiua-12869	39	38	(	(	PUNCT
aiua-12869	39	39	12	12	NUM
aiua-12869	39	40	,	,	PUNCT
aiua-12869	39	41	13	13	NUM
aiua-12869	39	42	)	)	PUNCT
aiua-12869	39	43	.	.	PUNCT
aiua-12869	40	1	selenium	selenium	NOUN
aiua-12869	40	2	(	(	PUNCT
aiua-12869	40	3	se	se	ADJ
aiua-12869	40	4	)	)	PUNCT
aiua-12869	40	5	and	and	CCONJ
aiua-12869	40	6	tomato	tomato	NOUN
aiua-12869	40	7	extracts	extract	NOUN
aiua-12869	40	8	(	(	PUNCT
aiua-12869	40	9	te	te	INTJ
aiua-12869	40	10	)	)	PUNCT
aiua-12869	40	11	are	be	AUX
aiua-12869	40	12	important	important	ADJ
aiua-12869	40	13	trace	trace	NOUN
aiua-12869	40	14	elements	element	NOUN
aiua-12869	40	15	in	in	ADP
aiua-12869	40	16	health	health	NOUN
aiua-12869	40	17	,	,	PUNCT
aiua-12869	40	18	and	and	CCONJ
aiua-12869	40	19	their	their	PRON
aiua-12869	40	20	role	role	NOUN
aiua-12869	40	21	has	have	AUX
aiua-12869	40	22	been	be	AUX
aiua-12869	40	23	widely	widely	ADV
aiua-12869	40	24	evaluated	evaluate	VERB
aiua-12869	40	25	even	even	ADV
aiua-12869	40	26	for	for	ADP
aiua-12869	40	27	bph	bph	NOUN
aiua-12869	40	28	and	and	CCONJ
aiua-12869	40	29	prostate	prostate	NOUN
aiua-12869	40	30	cancer	cancer	NOUN
aiua-12869	40	31	.	.	PUNCT
aiua-12869	41	1	se	se	PROPN
aiua-12869	41	2	may	may	AUX
aiua-12869	41	3	be	be	AUX
aiua-12869	41	4	able	able	ADJ
aiua-12869	41	5	to	to	PART
aiua-12869	41	6	prevent	prevent	VERB
aiua-12869	41	7	,	,	PUNCT
aiua-12869	41	8	inhibit	inhibit	VERB
aiua-12869	41	9	or	or	CCONJ
aiua-12869	41	10	reverse	reverse	VERB
aiua-12869	41	11	the	the	DET
aiua-12869	41	12	transition	transition	NOUN
aiua-12869	41	13	of	of	ADP
aiua-12869	41	14	the	the	DET
aiua-12869	41	15	epithelial	epithelial	ADJ
aiua-12869	41	16	cells	cell	NOUN
aiua-12869	41	17	to	to	ADP
aiua-12869	41	18	the	the	DET
aiua-12869	41	19	mesenchymal	mesenchymal	ADJ
aiua-12869	41	20	phenotype	phenotype	NOUN
aiua-12869	41	21	.	.	PUNCT
aiua-12869	42	1	both	both	PRON
aiua-12869	42	2	se	se	X
aiua-12869	42	3	and	and	CCONJ
aiua-12869	42	4	te	te	AUX
aiua-12869	42	5	proved	prove	VERB
aiua-12869	42	6	to	to	PART
aiua-12869	42	7	modify	modify	VERB
aiua-12869	42	8	anatomopathological	anatomopathological	ADJ
aiua-12869	42	9	results	result	NOUN
aiua-12869	42	10	when	when	SCONJ
aiua-12869	42	11	comparing	compare	VERB
aiua-12869	42	12	a	a	DET
aiua-12869	42	13	hyperplastic	hyperplastic	ADJ
aiua-12869	42	14	hypertrophic	hypertrophic	ADJ
aiua-12869	42	15	prostate	prostate	NOUN
aiua-12869	42	16	treated	treat	VERB
aiua-12869	42	17	with	with	ADP
aiua-12869	42	18	both	both	DET
aiua-12869	42	19	elements	element	NOUN
aiua-12869	42	20	and	and	CCONJ
aiua-12869	42	21	a	a	DET
aiua-12869	42	22	healthy	healthy	ADJ
aiua-12869	42	23	one	one	NUM
aiua-12869	42	24	.	.	PUNCT
aiua-12869	43	1	in	in	ADP
aiua-12869	43	2	particular	particular	ADJ
aiua-12869	43	3	,	,	PUNCT
aiua-12869	43	4	mild	mild	ADJ
aiua-12869	43	5	hyperplasia	hyperplasia	NOUN
aiua-12869	43	6	with	with	ADP
aiua-12869	43	7	predominance	predominance	NOUN
aiua-12869	43	8	of	of	ADP
aiua-12869	43	9	no	no	DET
aiua-12869	43	10	presence	presence	NOUN
aiua-12869	43	11	of	of	ADP
aiua-12869	43	12	glandular	glandular	ADJ
aiua-12869	43	13	hyperplasia	hyperplasia	NOUN
aiua-12869	43	14	and	and	CCONJ
aiua-12869	43	15	stromal	stromal	ADJ
aiua-12869	43	16	restructuring	restructuring	NOUN
aiua-12869	43	17	and	and	CCONJ
aiua-12869	43	18	decrease	decrease	NOUN
aiua-12869	43	19	in	in	ADP
aiua-12869	43	20	the	the	DET
aiua-12869	43	21	thickness	thickness	NOUN
aiua-12869	43	22	of	of	ADP
aiua-12869	43	23	the	the	DET
aiua-12869	43	24	epithelium	epithelium	NOUN
aiua-12869	43	25	was	be	AUX
aiua-12869	43	26	observed	observe	VERB
aiua-12869	43	27	.	.	PUNCT
aiua-12869	44	1	furthermore	furthermore	ADV
aiua-12869	44	2	,	,	PUNCT
aiua-12869	44	3	the	the	DET
aiua-12869	44	4	combination	combination	NOUN
aiua-12869	44	5	on	on	ADP
aiua-12869	44	6	se	se	ADV
aiua-12869	44	7	and	and	CCONJ
aiua-12869	44	8	te	te	AUX
aiua-12869	44	9	proved	prove	VERB
aiua-12869	44	10	to	to	PART
aiua-12869	44	11	be	be	AUX
aiua-12869	44	12	synergic	synergic	ADJ
aiua-12869	44	13	.	.	PUNCT
aiua-12869	45	1	in	in	ADP
aiua-12869	45	2	the	the	DET
aiua-12869	45	3	oxidative	oxidative	ADJ
aiua-12869	45	4	stress	stress	NOUN
aiua-12869	45	5	markers	marker	NOUN
aiua-12869	45	6	of	of	ADP
aiua-12869	45	7	the	the	DET
aiua-12869	45	8	bph	bph	NOUN
aiua-12869	45	9	group	group	NOUN
aiua-12869	45	10	,	,	PUNCT
aiua-12869	45	11	there	there	PRON
aiua-12869	45	12	was	be	VERB
aiua-12869	45	13	a	a	DET
aiua-12869	45	14	significant	significant	ADJ
aiua-12869	45	15	increase	increase	NOUN
aiua-12869	45	16	in	in	ADP
aiua-12869	45	17	malondialdehyde	malondialdehyde	NOUN
aiua-12869	45	18	(	(	PUNCT
aiua-12869	45	19	mda	mda	PROPN
aiua-12869	45	20	)	)	PUNCT
aiua-12869	45	21	and	and	CCONJ
aiua-12869	45	22	nitrites	nitrite	NOUN
aiua-12869	45	23	(	(	PUNCT
aiua-12869	45	24	no2	no2	NOUN
aiua-12869	45	25	)	)	PUNCT
aiua-12869	45	26	with	with	ADP
aiua-12869	45	27	respect	respect	NOUN
aiua-12869	45	28	to	to	ADP
aiua-12869	45	29	the	the	DET
aiua-12869	45	30	control	control	NOUN
aiua-12869	45	31	group	group	NOUN
aiua-12869	45	32	.	.	PUNCT
aiua-12869	46	1	oral	oral	ADJ
aiua-12869	46	2	administration	administration	NOUN
aiua-12869	46	3	of	of	ADP
aiua-12869	46	4	se	se	PROPN
aiua-12869	46	5	and	and	CCONJ
aiua-12869	46	6	te	te	INTJ
aiua-12869	46	7	,	,	PUNCT
aiua-12869	46	8	especially	especially	ADV
aiua-12869	46	9	when	when	SCONJ
aiua-12869	46	10	combined	combine	VERB
aiua-12869	46	11	,	,	PUNCT
aiua-12869	46	12	proved	prove	VERB
aiua-12869	46	13	to	to	PART
aiua-12869	46	14	significantly	significantly	ADV
aiua-12869	46	15	decrease	decrease	VERB
aiua-12869	46	16	the	the	DET
aiua-12869	46	17	levels	level	NOUN
aiua-12869	46	18	of	of	ADP
aiua-12869	46	19	those	those	DET
aiua-12869	46	20	markers	marker	NOUN
aiua-12869	46	21	,	,	PUNCT
aiua-12869	46	22	thus	thus	ADV
aiua-12869	46	23	showing	show	VERB
aiua-12869	46	24	an	an	DET
aiua-12869	46	25	antioxidant	antioxidant	ADJ
aiua-12869	46	26	effect	effect	NOUN
aiua-12869	46	27	(	(	PUNCT
aiua-12869	46	28	14	14	NUM
aiua-12869	46	29	,	,	PUNCT
aiua-12869	46	30	15	15	NUM
aiua-12869	46	31	)	)	PUNCT
aiua-12869	46	32	.	.	PUNCT
aiua-12869	47	1	the	the	DET
aiua-12869	47	2	aim	aim	NOUN
aiua-12869	47	3	of	of	ADP
aiua-12869	47	4	our	our	PRON
aiua-12869	47	5	study	study	NOUN
aiua-12869	47	6	was	be	AUX
aiua-12869	47	7	to	to	PART
aiua-12869	47	8	compare	compare	VERB
aiua-12869	47	9	two	two	NUM
aiua-12869	47	10	groups	group	NOUN
aiua-12869	47	11	of	of	ADP
aiua-12869	47	12	patients	patient	NOUN
aiua-12869	47	13	affected	affect	VERB
aiua-12869	47	14	by	by	ADP
aiua-12869	47	15	bph	bph	NOUN
aiua-12869	47	16	:	:	PUNCT
aiua-12869	47	17	the	the	DET
aiua-12869	47	18	first	first	ADJ
aiua-12869	47	19	was	be	AUX
aiua-12869	47	20	treated	treat	VERB
aiua-12869	47	21	with	with	ADP
aiua-12869	47	22	the	the	DET
aiua-12869	47	23	5ari	5ari	ADJ
aiua-12869	47	24	dutasteride	dutasteride	NOUN
aiua-12869	47	25	,	,	PUNCT
aiua-12869	47	26	the	the	DET
aiua-12869	47	27	second	second	ADJ
aiua-12869	47	28	,	,	PUNCT
aiua-12869	47	29	instead	instead	ADV
aiua-12869	47	30	,	,	PUNCT
aiua-12869	47	31	with	with	ADP
aiua-12869	47	32	a	a	DET
aiua-12869	47	33	combination	combination	NOUN
aiua-12869	47	34	of	of	ADP
aiua-12869	47	35	nutraceuticals	nutraceutical	NOUN
aiua-12869	47	36	:	:	PUNCT
aiua-12869	47	37	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-12869	47	38	(	(	PUNCT
aiua-12869	47	39	200	200	NUM
aiua-12869	47	40	mg	mg	NOUN
aiua-12869	47	41	)	)	PUNCT
aiua-12869	47	42	,	,	PUNCT
aiua-12869	47	43	phycocianin	phycocianin	PROPN
aiua-12869	47	44	(	(	PUNCT
aiua-12869	47	45	250	250	NUM
aiua-12869	47	46	mg	mg	NUM
aiua-12869	47	47	)	)	PUNCT
aiua-12869	47	48	and	and	CCONJ
aiua-12869	47	49	selenium	selenium	NOUN
aiua-12869	47	50	(	(	PUNCT
aiua-12869	47	51	55	55	NUM
aiua-12869	47	52	mcg	mcg	NOUN
aiua-12869	47	53	)	)	PUNCT
aiua-12869	47	54	.	.	PUNCT
aiua-12869	48	1	although	although	SCONJ
aiua-12869	48	2	synergic	synergic	ADJ
aiua-12869	48	3	effects	effect	NOUN
aiua-12869	48	4	between	between	ADP
aiua-12869	48	5	such	such	ADJ
aiua-12869	48	6	elements	element	NOUN
aiua-12869	48	7	have	have	AUX
aiua-12869	48	8	been	be	AUX
aiua-12869	48	9	hypothesized	hypothesize	VERB
aiua-12869	48	10	and	and	CCONJ
aiua-12869	48	11	,	,	PUNCT
aiua-12869	48	12	to	to	ADP
aiua-12869	48	13	some	some	DET
aiua-12869	48	14	extent	extent	NOUN
aiua-12869	48	15	,	,	PUNCT
aiua-12869	48	16	demonstrated	demonstrate	VERB
aiua-12869	48	17	,	,	PUNCT
aiua-12869	48	18	our	our	PRON
aiua-12869	48	19	aim	aim	NOUN
aiua-12869	48	20	is	be	AUX
aiua-12869	48	21	to	to	PART
aiua-12869	48	22	contribute	contribute	VERB
aiua-12869	48	23	to	to	ADP
aiua-12869	48	24	the	the	DET
aiua-12869	48	25	present	present	ADJ
aiua-12869	48	26	literature	literature	NOUN
aiua-12869	48	27	by	by	ADP
aiua-12869	48	28	describing	describe	VERB
aiua-12869	48	29	the	the	DET
aiua-12869	48	30	results	result	NOUN
aiua-12869	48	31	in	in	ADP
aiua-12869	48	32	this	this	DET
aiua-12869	48	33	cohort	cohort	NOUN
aiua-12869	48	34	of	of	ADP
aiua-12869	48	35	patients	patient	NOUN
aiua-12869	48	36	.	.	PUNCT
aiua-12869	49	1	material	material	NOUN
aiua-12869	49	2	and	and	CCONJ
aiua-12869	49	3	methods	method	NOUN
aiua-12869	49	4	we	we	PRON
aiua-12869	49	5	included	include	VERB
aiua-12869	49	6	in	in	ADP
aiua-12869	49	7	the	the	DET
aiua-12869	49	8	study	study	NOUN
aiua-12869	49	9	104	104	NUM
aiua-12869	49	10	patients	patient	NOUN
aiua-12869	49	11	who	who	PRON
aiua-12869	49	12	presented	present	VERB
aiua-12869	49	13	to	to	ADP
aiua-12869	49	14	the	the	DET
aiua-12869	49	15	istituto	istituto	NOUN
aiua-12869	49	16	clinico	clinico	PROPN
aiua-12869	49	17	città	città	PROPN
aiua-12869	49	18	studi	studi	PROPN
aiua-12869	49	19	(	(	PUNCT
aiua-12869	49	20	iccs	iccs	PROPN
aiua-12869	49	21	)	)	PUNCT
aiua-12869	49	22	in	in	ADP
aiua-12869	49	23	milan	milan	PROPN
aiua-12869	49	24	,	,	PUNCT
aiua-12869	49	25	italy	italy	PROPN
aiua-12869	49	26	,	,	PUNCT
aiua-12869	49	27	complaining	complain	VERB
aiua-12869	49	28	of	of	ADP
aiua-12869	49	29	symptoms	symptom	NOUN
aiua-12869	49	30	related	relate	VERB
aiua-12869	49	31	to	to	ADP
aiua-12869	49	32	bph	bph	NOUN
aiua-12869	49	33	.	.	PUNCT
aiua-12869	50	1	all	all	DET
aiua-12869	50	2	patients	patient	NOUN
aiua-12869	50	3	were	be	AUX
aiua-12869	50	4	aged	age	VERB
aiua-12869	50	5	between	between	ADP
aiua-12869	50	6	50	50	NUM
aiua-12869	50	7	and	and	CCONJ
aiua-12869	50	8	70	70	NUM
aiua-12869	50	9	years	year	NOUN
aiua-12869	50	10	,	,	PUNCT
aiua-12869	50	11	with	with	ADP
aiua-12869	50	12	prostate	prostate	NOUN
aiua-12869	50	13	specific	specific	ADJ
aiua-12869	50	14	antigen	antigen	NOUN
aiua-12869	50	15	(	(	PUNCT
aiua-12869	50	16	psa	psa	NOUN
aiua-12869	50	17	)	)	PUNCT
aiua-12869	50	18	values	value	NOUN
aiua-12869	50	19	between	between	ADP
aiua-12869	50	20	4	4	NUM
aiua-12869	50	21	and	and	CCONJ
aiua-12869	50	22	10	10	NUM
aiua-12869	50	23	ng	ng	PROPN
aiua-12869	50	24	/	/	SYM
aiua-12869	50	25	ml	ml	PROPN
aiua-12869	50	26	,	,	PUNCT
aiua-12869	50	27	prostate	prostate	NOUN
aiua-12869	50	28	volume	volume	NOUN
aiua-12869	50	29	,	,	PUNCT
aiua-12869	50	30	calculated	calculate	VERB
aiua-12869	50	31	through	through	ADP
aiua-12869	50	32	transrectal	transrectal	ADJ
aiua-12869	50	33	ultrasound	ultrasound	NOUN
aiua-12869	50	34	(	(	PUNCT
aiua-12869	50	35	trus	trus	NOUN
aiua-12869	50	36	)	)	PUNCT
aiua-12869	50	37	,	,	PUNCT
aiua-12869	50	38	between	between	ADP
aiua-12869	50	39	50	50	NUM
aiua-12869	50	40	and	and	CCONJ
aiua-12869	50	41	70	70	NUM
aiua-12869	50	42	ml	ml	NOUN
aiua-12869	50	43	,	,	PUNCT
aiua-12869	50	44	a	a	DET
aiua-12869	50	45	maximum	maximum	ADJ
aiua-12869	50	46	flow	flow	NOUN
aiua-12869	50	47	of	of	ADP
aiua-12869	50	48	urine	urine	NOUN
aiua-12869	50	49	value	value	NOUN
aiua-12869	50	50	greater	great	ADJ
aiua-12869	50	51	than	than	ADP
aiua-12869	50	52	or	or	CCONJ
aiua-12869	50	53	equal	equal	ADJ
aiua-12869	50	54	(	(	PUNCT
aiua-12869	50	55	4	4	NUM
aiua-12869	50	56	)	)	PUNCT
aiua-12869	50	57	to	to	ADP
aiua-12869	50	58	10	10	NUM
aiua-12869	50	59	ml	ml	NOUN
aiua-12869	50	60	/	/	SYM
aiua-12869	50	61	s	s	NOUN
aiua-12869	50	62	at	at	ADP
aiua-12869	50	63	uroflowmetry	uroflowmetry	NOUN
aiua-12869	50	64	,	,	PUNCT
aiua-12869	50	65	no	no	DET
aiua-12869	50	66	suspicious	suspicious	ADJ
aiua-12869	50	67	nodules	nodule	NOUN
aiua-12869	50	68	on	on	ADP
aiua-12869	50	69	digital	digital	ADJ
aiua-12869	50	70	rectal	rectal	ADJ
aiua-12869	50	71	examination	examination	NOUN
aiua-12869	50	72	(	(	PUNCT
aiua-12869	50	73	dre	dre	PROPN
aiua-12869	50	74	)	)	PUNCT
aiua-12869	50	75	,	,	PUNCT
aiua-12869	50	76	no	no	DET
aiua-12869	50	77	suspicious	suspicious	ADJ
aiua-12869	50	78	lesions	lesion	NOUN
aiua-12869	50	79	on	on	ADP
aiua-12869	50	80	mri	mri	NOUN
aiua-12869	50	81	(	(	PUNCT
aiua-12869	50	82	prostate	prostate	NOUN
aiua-12869	50	83	imaging	imaging	NOUN
aiua-12869	50	84	reporting	reporting	NOUN
aiua-12869	50	85	and	and	CCONJ
aiua-12869	50	86	data	datum	NOUN
aiua-12869	50	87	system	system	NOUN
aiua-12869	50	88	score	score	NOUN
aiua-12869	50	89	:	:	PUNCT
aiua-12869	50	90	1	1	NUM
aiua-12869	50	91	-	-	SYM
aiua-12869	50	92	2	2	NUM
aiua-12869	50	93	)	)	PUNCT
aiua-12869	50	94	,	,	PUNCT
aiua-12869	50	95	negative	negative	ADJ
aiua-12869	50	96	previous	previous	ADJ
aiua-12869	50	97	prostatic	prostatic	ADJ
aiua-12869	50	98	biopsies	biopsy	NOUN
aiua-12869	50	99	or	or	CCONJ
aiua-12869	50	100	never	never	ADV
aiua-12869	50	101	biopsied	biopsie	VERB
aiua-12869	50	102	.	.	PUNCT
aiua-12869	51	1	patients	patient	NOUN
aiua-12869	51	2	with	with	ADP
aiua-12869	51	3	diabetes	diabetes	NOUN
aiua-12869	51	4	mellitus	mellitus	NOUN
aiua-12869	51	5	or	or	CCONJ
aiua-12869	51	6	chronic	chronic	ADJ
aiua-12869	51	7	renal	renal	ADJ
aiua-12869	51	8	failure	failure	NOUN
aiua-12869	51	9	were	be	AUX
aiua-12869	51	10	excluded	exclude	VERB
aiua-12869	51	11	.	.	PUNCT
aiua-12869	52	1	we	we	PRON
aiua-12869	52	2	divided	divide	VERB
aiua-12869	52	3	our	our	PRON
aiua-12869	52	4	patients	patient	NOUN
aiua-12869	52	5	into	into	ADP
aiua-12869	52	6	two	two	NUM
aiua-12869	52	7	groups	group	NOUN
aiua-12869	52	8	:	:	PUNCT
aiua-12869	52	9	group	group	NOUN
aiua-12869	52	10	a	a	DET
aiua-12869	52	11	including	include	VERB
aiua-12869	52	12	54	54	NUM
aiua-12869	52	13	men	man	NOUN
aiua-12869	52	14	who	who	PRON
aiua-12869	52	15	were	be	AUX
aiua-12869	52	16	treated	treat	VERB
aiua-12869	52	17	using	use	VERB
aiua-12869	52	18	a	a	DET
aiua-12869	52	19	complex	complex	ADJ
aiua-12869	52	20	containing	contain	VERB
aiua-12869	52	21	phycocyanin	phycocyanin	NOUN
aiua-12869	52	22	,	,	PUNCT
aiua-12869	52	23	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-12869	52	24	and	and	CCONJ
aiua-12869	52	25	selenium	selenium	NOUN
aiua-12869	52	26	[	[	X
aiua-12869	52	27	ficoxpea	ficoxpea	NOUN
aiua-12869	52	28	(	(	PUNCT
aiua-12869	52	29	f	f	NOUN
aiua-12869	52	30	)	)	PUNCT
aiua-12869	52	31	,	,	PUNCT
aiua-12869	52	32	by	by	ADP
aiua-12869	52	33	kura	kura	PROPN
aiua-12869	52	34	®	®	PROPN
aiua-12869	52	35	]	]	PUNCT
aiua-12869	52	36	,	,	PUNCT
aiua-12869	52	37	and	and	CCONJ
aiua-12869	52	38	group	group	NOUN
aiua-12869	52	39	b	b	PROPN
aiua-12869	52	40	including	include	VERB
aiua-12869	52	41	50	50	NUM
aiua-12869	52	42	men	man	NOUN
aiua-12869	52	43	who	who	PRON
aiua-12869	52	44	were	be	AUX
aiua-12869	52	45	treated	treat	VERB
aiua-12869	52	46	using	use	VERB
aiua-12869	52	47	dutasteride	dutasteride	NOUN
aiua-12869	52	48	alone	alone	ADV
aiua-12869	52	49	(	(	PUNCT
aiua-12869	52	50	d	d	NOUN
aiua-12869	52	51	)	)	PUNCT
aiua-12869	52	52	.	.	PUNCT
aiua-12869	53	1	we	we	PRON
aiua-12869	53	2	re	re	VERB
aiua-12869	53	3	-	-	VERB
aiua-12869	53	4	evaluated	evaluate	VERB
aiua-12869	53	5	all	all	DET
aiua-12869	53	6	patients	patient	NOUN
aiua-12869	53	7	after	after	ADP
aiua-12869	53	8	6	6	NUM
aiua-12869	53	9	months	month	NOUN
aiua-12869	53	10	of	of	ADP
aiua-12869	53	11	therapy	therapy	NOUN
aiua-12869	53	12	,	,	PUNCT
aiua-12869	53	13	considering	consider	VERB
aiua-12869	53	14	the	the	DET
aiua-12869	53	15	following	follow	VERB
aiua-12869	53	16	parameters	parameter	NOUN
aiua-12869	53	17	:	:	PUNCT
aiua-12869	53	18	psa	psa	NOUN
aiua-12869	53	19	levels	level	NOUN
aiua-12869	53	20	,	,	PUNCT
aiua-12869	53	21	uroflowmetry	uroflowmetry	NOUN
aiua-12869	53	22	(	(	PUNCT
aiua-12869	53	23	ufm	ufm	PROPN
aiua-12869	53	24	)	)	PUNCT
aiua-12869	53	25	,	,	PUNCT
aiua-12869	53	26	prostate	prostate	NOUN
aiua-12869	53	27	volume	volume	NOUN
aiua-12869	53	28	.	.	PUNCT
aiua-12869	54	1	statistical	statistical	ADJ
aiua-12869	54	2	analysis	analysis	NOUN
aiua-12869	54	3	data	datum	NOUN
aiua-12869	54	4	were	be	AUX
aiua-12869	54	5	collected	collect	VERB
aiua-12869	54	6	using	use	VERB
aiua-12869	54	7	microsoft	microsoft	PROPN
aiua-12869	54	8	excel	excel	PROPN
aiua-12869	54	9	(	(	PUNCT
aiua-12869	54	10	v.	v.	NOUN
aiua-12869	54	11	12.2.4	12.2.4	NUM
aiua-12869	54	12	)	)	PUNCT
aiua-12869	54	13	and	and	CCONJ
aiua-12869	54	14	analyzed	analyze	VERB
aiua-12869	54	15	using	use	VERB
aiua-12869	54	16	the	the	DET
aiua-12869	54	17	spss	spss	PROPN
aiua-12869	54	18	statistics	statistic	NOUN
aiua-12869	54	19	v.29	v.29	PROPN
aiua-12869	54	20	software	software	NOUN
aiua-12869	54	21	(	(	PUNCT
aiua-12869	54	22	ibm	ibm	PROPN
aiua-12869	54	23	corporation	corporation	PROPN
aiua-12869	54	24	new	new	PROPN
aiua-12869	54	25	york	york	PROPN
aiua-12869	54	26	,	,	PUNCT
aiua-12869	54	27	usa	usa	PROPN
aiua-12869	54	28	)	)	PUNCT
aiua-12869	54	29	.	.	PUNCT
aiua-12869	55	1	statistical	statistical	ADJ
aiua-12869	55	2	analysis	analysis	NOUN
aiua-12869	55	3	of	of	ADP
aiua-12869	55	4	data	datum	NOUN
aiua-12869	55	5	was	be	AUX
aiua-12869	55	6	performed	perform	VERB
aiua-12869	55	7	using	use	VERB
aiua-12869	55	8	anova	anova	PROPN
aiua-12869	55	9	test	test	NOUN
aiua-12869	55	10	with	with	ADP
aiua-12869	55	11	tukey	tukey	PROPN
aiua-12869	55	12	’s	’s	PART
aiua-12869	55	13	post	post	ADJ
aiua-12869	55	14	-	-	ADJ
aiua-12869	55	15	hoc	hoc	ADJ
aiua-12869	55	16	correction	correction	NOUN
aiua-12869	55	17	.	.	PUNCT
aiua-12869	56	1	p	p	NOUN
aiua-12869	56	2	values	value	NOUN
aiua-12869	56	3	<	<	X
aiua-12869	56	4	0.05	0.05	NUM
aiua-12869	56	5	were	be	AUX
aiua-12869	56	6	considered	consider	VERB
aiua-12869	56	7	significant	significant	ADJ
aiua-12869	56	8	.	.	PUNCT
aiua-12869	57	1	all	all	DET
aiua-12869	57	2	data	datum	NOUN
aiua-12869	57	3	are	be	AUX
aiua-12869	57	4	expressed	express	VERB
aiua-12869	57	5	as	as	ADP
aiua-12869	57	6	mean	mean	NOUN
aiua-12869	57	7	±	±	NUM
aiua-12869	57	8	structural	structural	ADJ
aiua-12869	57	9	equation	equation	NOUN
aiua-12869	57	10	models	model	NOUN
aiua-12869	57	11	(	(	PUNCT
aiua-12869	57	12	sem	sem	NOUN
aiua-12869	57	13	)	)	PUNCT
aiua-12869	57	14	.	.	PUNCT
aiua-12869	58	1	results	result	VERB
aiua-12869	58	2	our	our	PRON
aiua-12869	58	3	results	result	NOUN
aiua-12869	58	4	showed	show	VERB
aiua-12869	58	5	a	a	DET
aiua-12869	58	6	significant	significant	ADJ
aiua-12869	58	7	decrease	decrease	NOUN
aiua-12869	58	8	in	in	ADP
aiua-12869	58	9	psa	psa	NOUN
aiua-12869	58	10	value	value	NOUN
aiua-12869	58	11	both	both	PRON
aiua-12869	58	12	for	for	ADP
aiua-12869	58	13	the	the	DET
aiua-12869	58	14	dutasteride	dutasteride	NOUN
aiua-12869	58	15	(	(	PUNCT
aiua-12869	58	16	-2.743	-2.743	PUNCT
aiua-12869	58	17	ng	ng	NOUN
aiua-12869	58	18	/	/	SYM
aiua-12869	59	1	ml	ml	NOUN
aiua-12869	59	2	after	after	ADP
aiua-12869	59	3	6	6	NUM
aiua-12869	59	4	months	month	NOUN
aiua-12869	59	5	of	of	ADP
aiua-12869	59	6	treatment	treatment	NOUN
aiua-12869	59	7	)	)	PUNCT
aiua-12869	59	8	and	and	CCONJ
aiua-12869	59	9	phytochemicals	phytochemical	NOUN
aiua-12869	59	10	complex	complex	ADJ
aiua-12869	59	11	(	(	PUNCT
aiua-12869	59	12	-0.9712	-0.9712	NOUN
aiua-12869	59	13	ng	ng	PROPN
aiua-12869	59	14	/	/	SYM
aiua-12869	59	15	ml	ml	NOUN
aiua-12869	59	16	after	after	ADP
aiua-12869	59	17	6	6	NUM
aiua-12869	59	18	months	month	NOUN
aiua-12869	59	19	of	of	ADP
aiua-12869	59	20	treatment	treatment	NOUN
aiua-12869	59	21	)	)	PUNCT
aiua-12869	59	22	groups	group	NOUN
aiua-12869	59	23	(	(	PUNCT
aiua-12869	59	24	figure	figure	NOUN
aiua-12869	59	25	1	1	NUM
aiua-12869	59	26	)	)	PUNCT
aiua-12869	59	27	.	.	PUNCT
aiua-12869	60	1	there	there	PRON
aiua-12869	60	2	was	be	VERB
aiua-12869	60	3	a	a	DET
aiua-12869	60	4	significant	significant	ADJ
aiua-12869	60	5	difference	difference	NOUN
aiua-12869	60	6	among	among	ADP
aiua-12869	60	7	the	the	DET
aiua-12869	60	8	psa	psa	NOUN
aiua-12869	60	9	values	value	NOUN
aiua-12869	60	10	between	between	ADP
aiua-12869	60	11	the	the	DET
aiua-12869	60	12	two	two	NUM
aiua-12869	60	13	groups	group	NOUN
aiua-12869	60	14	after	after	ADP
aiua-12869	60	15	6	6	NUM
aiua-12869	60	16	months	month	NOUN
aiua-12869	60	17	of	of	ADP
aiua-12869	60	18	treatment	treatment	NOUN
aiua-12869	60	19	(	(	PUNCT
aiua-12869	60	20	+1.865	+1.865	ADJ
aiua-12869	60	21	ng	ng	PROPN
aiua-12869	60	22	/	/	SYM
aiua-12869	60	23	ml	ml	NOUN
aiua-12869	60	24	higher	high	ADJ
aiua-12869	60	25	for	for	ADP
aiua-12869	60	26	the	the	DET
aiua-12869	60	27	phytochemicals	phytochemical	NOUN
aiua-12869	60	28	complex	complex	ADJ
aiua-12869	60	29	group	group	NOUN
aiua-12869	60	30	)	)	PUNCT
aiua-12869	60	31	(	(	PUNCT
aiua-12869	60	32	figure	figure	NOUN
aiua-12869	60	33	1	1	NUM
aiua-12869	60	34	)	)	PUNCT
aiua-12869	60	35	.	.	PUNCT
aiua-12869	61	1	regarding	regard	VERB
aiua-12869	61	2	ufm	ufm	PROPN
aiua-12869	61	3	,	,	PUNCT
aiua-12869	61	4	there	there	PRON
aiua-12869	61	5	was	be	VERB
aiua-12869	61	6	a	a	DET
aiua-12869	61	7	slight	slight	ADJ
aiua-12869	61	8	but	but	CCONJ
aiua-12869	61	9	significant	significant	ADJ
aiua-12869	61	10	increase	increase	NOUN
aiua-12869	61	11	in	in	ADP
aiua-12869	61	12	the	the	DET
aiua-12869	61	13	flow	flow	NOUN
aiua-12869	61	14	of	of	ADP
aiua-12869	61	15	urine	urine	NOUN
aiua-12869	61	16	(	(	PUNCT
aiua-12869	61	17	ml	ml	NOUN
aiua-12869	61	18	/	/	SYM
aiua-12869	61	19	s	s	NOUN
aiua-12869	61	20	)	)	PUNCT
aiua-12869	61	21	for	for	ADP
aiua-12869	61	22	the	the	DET
aiua-12869	61	23	dutasteride	dutasteride	PROPN
aiua-12869	61	24	group	group	NOUN
aiua-12869	61	25	(	(	PUNCT
aiua-12869	61	26	mean	mean	INTJ
aiua-12869	61	27	increase	increase	NOUN
aiua-12869	61	28	of	of	ADP
aiua-12869	61	29	+3.029	+3.029	NOUN
aiua-12869	61	30	ml	ml	PROPN
aiua-12869	61	31	/	/	SYM
aiua-12869	61	32	s	s	NOUN
aiua-12869	61	33	after	after	ADP
aiua-12869	61	34	6	6	NUM
aiua-12869	61	35	months	month	NOUN
aiua-12869	61	36	of	of	ADP
aiua-12869	61	37	treatarchivio	treatarchivio	NOUN
aiua-12869	61	38	italiano	italiano	NOUN
aiua-12869	61	39	di	di	X
aiua-12869	61	40	urologia	urologia	PROPN
aiua-12869	61	41	e	e	PROPN
aiua-12869	61	42	andrologia	andrologia	NOUN
aiua-12869	61	43	2024	2024	NUM
aiua-12869	61	44	;	;	PUNCT
aiua-12869	61	45	96(3):12869	96(3):12869	NUM
aiua-12869	61	46	3	3	NUM
aiua-12869	61	47	phytochemicals	phytochemical	NOUN
aiua-12869	61	48	versus	versus	ADP
aiua-12869	61	49	dutasteride	dutasteride	NOUN
aiua-12869	61	50	for	for	ADP
aiua-12869	61	51	luts	luts	PROPN
aiua-12869	61	52	due	due	ADP
aiua-12869	61	53	to	to	ADP
aiua-12869	61	54	bph	bph	NOUN
aiua-12869	61	55	ment	ment	NOUN
aiua-12869	61	56	)	)	PUNCT
aiua-12869	61	57	.	.	PUNCT
aiua-12869	62	1	the	the	DET
aiua-12869	62	2	phytochemicals	phytochemical	NOUN
aiua-12869	62	3	complex	complex	ADJ
aiua-12869	62	4	group	group	NOUN
aiua-12869	62	5	,	,	PUNCT
aiua-12869	62	6	on	on	ADP
aiua-12869	62	7	the	the	DET
aiua-12869	62	8	other	other	ADJ
aiua-12869	62	9	hand	hand	NOUN
aiua-12869	62	10	,	,	PUNCT
aiua-12869	62	11	showed	show	VERB
aiua-12869	62	12	a	a	DET
aiua-12869	62	13	greater	great	ADJ
aiua-12869	62	14	improvement	improvement	NOUN
aiua-12869	62	15	after	after	ADP
aiua-12869	62	16	the	the	DET
aiua-12869	62	17	administration	administration	NOUN
aiua-12869	62	18	of	of	ADP
aiua-12869	62	19	the	the	DET
aiua-12869	62	20	complex	complex	NOUN
aiua-12869	62	21	with	with	ADP
aiua-12869	62	22	a	a	DET
aiua-12869	62	23	mean	mean	ADJ
aiua-12869	62	24	increase	increase	NOUN
aiua-12869	62	25	of	of	ADP
aiua-12869	62	26	+13.03	+13.03	ADJ
aiua-12869	62	27	ml	ml	NOUN
aiua-12869	62	28	/	/	SYM
aiua-12869	62	29	s	s	X
aiua-12869	62	30	(	(	PUNCT
aiua-12869	62	31	p	p	X
aiua-12869	62	32	<	<	X
aiua-12869	62	33	0.001	0.001	NUM
aiua-12869	62	34	)	)	PUNCT
aiua-12869	62	35	after	after	ADP
aiua-12869	62	36	6	6	NUM
aiua-12869	62	37	months	month	NOUN
aiua-12869	62	38	of	of	ADP
aiua-12869	62	39	treatment	treatment	NOUN
aiua-12869	62	40	(	(	PUNCT
aiua-12869	62	41	figure	figure	NOUN
aiua-12869	62	42	2	2	NUM
aiua-12869	62	43	)	)	PUNCT
aiua-12869	62	44	.	.	PUNCT
aiua-12869	63	1	the	the	DET
aiua-12869	63	2	improvement	improvement	NOUN
aiua-12869	63	3	in	in	ADP
aiua-12869	63	4	the	the	DET
aiua-12869	63	5	flow	flow	NOUN
aiua-12869	63	6	of	of	ADP
aiua-12869	63	7	urine	urine	NOUN
aiua-12869	63	8	was	be	AUX
aiua-12869	63	9	statistically	statistically	ADV
aiua-12869	63	10	higher	high	ADJ
aiua-12869	63	11	than	than	ADP
aiua-12869	63	12	that	that	PRON
aiua-12869	63	13	of	of	ADP
aiua-12869	63	14	the	the	DET
aiua-12869	63	15	dutasteride	dutasteride	PROPN
aiua-12869	63	16	group	group	NOUN
aiua-12869	63	17	(	(	PUNCT
aiua-12869	63	18	+13.03	+13.03	ADJ
aiua-12869	63	19	ml	ml	NOUN
aiua-12869	63	20	/	/	SYM
aiua-12869	63	21	s	s	PROPN
aiua-12869	63	22	vs	vs	ADP
aiua-12869	63	23	+3.029	+3.029	NOUN
aiua-12869	63	24	ml	ml	PROPN
aiua-12869	63	25	/	/	SYM
aiua-12869	63	26	s	s	PROPN
aiua-12869	63	27	,	,	PUNCT
aiua-12869	63	28	p	p	X
aiua-12869	63	29	<	<	X
aiua-12869	63	30	0.001	0.001	NUM
aiua-12869	63	31	)	)	PUNCT
aiua-12869	63	32	(	(	PUNCT
aiua-12869	63	33	figure	figure	NOUN
aiua-12869	63	34	2	2	NUM
aiua-12869	63	35	)	)	PUNCT
aiua-12869	63	36	.	.	PUNCT
aiua-12869	64	1	the	the	DET
aiua-12869	64	2	mean	mean	NOUN
aiua-12869	64	3	voided	void	VERB
aiua-12869	64	4	volume	volume	NOUN
aiua-12869	64	5	(	(	PUNCT
aiua-12869	64	6	vv	vv	NOUN
aiua-12869	64	7	)	)	PUNCT
aiua-12869	64	8	was	be	AUX
aiua-12869	64	9	greater	great	ADJ
aiua-12869	64	10	than	than	ADP
aiua-12869	64	11	150	150	NUM
aiua-12869	64	12	ml	ml	NOUN
aiua-12869	64	13	(	(	PUNCT
aiua-12869	64	14	154	154	NUM
aiua-12869	64	15	-	-	SYM
aiua-12869	64	16	347	347	NUM
aiua-12869	64	17	ml	ml	NOUN
aiua-12869	64	18	)	)	PUNCT
aiua-12869	64	19	at	at	ADP
aiua-12869	64	20	the	the	DET
aiua-12869	64	21	first	first	ADJ
aiua-12869	64	22	observation	observation	NOUN
aiua-12869	64	23	and	and	CCONJ
aiua-12869	64	24	also	also	ADV
aiua-12869	64	25	after	after	ADP
aiua-12869	64	26	the	the	DET
aiua-12869	64	27	medical	medical	ADJ
aiua-12869	64	28	therapy	therapy	NOUN
aiua-12869	64	29	(	(	PUNCT
aiua-12869	64	30	157	157	NUM
aiua-12869	64	31	-	-	SYM
aiua-12869	64	32	418	418	NUM
aiua-12869	64	33	ml	ml	NOUN
aiua-12869	64	34	)	)	PUNCT
aiua-12869	64	35	.	.	PUNCT
aiua-12869	65	1	the	the	DET
aiua-12869	65	2	post	post	NOUN
aiua-12869	65	3	void	void	VERB
aiua-12869	65	4	residual	residual	ADJ
aiua-12869	65	5	(	(	PUNCT
aiua-12869	65	6	pvr	pvr	NOUN
aiua-12869	65	7	)	)	PUNCT
aiua-12869	65	8	volume	volume	NOUN
aiua-12869	65	9	was	be	AUX
aiua-12869	65	10	greater	great	ADJ
aiua-12869	65	11	than	than	ADP
aiua-12869	65	12	50	50	NUM
aiua-12869	65	13	ml	ml	NOUN
aiua-12869	65	14	(	(	PUNCT
aiua-12869	65	15	55	55	NUM
aiua-12869	65	16	-	-	SYM
aiua-12869	65	17	165	165	NUM
aiua-12869	65	18	ml	ml	NOUN
aiua-12869	65	19	)	)	PUNCT
aiua-12869	65	20	before	before	ADP
aiua-12869	65	21	treatment	treatment	NOUN
aiua-12869	65	22	and	and	CCONJ
aiua-12869	65	23	slightly	slightly	ADV
aiua-12869	65	24	decreased	decrease	VERB
aiua-12869	65	25	in	in	ADP
aiua-12869	65	26	both	both	DET
aiua-12869	65	27	groups	group	NOUN
aiua-12869	65	28	after	after	ADP
aiua-12869	65	29	6	6	NUM
aiua-12869	65	30	months	month	NOUN
aiua-12869	65	31	(	(	PUNCT
aiua-12869	65	32	45	45	NUM
aiua-12869	65	33	-	-	SYM
aiua-12869	65	34	150	150	NUM
aiua-12869	65	35	ml	ml	NOUN
aiua-12869	65	36	)	)	PUNCT
aiua-12869	65	37	.	.	PUNCT
aiua-12869	66	1	no	no	DET
aiua-12869	66	2	particular	particular	ADJ
aiua-12869	66	3	differences	difference	NOUN
aiua-12869	66	4	were	be	AUX
aiua-12869	66	5	found	find	VERB
aiua-12869	66	6	between	between	ADP
aiua-12869	66	7	the	the	DET
aiua-12869	66	8	2	2	NUM
aiua-12869	66	9	groups	group	NOUN
aiua-12869	66	10	regarding	regard	VERB
aiua-12869	66	11	these	these	DET
aiua-12869	66	12	parameters	parameter	NOUN
aiua-12869	66	13	.	.	PUNCT
aiua-12869	67	1	lastly	lastly	ADV
aiua-12869	67	2	,	,	PUNCT
aiua-12869	67	3	prostate	prostate	NOUN
aiua-12869	67	4	volume	volume	NOUN
aiua-12869	67	5	evaluated	evaluate	VERB
aiua-12869	67	6	through	through	ADP
aiua-12869	67	7	trus	trus	NOUN
aiua-12869	67	8	showed	show	VERB
aiua-12869	67	9	significant	significant	ADJ
aiua-12869	67	10	improvements	improvement	NOUN
aiua-12869	67	11	in	in	ADP
aiua-12869	67	12	both	both	DET
aiua-12869	67	13	groups	group	NOUN
aiua-12869	67	14	.	.	PUNCT
aiua-12869	68	1	for	for	ADP
aiua-12869	68	2	the	the	DET
aiua-12869	68	3	dutasteride	dutasteride	PROPN
aiua-12869	68	4	group	group	NOUN
aiua-12869	68	5	,	,	PUNCT
aiua-12869	68	6	a	a	DET
aiua-12869	68	7	mean	mean	ADJ
aiua-12869	68	8	volume	volume	NOUN
aiua-12869	68	9	decrease	decrease	NOUN
aiua-12869	68	10	of	of	ADP
aiua-12869	68	11	-22.14	-22.14	PROPN
aiua-12869	68	12	ml	ml	PROPN
aiua-12869	68	13	(	(	PUNCT
aiua-12869	68	14	p	p	X
aiua-12869	68	15	<	<	X
aiua-12869	68	16	0.001	0.001	NUM
aiua-12869	68	17	)	)	PUNCT
aiua-12869	68	18	after	after	SCONJ
aiua-12869	68	19	6	6	NUM
aiua-12869	68	20	months	month	NOUN
aiua-12869	68	21	of	of	ADP
aiua-12869	68	22	treatment	treatment	NOUN
aiua-12869	68	23	was	be	AUX
aiua-12869	68	24	found	find	VERB
aiua-12869	68	25	;	;	PUNCT
aiua-12869	68	26	for	for	ADP
aiua-12869	68	27	the	the	DET
aiua-12869	68	28	phytochemicals	phytochemical	NOUN
aiua-12869	68	29	complex	complex	ADJ
aiua-12869	68	30	group	group	NOUN
aiua-12869	68	31	,	,	PUNCT
aiua-12869	68	32	despite	despite	SCONJ
aiua-12869	68	33	being	be	AUX
aiua-12869	68	34	still	still	ADV
aiua-12869	68	35	significant	significant	ADJ
aiua-12869	68	36	from	from	ADP
aiua-12869	68	37	a	a	DET
aiua-12869	68	38	statistical	statistical	ADJ
aiua-12869	68	39	point	point	NOUN
aiua-12869	68	40	of	of	ADP
aiua-12869	68	41	view	view	NOUN
aiua-12869	68	42	,	,	PUNCT
aiua-12869	68	43	the	the	DET
aiua-12869	68	44	mean	mean	ADJ
aiua-12869	68	45	decrease	decrease	NOUN
aiua-12869	68	46	was	be	AUX
aiua-12869	68	47	much	much	ADV
aiua-12869	68	48	lower	low	ADJ
aiua-12869	68	49	:	:	PUNCT
aiua-12869	68	50	-10.04	-10.04	PROPN
aiua-12869	68	51	ml	ml	X
aiua-12869	68	52	(	(	PUNCT
aiua-12869	68	53	p	p	X
aiua-12869	68	54	<	<	X
aiua-12869	68	55	0.001	0.001	NUM
aiua-12869	68	56	)	)	PUNCT
aiua-12869	68	57	after	after	ADP
aiua-12869	68	58	6	6	NUM
aiua-12869	68	59	months	month	NOUN
aiua-12869	68	60	of	of	ADP
aiua-12869	68	61	treatment	treatment	NOUN
aiua-12869	68	62	(	(	PUNCT
aiua-12869	68	63	figure	figure	NOUN
aiua-12869	68	64	3	3	NUM
aiua-12869	68	65	)	)	PUNCT
aiua-12869	68	66	.	.	PUNCT
aiua-12869	69	1	the	the	DET
aiua-12869	69	2	difference	difference	NOUN
aiua-12869	69	3	in	in	ADP
aiua-12869	69	4	mean	mean	ADJ
aiua-12869	69	5	volume	volume	NOUN
aiua-12869	69	6	decrease	decrease	NOUN
aiua-12869	69	7	was	be	AUX
aiua-12869	69	8	much	much	ADV
aiua-12869	69	9	higher	high	ADJ
aiua-12869	69	10	in	in	ADP
aiua-12869	69	11	the	the	DET
aiua-12869	69	12	dutasteride	dutasteride	PROPN
aiua-12869	69	13	group	group	NOUN
aiua-12869	69	14	,	,	PUNCT
aiua-12869	69	15	when	when	SCONJ
aiua-12869	69	16	compared	compare	VERB
aiua-12869	69	17	to	to	ADP
aiua-12869	69	18	the	the	DET
aiua-12869	69	19	phytochemicals	phytochemical	NOUN
aiua-12869	69	20	complex	complex	ADJ
aiua-12869	69	21	group	group	NOUN
aiua-12869	69	22	(	(	PUNCT
aiua-12869	69	23	-22.14	-22.14	PROPN
aiua-12869	69	24	ml	ml	PROPN
aiua-12869	69	25	vs	vs	ADP
aiua-12869	69	26	-10.04	-10.04	PROPN
aiua-12869	69	27	ml	ml	NOUN
aiua-12869	69	28	,	,	PUNCT
aiua-12869	69	29	p	p	X
aiua-12869	69	30	<	<	X
aiua-12869	69	31	0.001	0.001	NUM
aiua-12869	69	32	)	)	PUNCT
aiua-12869	69	33	(	(	PUNCT
aiua-12869	69	34	figure	figure	NOUN
aiua-12869	69	35	3	3	NUM
aiua-12869	69	36	)	)	PUNCT
aiua-12869	69	37	.	.	PUNCT
aiua-12869	70	1	discussion	discussion	NOUN
aiua-12869	70	2	the	the	DET
aiua-12869	70	3	efficacy	efficacy	NOUN
aiua-12869	70	4	of	of	ADP
aiua-12869	70	5	nutraceuticals	nutraceutical	NOUN
aiua-12869	70	6	for	for	ADP
aiua-12869	70	7	the	the	DET
aiua-12869	70	8	treatment	treatment	NOUN
aiua-12869	70	9	of	of	ADP
aiua-12869	70	10	bphrelated	bphrelate	VERB
aiua-12869	70	11	urinary	urinary	ADJ
aiua-12869	70	12	symptoms	symptom	NOUN
aiua-12869	70	13	is	be	AUX
aiua-12869	70	14	a	a	DET
aiua-12869	70	15	wide	wide	ADJ
aiua-12869	70	16	field	field	NOUN
aiua-12869	70	17	of	of	ADP
aiua-12869	70	18	interest	interest	NOUN
aiua-12869	70	19	in	in	ADP
aiua-12869	70	20	urology	urology	NOUN
aiua-12869	70	21	.	.	PUNCT
aiua-12869	71	1	our	our	PRON
aiua-12869	71	2	study	study	NOUN
aiua-12869	71	3	aims	aim	VERB
aiua-12869	71	4	to	to	PART
aiua-12869	71	5	enriching	enrich	VERB
aiua-12869	71	6	the	the	DET
aiua-12869	71	7	present	present	ADJ
aiua-12869	71	8	literature	literature	NOUN
aiua-12869	71	9	for	for	ADP
aiua-12869	71	10	what	what	PRON
aiua-12869	71	11	concerns	concern	VERB
aiua-12869	71	12	the	the	DET
aiua-12869	71	13	comparison	comparison	NOUN
aiua-12869	71	14	between	between	ADP
aiua-12869	71	15	commonly	commonly	ADV
aiua-12869	71	16	used	use	VERB
aiua-12869	71	17	drugs	drug	NOUN
aiua-12869	71	18	,	,	PUNCT
aiua-12869	71	19	like	like	ADP
aiua-12869	71	20	5	5	NUM
aiua-12869	71	21	-	-	PUNCT
aiua-12869	71	22	ari	ari	PROPN
aiua-12869	71	23	dutasteride	dutasteride	NOUN
aiua-12869	71	24	,	,	PUNCT
aiua-12869	71	25	and	and	CCONJ
aiua-12869	71	26	a	a	DET
aiua-12869	71	27	combination	combination	NOUN
aiua-12869	71	28	of	of	ADP
aiua-12869	71	29	nutraceuticals	nutraceutical	NOUN
aiua-12869	71	30	like	like	ADP
aiua-12869	71	31	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-12869	71	32	,	,	PUNCT
aiua-12869	71	33	selenium	selenium	NOUN
aiua-12869	71	34	and	and	CCONJ
aiua-12869	71	35	phycocianin	phycocianin	NOUN
aiua-12869	71	36	.	.	PUNCT
aiua-12869	72	1	our	our	PRON
aiua-12869	72	2	results	result	NOUN
aiua-12869	72	3	show	show	VERB
aiua-12869	72	4	that	that	SCONJ
aiua-12869	72	5	both	both	CCONJ
aiua-12869	72	6	the	the	DET
aiua-12869	72	7	alternatives	alternative	NOUN
aiua-12869	72	8	are	be	AUX
aiua-12869	72	9	valid	valid	ADJ
aiua-12869	72	10	for	for	ADP
aiua-12869	72	11	the	the	DET
aiua-12869	72	12	treatment	treatment	NOUN
aiua-12869	72	13	of	of	ADP
aiua-12869	72	14	such	such	ADJ
aiua-12869	72	15	symptoms	symptom	NOUN
aiua-12869	72	16	and	and	CCONJ
aiua-12869	72	17	suggest	suggest	VERB
aiua-12869	72	18	that	that	SCONJ
aiua-12869	72	19	treating	treat	VERB
aiua-12869	72	20	bph	bph	NOUN
aiua-12869	72	21	does	do	AUX
aiua-12869	72	22	not	not	PART
aiua-12869	72	23	necessarily	necessarily	ADV
aiua-12869	72	24	require	require	VERB
aiua-12869	72	25	the	the	DET
aiua-12869	72	26	administration	administration	NOUN
aiua-12869	72	27	of	of	ADP
aiua-12869	72	28	drugs	drug	NOUN
aiua-12869	72	29	,	,	PUNCT
aiua-12869	72	30	such	such	ADJ
aiua-12869	72	31	as	as	ADP
aiua-12869	72	32	5	5	NUM
aiua-12869	72	33	-	-	PUNCT
aiua-12869	72	34	aris	aris	NOUN
aiua-12869	72	35	,	,	PUNCT
aiua-12869	72	36	that	that	PRON
aiua-12869	72	37	usually	usually	ADV
aiua-12869	72	38	heavily	heavily	ADV
aiua-12869	72	39	impact	impact	VERB
aiua-12869	72	40	the	the	DET
aiua-12869	72	41	qol	qol	NOUN
aiua-12869	72	42	because	because	SCONJ
aiua-12869	72	43	of	of	ADP
aiua-12869	72	44	their	their	PRON
aiua-12869	72	45	side	side	NOUN
aiua-12869	72	46	effects	effect	NOUN
aiua-12869	72	47	.	.	PUNCT
aiua-12869	73	1	5	5	NUM
aiua-12869	73	2	-	-	PUNCT
aiua-12869	73	3	ari	ari	PROPN
aiua-12869	73	4	dutasteride	dutasteride	PROPN
aiua-12869	73	5	is	be	AUX
aiua-12869	73	6	well	well	ADV
aiua-12869	73	7	-	-	PUNCT
aiua-12869	73	8	known	know	VERB
aiua-12869	73	9	for	for	ADP
aiua-12869	73	10	its	its	PRON
aiua-12869	73	11	capability	capability	NOUN
aiua-12869	73	12	in	in	ADP
aiua-12869	73	13	reducing	reduce	VERB
aiua-12869	73	14	psa	psa	NOUN
aiua-12869	73	15	values	value	NOUN
aiua-12869	73	16	,	,	PUNCT
aiua-12869	73	17	the	the	DET
aiua-12869	73	18	prostate	prostate	NOUN
aiua-12869	73	19	volume	volume	NOUN
aiua-12869	73	20	and	and	CCONJ
aiua-12869	73	21	improving	improve	VERB
aiua-12869	73	22	ufm	ufm	NOUN
aiua-12869	73	23	parameters	parameter	NOUN
aiua-12869	73	24	and	and	CCONJ
aiua-12869	73	25	our	our	PRON
aiua-12869	73	26	results	result	NOUN
aiua-12869	73	27	agree	agree	VERB
aiua-12869	73	28	with	with	ADP
aiua-12869	73	29	this	this	PRON
aiua-12869	73	30	.	.	PUNCT
aiua-12869	74	1	however	however	ADV
aiua-12869	74	2	,	,	PUNCT
aiua-12869	74	3	5α	5α	NOUN
aiua-12869	74	4	-	-	PUNCT
aiua-12869	74	5	reductases	reductase	NOUN
aiua-12869	74	6	(	(	PUNCT
aiua-12869	74	7	5α	5α	NOUN
aiua-12869	74	8	-	-	PUNCT
aiua-12869	74	9	rs	rs	NOUN
aiua-12869	74	10	)	)	PUNCT
aiua-12869	74	11	,	,	PUNCT
aiua-12869	74	12	a	a	DET
aiua-12869	74	13	family	family	NOUN
aiua-12869	74	14	of	of	ADP
aiua-12869	74	15	several	several	ADJ
aiua-12869	74	16	isozymes	isozyme	NOUN
aiua-12869	74	17	whose	whose	DET
aiua-12869	74	18	activity	activity	NOUN
aiua-12869	74	19	is	be	AUX
aiua-12869	74	20	inhibited	inhibit	VERB
aiua-12869	74	21	by	by	ADP
aiua-12869	74	22	the	the	DET
aiua-12869	74	23	administration	administration	NOUN
aiua-12869	74	24	of	of	ADP
aiua-12869	74	25	5	5	PROPN
aiua-12869	74	26	-	-	PUNCT
aiua-12869	74	27	aris	aris	NOUN
aiua-12869	74	28	,	,	PUNCT
aiua-12869	74	29	play	play	VERB
aiua-12869	74	30	an	an	DET
aiua-12869	74	31	important	important	ADJ
aiua-12869	74	32	role	role	NOUN
aiua-12869	74	33	in	in	ADP
aiua-12869	74	34	human	human	ADJ
aiua-12869	74	35	physiology	physiology	NOUN
aiua-12869	74	36	by	by	ADP
aiua-12869	74	37	figure	figure	NOUN
aiua-12869	74	38	1	1	NUM
aiua-12869	74	39	.	.	PUNCT
aiua-12869	74	40	difference	difference	NOUN
aiua-12869	74	41	of	of	ADP
aiua-12869	74	42	basal	basal	NOUN
aiua-12869	74	43	and	and	CCONJ
aiua-12869	74	44	6	6	NUM
aiua-12869	74	45	-	-	PUNCT
aiua-12869	74	46	month	month	NOUN
aiua-12869	74	47	follow	follow	NOUN
aiua-12869	74	48	up	up	ADP
aiua-12869	74	49	psa	psa	NOUN
aiua-12869	74	50	values	value	NOUN
aiua-12869	74	51	in	in	ADP
aiua-12869	74	52	dutasteride	dutasteride	NOUN
aiua-12869	74	53	and	and	CCONJ
aiua-12869	74	54	phytochemical	phytochemical	ADJ
aiua-12869	74	55	complex	complex	ADJ
aiua-12869	74	56	groups	group	NOUN
aiua-12869	74	57	:	:	PUNCT
aiua-12869	74	58	significant	significant	ADJ
aiua-12869	74	59	decrease	decrease	NOUN
aiua-12869	74	60	in	in	ADP
aiua-12869	74	61	both	both	DET
aiua-12869	74	62	groups	group	NOUN
aiua-12869	74	63	*	*	PUNCT
aiua-12869	74	64	.	.	PUNCT
aiua-12869	75	1	lower	low	ADJ
aiua-12869	75	2	mean	mean	ADJ
aiua-12869	75	3	psa	psa	NOUN
aiua-12869	75	4	in	in	ADP
aiua-12869	75	5	dutasteride	dutasteride	PROPN
aiua-12869	75	6	group	group	NOUN
aiua-12869	75	7	at	at	ADP
aiua-12869	75	8	6	6	NUM
aiua-12869	75	9	month	month	NOUN
aiua-12869	75	10	follow	follow	NOUN
aiua-12869	75	11	up	up	ADV
aiua-12869	75	12	.	.	PUNCT
aiua-12869	76	1	figure	figure	VERB
aiua-12869	76	2	3	3	NUM
aiua-12869	76	3	.	.	NOUN
aiua-12869	76	4	difference	difference	NOUN
aiua-12869	76	5	of	of	ADP
aiua-12869	76	6	basal	basal	NOUN
aiua-12869	76	7	and	and	CCONJ
aiua-12869	76	8	6	6	NUM
aiua-12869	76	9	-	-	PUNCT
aiua-12869	76	10	month	month	NOUN
aiua-12869	76	11	follow	follow	NOUN
aiua-12869	76	12	up	up	ADP
aiua-12869	76	13	prostate	prostate	NOUN
aiua-12869	76	14	volume	volume	NOUN
aiua-12869	76	15	values	value	NOUN
aiua-12869	76	16	in	in	ADP
aiua-12869	76	17	dutasteride	dutasteride	NOUN
aiua-12869	76	18	and	and	CCONJ
aiua-12869	76	19	phytochemical	phytochemical	ADJ
aiua-12869	76	20	complex	complex	ADJ
aiua-12869	76	21	groups	group	NOUN
aiua-12869	76	22	:	:	PUNCT
aiua-12869	76	23	significant	significant	ADJ
aiua-12869	76	24	decrease	decrease	NOUN
aiua-12869	76	25	in	in	ADP
aiua-12869	76	26	both	both	DET
aiua-12869	76	27	groups	group	NOUN
aiua-12869	76	28	*	*	PUNCT
aiua-12869	76	29	.	.	PUNCT
aiua-12869	77	1	lower	low	ADJ
aiua-12869	77	2	mean	mean	ADJ
aiua-12869	77	3	volume	volume	NOUN
aiua-12869	77	4	in	in	ADP
aiua-12869	77	5	dutasteride	dutasteride	PROPN
aiua-12869	77	6	group	group	NOUN
aiua-12869	77	7	at	at	ADP
aiua-12869	77	8	6	6	NUM
aiua-12869	77	9	-	-	PUNCT
aiua-12869	77	10	month	month	NOUN
aiua-12869	77	11	follow	follow	VERB
aiua-12869	77	12	up	up	ADV
aiua-12869	77	13	#	#	SYM
aiua-12869	77	14	.	.	PUNCT
aiua-12869	78	1	figure	figure	NOUN
aiua-12869	78	2	2	2	NUM
aiua-12869	78	3	.	.	NOUN
aiua-12869	78	4	difference	difference	NOUN
aiua-12869	78	5	of	of	ADP
aiua-12869	78	6	basal	basal	NOUN
aiua-12869	78	7	and	and	CCONJ
aiua-12869	78	8	6	6	NUM
aiua-12869	78	9	-	-	PUNCT
aiua-12869	78	10	month	month	NOUN
aiua-12869	78	11	follow	follow	NOUN
aiua-12869	78	12	up	up	ADP
aiua-12869	78	13	uroflowmetry	uroflowmetry	NOUN
aiua-12869	78	14	values	value	NOUN
aiua-12869	78	15	in	in	ADP
aiua-12869	78	16	dutasteride	dutasteride	NOUN
aiua-12869	78	17	and	and	CCONJ
aiua-12869	78	18	phytochemical	phytochemical	ADJ
aiua-12869	78	19	complex	complex	ADJ
aiua-12869	78	20	groups	group	NOUN
aiua-12869	78	21	:	:	PUNCT
aiua-12869	78	22	significant	significant	ADJ
aiua-12869	78	23	improvement	improvement	NOUN
aiua-12869	78	24	in	in	ADP
aiua-12869	78	25	both	both	DET
aiua-12869	78	26	groups	group	NOUN
aiua-12869	78	27	*	*	PUNCT
aiua-12869	78	28	.	.	PUNCT
aiua-12869	79	1	higher	high	ADJ
aiua-12869	79	2	mean	mean	PROPN
aiua-12869	79	3	qmax	qmax	PROPN
aiua-12869	79	4	values	value	NOUN
aiua-12869	79	5	in	in	ADP
aiua-12869	79	6	the	the	DET
aiua-12869	79	7	phytochemical	phytochemical	ADJ
aiua-12869	79	8	complex	complex	ADJ
aiua-12869	79	9	group	group	NOUN
aiua-12869	79	10	at	at	ADP
aiua-12869	79	11	6	6	NUM
aiua-12869	79	12	-	-	PUNCT
aiua-12869	79	13	month	month	NOUN
aiua-12869	79	14	follow	follow	VERB
aiua-12869	79	15	up	up	ADV
aiua-12869	79	16	#	#	SYM
aiua-12869	79	17	.	.	PUNCT
aiua-12869	80	1	archivio	archivio	NOUN
aiua-12869	80	2	italiano	italiano	X
aiua-12869	80	3	di	di	PROPN
aiua-12869	80	4	urologia	urologia	PROPN
aiua-12869	80	5	e	e	PROPN
aiua-12869	80	6	andrologia	andrologia	NOUN
aiua-12869	80	7	2024	2024	NUM
aiua-12869	80	8	;	;	PUNCT
aiua-12869	80	9	96(3):12869	96(3):12869	NUM
aiua-12869	80	10	g.	g.	NOUN
aiua-12869	80	11	saitta	saitta	PROPN
aiua-12869	80	12	,	,	PUNCT
aiua-12869	80	13	f.a	f.a	PROPN
aiua-12869	80	14	.	.	PROPN
aiua-12869	80	15	mantovani	mantovani	PROPN
aiua-12869	80	16	,	,	PUNCT
aiua-12869	80	17	b.	b.	PROPN
aiua-12869	80	18	calabrese	calabrese	PROPN
aiua-12869	80	19	,	,	PUNCT
aiua-12869	80	20	et	et	PROPN
aiua-12869	80	21	al	al	PROPN
aiua-12869	80	22	.	.	PROPN
aiua-12869	80	23	4	4	NUM
aiua-12869	80	24	regulating	regulate	VERB
aiua-12869	80	25	cellular	cellular	ADJ
aiua-12869	80	26	metabolism	metabolism	NOUN
aiua-12869	80	27	of	of	ADP
aiua-12869	80	28	androgens	androgen	NOUN
aiua-12869	80	29	,	,	PUNCT
aiua-12869	80	30	glucocorticoids	glucocorticoid	NOUN
aiua-12869	80	31	and	and	CCONJ
aiua-12869	80	32	other	other	ADJ
aiua-12869	80	33	steroids	steroid	NOUN
aiua-12869	80	34	.	.	PUNCT
aiua-12869	81	1	along	along	ADP
aiua-12869	81	2	with	with	ADP
aiua-12869	81	3	hypoactive	hypoactive	ADJ
aiua-12869	81	4	sexual	sexual	ADJ
aiua-12869	81	5	desire	desire	NOUN
aiua-12869	81	6	,	,	PUNCT
aiua-12869	81	7	erectile	erectile	ADJ
aiua-12869	81	8	dysfunction	dysfunction	NOUN
aiua-12869	81	9	,	,	PUNCT
aiua-12869	81	10	gynecomastia	gynecomastia	NOUN
aiua-12869	81	11	and	and	CCONJ
aiua-12869	81	12	psychiatric	psychiatric	ADJ
aiua-12869	81	13	side	side	NOUN
aiua-12869	81	14	effects	effect	NOUN
aiua-12869	81	15	such	such	ADJ
aiua-12869	81	16	as	as	ADP
aiua-12869	81	17	a	a	DET
aiua-12869	81	18	higher	high	ADJ
aiua-12869	81	19	risk	risk	NOUN
aiua-12869	81	20	of	of	ADP
aiua-12869	81	21	major	major	ADJ
aiua-12869	81	22	depression	depression	NOUN
aiua-12869	81	23	,	,	PUNCT
aiua-12869	81	24	some	some	DET
aiua-12869	81	25	studies	study	NOUN
aiua-12869	81	26	suggest	suggest	VERB
aiua-12869	81	27	that	that	SCONJ
aiua-12869	81	28	such	such	ADJ
aiua-12869	81	29	treatments	treatment	NOUN
aiua-12869	81	30	may	may	AUX
aiua-12869	81	31	result	result	VERB
aiua-12869	81	32	in	in	ADP
aiua-12869	81	33	development	development	NOUN
aiua-12869	81	34	of	of	ADP
aiua-12869	81	35	non	non	ADJ
aiua-12869	81	36	-	-	ADJ
aiua-12869	81	37	alcoholic	alcoholic	ADJ
aiua-12869	81	38	fatty	fatty	NOUN
aiua-12869	81	39	liver	liver	NOUN
aiua-12869	81	40	diseases	disease	NOUN
aiua-12869	81	41	(	(	PUNCT
aiua-12869	81	42	nafld	nafld	ADV
aiua-12869	81	43	)	)	PUNCT
aiua-12869	81	44	,	,	PUNCT
aiua-12869	81	45	insulin	insulin	NOUN
aiua-12869	81	46	resistance	resistance	NOUN
aiua-12869	81	47	(	(	PUNCT
aiua-12869	81	48	ir	ir	NOUN
aiua-12869	81	49	)	)	PUNCT
aiua-12869	81	50	,	,	PUNCT
aiua-12869	81	51	type	type	NOUN
aiua-12869	81	52	2	2	NUM
aiua-12869	81	53	diabetes	diabetes	NOUN
aiua-12869	81	54	(	(	PUNCT
aiua-12869	81	55	t2	t2	NOUN
aiua-12869	81	56	dm	dm	PROPN
aiua-12869	81	57	)	)	PUNCT
aiua-12869	81	58	,	,	PUNCT
aiua-12869	81	59	dry	dry	ADJ
aiua-12869	81	60	eye	eye	NOUN
aiua-12869	81	61	disease	disease	NOUN
aiua-12869	81	62	,	,	PUNCT
aiua-12869	81	63	potential	potential	ADJ
aiua-12869	81	64	kidney	kidney	NOUN
aiua-12869	81	65	dysfunction	dysfunction	NOUN
aiua-12869	81	66	,	,	PUNCT
aiua-12869	81	67	among	among	ADP
aiua-12869	81	68	other	other	ADJ
aiua-12869	81	69	metabolic	metabolic	NOUN
aiua-12869	81	70	dysfunctions	dysfunction	NOUN
aiua-12869	81	71	(	(	PUNCT
aiua-12869	81	72	16	16	NUM
aiua-12869	81	73	,	,	PUNCT
aiua-12869	81	74	17	17	NUM
aiua-12869	81	75	)	)	PUNCT
aiua-12869	81	76	.	.	PUNCT
aiua-12869	82	1	not	not	PART
aiua-12869	82	2	many	many	ADJ
aiua-12869	82	3	studies	study	NOUN
aiua-12869	82	4	in	in	ADP
aiua-12869	82	5	literature	literature	NOUN
aiua-12869	82	6	have	have	AUX
aiua-12869	82	7	evaluated	evaluate	VERB
aiua-12869	82	8	the	the	DET
aiua-12869	82	9	role	role	NOUN
aiua-12869	82	10	of	of	ADP
aiua-12869	82	11	less	less	ADV
aiua-12869	82	12	known	know	VERB
aiua-12869	82	13	nutraceuticals	nutraceutical	NOUN
aiua-12869	82	14	in	in	ADP
aiua-12869	82	15	the	the	DET
aiua-12869	82	16	treatment	treatment	NOUN
aiua-12869	82	17	of	of	ADP
aiua-12869	82	18	bph	bph	NOUN
aiua-12869	82	19	(	(	PUNCT
aiua-12869	82	20	pea	pea	NOUN
aiua-12869	82	21	,	,	PUNCT
aiua-12869	82	22	selenium	selenium	NOUN
aiua-12869	82	23	,	,	PUNCT
aiua-12869	82	24	phycocyanin	phycocyanin	ADV
aiua-12869	82	25	,	,	PUNCT
aiua-12869	82	26	etc	etc	X
aiua-12869	82	27	.	.	X
aiua-12869	82	28	)	)	PUNCT
aiua-12869	82	29	.	.	PUNCT
aiua-12869	83	1	however	however	ADV
aiua-12869	83	2	,	,	PUNCT
aiua-12869	83	3	based	base	VERB
aiua-12869	83	4	on	on	ADP
aiua-12869	83	5	the	the	DET
aiua-12869	83	6	biochemical	biochemical	ADJ
aiua-12869	83	7	activities	activity	NOUN
aiua-12869	83	8	of	of	ADP
aiua-12869	83	9	such	such	ADJ
aiua-12869	83	10	molecules	molecule	NOUN
aiua-12869	83	11	,	,	PUNCT
aiua-12869	83	12	it	it	PRON
aiua-12869	83	13	is	be	AUX
aiua-12869	83	14	reasonable	reasonable	ADJ
aiua-12869	83	15	to	to	PART
aiua-12869	83	16	suppose	suppose	VERB
aiua-12869	83	17	that	that	SCONJ
aiua-12869	83	18	their	their	PRON
aiua-12869	83	19	main	main	ADJ
aiua-12869	83	20	action	action	NOUN
aiua-12869	83	21	is	be	AUX
aiua-12869	83	22	towards	towards	ADP
aiua-12869	83	23	inflammation	inflammation	NOUN
aiua-12869	83	24	and	and	CCONJ
aiua-12869	83	25	its	its	PRON
aiua-12869	83	26	pathways	pathway	NOUN
aiua-12869	83	27	.	.	PUNCT
aiua-12869	84	1	today	today	NOUN
aiua-12869	84	2	,	,	PUNCT
aiua-12869	84	3	it	it	PRON
aiua-12869	84	4	is	be	AUX
aiua-12869	84	5	only	only	ADV
aiua-12869	84	6	possible	possible	ADJ
aiua-12869	84	7	to	to	PART
aiua-12869	84	8	estimate	estimate	VERB
aiua-12869	84	9	the	the	DET
aiua-12869	84	10	effects	effect	NOUN
aiua-12869	84	11	of	of	ADP
aiua-12869	84	12	such	such	ADJ
aiua-12869	84	13	chemicals	chemical	NOUN
aiua-12869	84	14	on	on	ADP
aiua-12869	84	15	the	the	DET
aiua-12869	84	16	prostate	prostate	NOUN
aiua-12869	84	17	function	function	NOUN
aiua-12869	84	18	.	.	PUNCT
aiua-12869	85	1	for	for	ADP
aiua-12869	85	2	instance	instance	NOUN
aiua-12869	85	3	,	,	PUNCT
aiua-12869	85	4	pea	pea	NOUN
aiua-12869	85	5	has	have	AUX
aiua-12869	85	6	been	be	AUX
aiua-12869	85	7	demonstrated	demonstrate	VERB
aiua-12869	85	8	to	to	PART
aiua-12869	85	9	play	play	VERB
aiua-12869	85	10	a	a	DET
aiua-12869	85	11	significant	significant	ADJ
aiua-12869	85	12	neuroprotective	neuroprotective	ADJ
aiua-12869	85	13	effect	effect	NOUN
aiua-12869	85	14	on	on	ADP
aiua-12869	85	15	chronic	chronic	ADJ
aiua-12869	85	16	pelvic	pelvic	ADJ
aiua-12869	85	17	pain	pain	NOUN
aiua-12869	85	18	,	,	PUNCT
aiua-12869	85	19	but	but	CCONJ
aiua-12869	85	20	it	it	PRON
aiua-12869	85	21	may	may	AUX
aiua-12869	85	22	also	also	ADV
aiua-12869	85	23	play	play	VERB
aiua-12869	85	24	an	an	DET
aiua-12869	85	25	important	important	ADJ
aiua-12869	85	26	role	role	NOUN
aiua-12869	85	27	in	in	ADP
aiua-12869	85	28	reducing	reduce	VERB
aiua-12869	85	29	inflammation	inflammation	NOUN
aiua-12869	85	30	by	by	ADP
aiua-12869	85	31	interfering	interfere	VERB
aiua-12869	85	32	with	with	ADP
aiua-12869	85	33	the	the	DET
aiua-12869	85	34	androgenic	androgenic	ADJ
aiua-12869	85	35	pathways	pathway	NOUN
aiua-12869	85	36	.	.	PUNCT
aiua-12869	86	1	as	as	SCONJ
aiua-12869	86	2	previously	previously	ADV
aiua-12869	86	3	said	say	VERB
aiua-12869	86	4	,	,	PUNCT
aiua-12869	86	5	daily	daily	PROPN
aiua-12869	86	6	administration	administration	NOUN
aiua-12869	86	7	of	of	ADP
aiua-12869	86	8	pea	pea	NOUN
aiua-12869	86	9	is	be	AUX
aiua-12869	86	10	capable	capable	ADJ
aiua-12869	86	11	of	of	ADP
aiua-12869	86	12	reducing	reduce	VERB
aiua-12869	86	13	the	the	DET
aiua-12869	86	14	levels	level	NOUN
aiua-12869	86	15	of	of	ADP
aiua-12869	86	16	testosterone	testosterone	NOUN
aiua-12869	86	17	,	,	PUNCT
aiua-12869	86	18	dht	dht	NOUN
aiua-12869	86	19	and	and	CCONJ
aiua-12869	86	20	decreasing	decrease	VERB
aiua-12869	86	21	the	the	DET
aiua-12869	86	22	expression	expression	NOUN
aiua-12869	86	23	of	of	ADP
aiua-12869	86	24	markers	marker	NOUN
aiua-12869	86	25	like	like	ADP
aiua-12869	86	26	psa	psa	NOUN
aiua-12869	86	27	and	and	CCONJ
aiua-12869	86	28	5αreductases	5αreductases	NUM
aiua-12869	86	29	in	in	ADP
aiua-12869	86	30	the	the	DET
aiua-12869	86	31	prostate	prostate	NOUN
aiua-12869	86	32	tissue	tissue	NOUN
aiua-12869	86	33	(	(	PUNCT
aiua-12869	86	34	11	11	NUM
aiua-12869	86	35	)	)	PUNCT
aiua-12869	86	36	.	.	PUNCT
aiua-12869	87	1	this	this	DET
aiua-12869	87	2	mechanism	mechanism	NOUN
aiua-12869	87	3	may	may	AUX
aiua-12869	87	4	lead	lead	VERB
aiua-12869	87	5	to	to	ADP
aiua-12869	87	6	the	the	DET
aiua-12869	87	7	reduction	reduction	NOUN
aiua-12869	87	8	in	in	ADP
aiua-12869	87	9	prostate	prostate	NOUN
aiua-12869	87	10	weight	weight	NOUN
aiua-12869	87	11	and	and	CCONJ
aiua-12869	87	12	inflammation	inflammation	NOUN
aiua-12869	87	13	markers	marker	NOUN
aiua-12869	87	14	that	that	PRON
aiua-12869	87	15	eventually	eventually	ADV
aiua-12869	87	16	is	be	AUX
aiua-12869	87	17	responsible	responsible	ADJ
aiua-12869	87	18	for	for	ADP
aiua-12869	87	19	the	the	DET
aiua-12869	87	20	improvement	improvement	NOUN
aiua-12869	87	21	of	of	ADP
aiua-12869	87	22	bph	bph	NOUN
aiua-12869	87	23	-	-	PUNCT
aiua-12869	87	24	related	relate	VERB
aiua-12869	87	25	luts	lut	NOUN
aiua-12869	87	26	that	that	PRON
aiua-12869	87	27	we	we	PRON
aiua-12869	87	28	have	have	AUX
aiua-12869	87	29	observed	observe	VERB
aiua-12869	87	30	in	in	ADP
aiua-12869	87	31	our	our	PRON
aiua-12869	87	32	results	result	NOUN
aiua-12869	87	33	.	.	PUNCT
aiua-12869	88	1	according	accord	VERB
aiua-12869	88	2	to	to	ADP
aiua-12869	88	3	our	our	PRON
aiua-12869	88	4	data	datum	NOUN
aiua-12869	88	5	,	,	PUNCT
aiua-12869	88	6	even	even	ADV
aiua-12869	88	7	if	if	SCONJ
aiua-12869	88	8	analysis	analysis	NOUN
aiua-12869	88	9	is	be	AUX
aiua-12869	88	10	biased	bias	VERB
aiua-12869	88	11	by	by	ADP
aiua-12869	88	12	the	the	DET
aiua-12869	88	13	low	low	ADJ
aiua-12869	88	14	number	number	NOUN
aiua-12869	88	15	of	of	ADP
aiua-12869	88	16	patients	patient	NOUN
aiua-12869	88	17	taken	take	VERB
aiua-12869	88	18	into	into	ADP
aiua-12869	88	19	consideration	consideration	NOUN
aiua-12869	88	20	,	,	PUNCT
aiua-12869	88	21	our	our	PRON
aiua-12869	88	22	results	result	NOUN
aiua-12869	88	23	show	show	VERB
aiua-12869	88	24	that	that	SCONJ
aiua-12869	88	25	the	the	DET
aiua-12869	88	26	complex	complex	NOUN
aiua-12869	88	27	was	be	AUX
aiua-12869	88	28	able	able	ADJ
aiua-12869	88	29	to	to	PART
aiua-12869	88	30	improve	improve	VERB
aiua-12869	88	31	the	the	DET
aiua-12869	88	32	maximum	maximum	ADJ
aiua-12869	88	33	flow	flow	NOUN
aiua-12869	88	34	of	of	ADP
aiua-12869	88	35	urine	urine	NOUN
aiua-12869	88	36	by	by	ADP
aiua-12869	88	37	+13.03	+13.03	ADJ
aiua-12869	88	38	ml	ml	NOUN
aiua-12869	88	39	/	/	SYM
aiua-12869	88	40	s	s	NOUN
aiua-12869	88	41	after	after	ADP
aiua-12869	88	42	6	6	NUM
aiua-12869	88	43	months	month	NOUN
aiua-12869	88	44	of	of	ADP
aiua-12869	88	45	treatment	treatment	NOUN
aiua-12869	88	46	without	without	ADP
aiua-12869	88	47	dramatically	dramatically	ADV
aiua-12869	88	48	reducing	reduce	VERB
aiua-12869	88	49	the	the	DET
aiua-12869	88	50	prostate	prostate	NOUN
aiua-12869	88	51	volume	volume	NOUN
aiua-12869	88	52	in	in	ADP
aiua-12869	88	53	the	the	DET
aiua-12869	88	54	meantime	meantime	NOUN
aiua-12869	88	55	.	.	PUNCT
aiua-12869	89	1	not	not	PART
aiua-12869	89	2	only	only	ADV
aiua-12869	89	3	is	be	AUX
aiua-12869	89	4	this	this	DET
aiua-12869	89	5	evidence	evidence	NOUN
aiua-12869	89	6	significant	significant	ADJ
aiua-12869	89	7	,	,	PUNCT
aiua-12869	89	8	but	but	CCONJ
aiua-12869	89	9	it	it	PRON
aiua-12869	89	10	is	be	AUX
aiua-12869	89	11	also	also	ADV
aiua-12869	89	12	very	very	ADV
aiua-12869	89	13	puzzling	puzzling	ADJ
aiua-12869	89	14	when	when	SCONJ
aiua-12869	89	15	compared	compare	VERB
aiua-12869	89	16	to	to	ADP
aiua-12869	89	17	the	the	DET
aiua-12869	89	18	+3.029	+3.029	NOUN
aiua-12869	89	19	ml	ml	PROPN
aiua-12869	89	20	/	/	SYM
aiua-12869	89	21	s	s	PART
aiua-12869	89	22	increase	increase	NOUN
aiua-12869	89	23	in	in	ADP
aiua-12869	89	24	patients	patient	NOUN
aiua-12869	89	25	treated	treat	VERB
aiua-12869	89	26	with	with	ADP
aiua-12869	89	27	dutasteride	dutasteride	NOUN
aiua-12869	89	28	.	.	PUNCT
aiua-12869	90	1	even	even	ADV
aiua-12869	90	2	though	though	SCONJ
aiua-12869	90	3	this	this	DET
aiua-12869	90	4	result	result	NOUN
aiua-12869	90	5	may	may	AUX
aiua-12869	90	6	be	be	AUX
aiua-12869	90	7	paradoxical	paradoxical	ADJ
aiua-12869	90	8	to	to	ADP
aiua-12869	90	9	some	some	DET
aiua-12869	90	10	extent	extent	NOUN
aiua-12869	90	11	,	,	PUNCT
aiua-12869	90	12	it	it	PRON
aiua-12869	90	13	is	be	AUX
aiua-12869	90	14	possible	possible	ADJ
aiua-12869	90	15	to	to	PART
aiua-12869	90	16	deduce	deduce	VERB
aiua-12869	90	17	that	that	SCONJ
aiua-12869	90	18	this	this	DET
aiua-12869	90	19	combination	combination	NOUN
aiua-12869	90	20	of	of	ADP
aiua-12869	90	21	nutraceuticals	nutraceutical	NOUN
aiua-12869	90	22	may	may	AUX
aiua-12869	90	23	have	have	VERB
aiua-12869	90	24	a	a	DET
aiua-12869	90	25	stronger	strong	ADJ
aiua-12869	90	26	impact	impact	NOUN
aiua-12869	90	27	on	on	ADP
aiua-12869	90	28	ufm	ufm	NOUN
aiua-12869	90	29	parameters	parameter	NOUN
aiua-12869	90	30	than	than	ADP
aiua-12869	90	31	on	on	ADP
aiua-12869	90	32	prostate	prostate	NOUN
aiua-12869	90	33	weight	weight	NOUN
aiua-12869	90	34	or	or	CCONJ
aiua-12869	90	35	psa	psa	VERB
aiua-12869	90	36	serum	serum	NOUN
aiua-12869	90	37	levels	level	NOUN
aiua-12869	90	38	,	,	PUNCT
aiua-12869	90	39	where	where	SCONJ
aiua-12869	90	40	dutasteride	dutasteride	PROPN
aiua-12869	90	41	seemed	seem	VERB
aiua-12869	90	42	to	to	PART
aiua-12869	90	43	perform	perform	VERB
aiua-12869	90	44	better	well	ADV
aiua-12869	90	45	,	,	PUNCT
aiua-12869	90	46	because	because	SCONJ
aiua-12869	90	47	of	of	ADP
aiua-12869	90	48	their	their	PRON
aiua-12869	90	49	effect	effect	NOUN
aiua-12869	90	50	on	on	ADP
aiua-12869	90	51	inflammation	inflammation	NOUN
aiua-12869	90	52	.	.	PUNCT
aiua-12869	91	1	this	this	DET
aiua-12869	91	2	result	result	NOUN
aiua-12869	91	3	supposedly	supposedly	ADV
aiua-12869	91	4	highlights	highlight	VERB
aiua-12869	91	5	the	the	DET
aiua-12869	91	6	importance	importance	NOUN
aiua-12869	91	7	of	of	ADP
aiua-12869	91	8	inflammation	inflammation	NOUN
aiua-12869	91	9	pathways	pathway	NOUN
aiua-12869	91	10	in	in	ADP
aiua-12869	91	11	determining	determine	VERB
aiua-12869	91	12	urinary	urinary	ADJ
aiua-12869	91	13	symptoms	symptom	NOUN
aiua-12869	91	14	and	and	CCONJ
aiua-12869	91	15	the	the	DET
aiua-12869	91	16	fact	fact	NOUN
aiua-12869	91	17	that	that	SCONJ
aiua-12869	91	18	such	such	ADJ
aiua-12869	91	19	combination	combination	NOUN
aiua-12869	91	20	of	of	ADP
aiua-12869	91	21	nutraceuticals	nutraceutical	NOUN
aiua-12869	91	22	may	may	AUX
aiua-12869	91	23	have	have	AUX
aiua-12869	91	24	an	an	DET
aiua-12869	91	25	equal	equal	ADJ
aiua-12869	91	26	or	or	CCONJ
aiua-12869	91	27	even	even	ADV
aiua-12869	91	28	slightly	slightly	ADV
aiua-12869	91	29	stronger	strong	ADJ
aiua-12869	91	30	anti	anti	ADJ
aiua-12869	91	31	-	-	ADJ
aiua-12869	91	32	inflammatory	inflammatory	ADJ
aiua-12869	91	33	effect	effect	NOUN
aiua-12869	91	34	compared	compare	VERB
aiua-12869	91	35	to	to	ADP
aiua-12869	91	36	that	that	PRON
aiua-12869	91	37	of	of	ADP
aiua-12869	91	38	5	5	NUM
aiua-12869	91	39	-	-	PUNCT
aiua-12869	91	40	ari	ari	PROPN
aiua-12869	91	41	dutasteride	dutasteride	PROPN
aiua-12869	91	42	in	in	ADP
aiua-12869	91	43	bph	bph	NOUN
aiua-12869	91	44	,	,	PUNCT
aiua-12869	91	45	thus	thus	ADV
aiua-12869	91	46	undermining	undermine	VERB
aiua-12869	91	47	the	the	DET
aiua-12869	91	48	importance	importance	NOUN
aiua-12869	91	49	of	of	ADP
aiua-12869	91	50	the	the	DET
aiua-12869	91	51	absolute	absolute	ADJ
aiua-12869	91	52	value	value	NOUN
aiua-12869	91	53	of	of	ADP
aiua-12869	91	54	the	the	DET
aiua-12869	91	55	prostate	prostate	NOUN
aiua-12869	91	56	volume	volume	NOUN
aiua-12869	91	57	,	,	PUNCT
aiua-12869	91	58	main	main	ADJ
aiua-12869	91	59	target	target	NOUN
aiua-12869	91	60	of	of	ADP
aiua-12869	91	61	5	5	NUM
aiua-12869	91	62	-	-	PUNCT
aiua-12869	91	63	aris	aris	NOUN
aiua-12869	91	64	,	,	PUNCT
aiua-12869	91	65	in	in	ADP
aiua-12869	91	66	causing	cause	VERB
aiua-12869	91	67	bph	bph	NOUN
aiua-12869	91	68	-	-	PUNCT
aiua-12869	91	69	related	relate	VERB
aiua-12869	91	70	luts	lut	NOUN
aiua-12869	91	71	.	.	PUNCT
aiua-12869	92	1	however	however	ADV
aiua-12869	92	2	,	,	PUNCT
aiua-12869	92	3	it	it	PRON
aiua-12869	92	4	is	be	AUX
aiua-12869	92	5	important	important	ADJ
aiua-12869	92	6	to	to	PART
aiua-12869	92	7	acknowledge	acknowledge	VERB
aiua-12869	92	8	the	the	DET
aiua-12869	92	9	intrinsic	intrinsic	ADJ
aiua-12869	92	10	limits	limit	NOUN
aiua-12869	92	11	of	of	ADP
aiua-12869	92	12	this	this	DET
aiua-12869	92	13	study	study	NOUN
aiua-12869	92	14	.	.	PUNCT
aiua-12869	93	1	the	the	DET
aiua-12869	93	2	limited	limited	ADJ
aiua-12869	93	3	number	number	NOUN
aiua-12869	93	4	of	of	ADP
aiua-12869	93	5	patients	patient	NOUN
aiua-12869	93	6	,	,	PUNCT
aiua-12869	93	7	and	and	CCONJ
aiua-12869	93	8	the	the	DET
aiua-12869	93	9	fact	fact	NOUN
aiua-12869	93	10	that	that	SCONJ
aiua-12869	93	11	most	most	ADJ
aiua-12869	93	12	of	of	ADP
aiua-12869	93	13	them	they	PRON
aiua-12869	93	14	had	have	AUX
aiua-12869	93	15	seen	see	VERB
aiua-12869	93	16	a	a	DET
aiua-12869	93	17	urologist	urologist	NOUN
aiua-12869	93	18	prior	prior	ADV
aiua-12869	93	19	to	to	ADP
aiua-12869	93	20	the	the	DET
aiua-12869	93	21	inclusion	inclusion	NOUN
aiua-12869	93	22	in	in	ADP
aiua-12869	93	23	the	the	DET
aiua-12869	93	24	study	study	NOUN
aiua-12869	93	25	,	,	PUNCT
aiua-12869	93	26	hence	hence	ADV
aiua-12869	93	27	probably	probably	ADV
aiua-12869	93	28	being	be	AUX
aiua-12869	93	29	exposed	expose	VERB
aiua-12869	93	30	to	to	ADP
aiua-12869	93	31	serenoa	serenoa	ADJ
aiua-12869	93	32	repens	repen	NOUN
aiua-12869	93	33	and/or	and/or	CCONJ
aiua-12869	93	34	modifications	modification	NOUN
aiua-12869	93	35	of	of	ADP
aiua-12869	93	36	their	their	PRON
aiua-12869	93	37	lifestyle	lifestyle	NOUN
aiua-12869	93	38	,	,	PUNCT
aiua-12869	93	39	could	could	AUX
aiua-12869	93	40	have	have	AUX
aiua-12869	93	41	affected	affect	VERB
aiua-12869	93	42	the	the	DET
aiua-12869	93	43	astonishing	astonishing	ADJ
aiua-12869	93	44	result	result	NOUN
aiua-12869	93	45	that	that	SCONJ
aiua-12869	93	46	we	we	PRON
aiua-12869	93	47	have	have	AUX
aiua-12869	93	48	obtained	obtain	VERB
aiua-12869	93	49	regarding	regard	VERB
aiua-12869	93	50	the	the	DET
aiua-12869	93	51	ufm	ufm	NOUN
aiua-12869	93	52	parameters	parameter	NOUN
aiua-12869	93	53	.	.	PUNCT
aiua-12869	94	1	the	the	DET
aiua-12869	94	2	role	role	NOUN
aiua-12869	94	3	of	of	ADP
aiua-12869	94	4	prostate	prostate	NOUN
aiua-12869	94	5	inflammation	inflammation	NOUN
aiua-12869	94	6	in	in	ADP
aiua-12869	94	7	determining	determine	VERB
aiua-12869	94	8	bphrelated	bphrelate	VERB
aiua-12869	94	9	luts	luts	PROPN
aiua-12869	94	10	is	be	AUX
aiua-12869	94	11	controversial	controversial	ADJ
aiua-12869	94	12	and	and	CCONJ
aiua-12869	94	13	many	many	ADJ
aiua-12869	94	14	studies	study	NOUN
aiua-12869	94	15	are	be	AUX
aiua-12869	94	16	being	be	AUX
aiua-12869	94	17	conducted	conduct	VERB
aiua-12869	94	18	as	as	ADP
aiua-12869	94	19	to	to	PART
aiua-12869	94	20	explain	explain	VERB
aiua-12869	94	21	its	its	PRON
aiua-12869	94	22	exact	exact	ADJ
aiua-12869	94	23	role	role	NOUN
aiua-12869	94	24	in	in	ADP
aiua-12869	94	25	the	the	DET
aiua-12869	94	26	pathophysiology	pathophysiology	NOUN
aiua-12869	94	27	of	of	ADP
aiua-12869	94	28	bph	bph	NOUN
aiua-12869	94	29	.	.	PUNCT
aiua-12869	95	1	it	it	PRON
aiua-12869	95	2	is	be	AUX
aiua-12869	95	3	well	well	ADV
aiua-12869	95	4	known	know	VERB
aiua-12869	95	5	that	that	SCONJ
aiua-12869	95	6	prostate	prostate	NOUN
aiua-12869	95	7	tissue	tissue	NOUN
aiua-12869	95	8	affected	affect	VERB
aiua-12869	95	9	by	by	ADP
aiua-12869	95	10	bph	bph	NOUN
aiua-12869	95	11	carries	carry	VERB
aiua-12869	95	12	a	a	DET
aiua-12869	95	13	particular	particular	ADJ
aiua-12869	95	14	kind	kind	NOUN
aiua-12869	95	15	of	of	ADP
aiua-12869	95	16	inflammatory	inflammatory	ADJ
aiua-12869	95	17	infiltrate	infiltrate	NOUN
aiua-12869	95	18	(	(	PUNCT
aiua-12869	95	19	cd3	cd3	VERB
aiua-12869	95	20	+	+	PROPN
aiua-12869	95	21	t	t	NOUN
aiua-12869	95	22	lymphocytes	lymphocyte	VERB
aiua-12869	95	23	,	,	PUNCT
aiua-12869	95	24	cd19	cd19	PROPN
aiua-12869	95	25	or	or	CCONJ
aiua-12869	95	26	cd20	cd20	PROPN
aiua-12869	95	27	b	b	PROPN
aiua-12869	95	28	lymphocytes	lymphocyte	NOUN
aiua-12869	95	29	,	,	PUNCT
aiua-12869	95	30	and	and	CCONJ
aiua-12869	95	31	macrophages	macrophage	NOUN
aiua-12869	95	32	)	)	PUNCT
aiua-12869	95	33	.	.	PUNCT
aiua-12869	96	1	most	most	ADJ
aiua-12869	96	2	t	t	NOUN
aiua-12869	96	3	cells	cell	NOUN
aiua-12869	96	4	in	in	ADP
aiua-12869	96	5	the	the	DET
aiua-12869	96	6	inflammatory	inflammatory	ADJ
aiua-12869	96	7	areas	area	NOUN
aiua-12869	96	8	are	be	AUX
aiua-12869	96	9	cd4	cd4	PROPN
aiua-12869	96	10	+	+	PROPN
aiua-12869	96	11	that	that	PRON
aiua-12869	96	12	are	be	AUX
aiua-12869	96	13	not	not	PART
aiua-12869	96	14	present	present	ADJ
aiua-12869	96	15	in	in	ADP
aiua-12869	96	16	normal	normal	ADJ
aiua-12869	96	17	prostate	prostate	NOUN
aiua-12869	96	18	tissue	tissue	NOUN
aiua-12869	96	19	(	(	PUNCT
aiua-12869	96	20	scattered	scatter	VERB
aiua-12869	96	21	stromal	stromal	ADJ
aiua-12869	96	22	and	and	CCONJ
aiua-12869	96	23	intraepithelial	intraepithelial	ADJ
aiua-12869	96	24	t	t	PROPN
aiua-12869	96	25	,	,	PUNCT
aiua-12869	96	26	70	70	NUM
aiua-12869	96	27	%	%	NOUN
aiua-12869	96	28	of	of	ADP
aiua-12869	96	29	which	which	PRON
aiua-12869	96	30	are	be	AUX
aiua-12869	96	31	cd8	cd8	PROPN
aiua-12869	96	32	+	+	PROPN
aiua-12869	96	33	,	,	PUNCT
aiua-12869	96	34	and	and	CCONJ
aiua-12869	96	35	b	b	X
aiua-12869	96	36	lymphocytes	lymphocyte	NOUN
aiua-12869	96	37	,	,	PUNCT
aiua-12869	96	38	macrophages	macrophage	NOUN
aiua-12869	96	39	,	,	PUNCT
aiua-12869	96	40	and	and	CCONJ
aiua-12869	96	41	mast	mast	NOUN
aiua-12869	96	42	cells	cell	NOUN
aiua-12869	96	43	)	)	PUNCT
aiua-12869	96	44	.	.	PUNCT
aiua-12869	97	1	however	however	ADV
aiua-12869	97	2	,	,	PUNCT
aiua-12869	97	3	the	the	DET
aiua-12869	97	4	stimulus	stimulus	NOUN
aiua-12869	97	5	for	for	ADP
aiua-12869	97	6	an	an	DET
aiua-12869	97	7	inflammatory	inflammatory	ADJ
aiua-12869	97	8	response	response	NOUN
aiua-12869	97	9	in	in	ADP
aiua-12869	97	10	the	the	DET
aiua-12869	97	11	prostates	prostate	NOUN
aiua-12869	97	12	of	of	ADP
aiua-12869	97	13	older	old	ADJ
aiua-12869	97	14	males	male	NOUN
aiua-12869	97	15	is	be	AUX
aiua-12869	97	16	not	not	PART
aiua-12869	97	17	fully	fully	ADV
aiua-12869	97	18	understood	understand	VERB
aiua-12869	97	19	and	and	CCONJ
aiua-12869	97	20	it	it	PRON
aiua-12869	97	21	is	be	AUX
aiua-12869	97	22	likely	likely	ADJ
aiua-12869	97	23	to	to	PART
aiua-12869	97	24	be	be	AUX
aiua-12869	97	25	multifactorial	multifactorial	ADJ
aiua-12869	97	26	(	(	PUNCT
aiua-12869	97	27	18	18	NUM
aiua-12869	97	28	)	)	PUNCT
aiua-12869	97	29	.	.	PUNCT
aiua-12869	98	1	in	in	ADP
aiua-12869	98	2	an	an	DET
aiua-12869	98	3	interesting	interesting	ADJ
aiua-12869	98	4	clinical	clinical	ADJ
aiua-12869	98	5	study	study	NOUN
aiua-12869	98	6	,	,	PUNCT
aiua-12869	98	7	kwon	kwon	VERB
aiua-12869	98	8	et	et	PROPN
aiua-12869	98	9	al	al	PROPN
aiua-12869	98	10	.	.	PROPN
aiua-12869	98	11	observed	observe	VERB
aiua-12869	98	12	that	that	SCONJ
aiua-12869	98	13	in	in	ADP
aiua-12869	98	14	patients	patient	NOUN
aiua-12869	98	15	with	with	ADP
aiua-12869	98	16	high	high	ADJ
aiua-12869	98	17	-	-	PUNCT
aiua-12869	98	18	grade	grade	NOUN
aiua-12869	98	19	prostatic	prostatic	ADJ
aiua-12869	98	20	inflammation	inflammation	NOUN
aiua-12869	98	21	,	,	PUNCT
aiua-12869	98	22	the	the	DET
aiua-12869	98	23	use	use	NOUN
aiua-12869	98	24	of	of	ADP
aiua-12869	98	25	ablockers	ablocker	NOUN
aiua-12869	98	26	with	with	ADP
aiua-12869	98	27	5	5	NUM
aiua-12869	98	28	-	-	PUNCT
aiua-12869	98	29	aris	aris	NOUN
aiua-12869	98	30	can	can	AUX
aiua-12869	98	31	be	be	AUX
aiua-12869	98	32	insufficient	insufficient	ADJ
aiua-12869	98	33	to	to	PART
aiua-12869	98	34	reduce	reduce	VERB
aiua-12869	98	35	symptom	symptom	NOUN
aiua-12869	98	36	severity	severity	NOUN
aiua-12869	98	37	.	.	PUNCT
aiua-12869	99	1	patients	patient	NOUN
aiua-12869	99	2	with	with	ADP
aiua-12869	99	3	highgrade	highgrade	NOUN
aiua-12869	99	4	chronic	chronic	ADJ
aiua-12869	99	5	inflammation	inflammation	NOUN
aiua-12869	99	6	reported	report	VERB
aiua-12869	99	7	significantly	significantly	ADV
aiua-12869	99	8	lower	low	ADJ
aiua-12869	99	9	changes	change	NOUN
aiua-12869	99	10	in	in	ADP
aiua-12869	99	11	ipss	ipss	PROPN
aiua-12869	99	12	and	and	CCONJ
aiua-12869	99	13	storage	storage	NOUN
aiua-12869	99	14	symptom	symptom	NOUN
aiua-12869	99	15	scores	score	NOUN
aiua-12869	99	16	compared	compare	VERB
aiua-12869	99	17	to	to	ADP
aiua-12869	99	18	patients	patient	NOUN
aiua-12869	99	19	with	with	ADP
aiua-12869	99	20	lowgrade	lowgrade	NOUN
aiua-12869	99	21	inflammation	inflammation	NOUN
aiua-12869	99	22	(	(	PUNCT
aiua-12869	99	23	19	19	NUM
aiua-12869	99	24	)	)	PUNCT
aiua-12869	99	25	.	.	PUNCT
aiua-12869	100	1	a	a	DET
aiua-12869	100	2	meta	meta	ADJ
aiua-12869	100	3	-	-	PUNCT
aiua-12869	100	4	analysis	analysis	NOUN
aiua-12869	100	5	of	of	ADP
aiua-12869	100	6	three	three	NUM
aiua-12869	100	7	randomized	randomized	ADJ
aiua-12869	100	8	controlled	control	VERB
aiua-12869	100	9	trials	trial	NOUN
aiua-12869	100	10	showed	show	VERB
aiua-12869	100	11	that	that	SCONJ
aiua-12869	100	12	non	non	ADJ
aiua-12869	100	13	-	-	ADJ
aiua-12869	100	14	steroidal	steroidal	ADJ
aiua-12869	100	15	antiinflammatory	antiinflammatory	NOUN
aiua-12869	100	16	drugs	drug	NOUN
aiua-12869	100	17	(	(	PUNCT
aiua-12869	100	18	nsaids	nsaid	NOUN
aiua-12869	100	19	)	)	PUNCT
aiua-12869	100	20	,	,	PUNCT
aiua-12869	100	21	when	when	SCONJ
aiua-12869	100	22	given	give	VERB
aiua-12869	100	23	over	over	ADP
aiua-12869	100	24	periods	period	NOUN
aiua-12869	100	25	of	of	ADP
aiua-12869	100	26	4	4	NUM
aiua-12869	100	27	-	-	SYM
aiua-12869	100	28	24	24	NUM
aiua-12869	100	29	weeks	week	NOUN
aiua-12869	100	30	,	,	PUNCT
aiua-12869	100	31	improved	improve	VERB
aiua-12869	100	32	symptoms	symptom	NOUN
aiua-12869	100	33	by	by	ADP
aiua-12869	100	34	2.9	2.9	NUM
aiua-12869	100	35	ipss	ipss	PROPN
aiua-12869	100	36	points	point	NOUN
aiua-12869	100	37	and	and	CCONJ
aiua-12869	100	38	flow	flow	NOUN
aiua-12869	100	39	by	by	ADP
aiua-12869	100	40	0.89	0.89	NUM
aiua-12869	100	41	ml	ml	NOUN
aiua-12869	100	42	/	/	SYM
aiua-12869	100	43	second	second	ADJ
aiua-12869	100	44	(	(	PUNCT
aiua-12869	100	45	20	20	NUM
aiua-12869	100	46	)	)	PUNCT
aiua-12869	100	47	.	.	PUNCT
aiua-12869	101	1	these	these	DET
aiua-12869	101	2	studies	study	NOUN
aiua-12869	101	3	suggest	suggest	VERB
aiua-12869	101	4	the	the	DET
aiua-12869	101	5	need	need	NOUN
aiua-12869	101	6	to	to	PART
aiua-12869	101	7	treat	treat	VERB
aiua-12869	101	8	inflammation	inflammation	NOUN
aiua-12869	101	9	accordingly	accordingly	ADV
aiua-12869	101	10	,	,	PUNCT
aiua-12869	101	11	a	a	DET
aiua-12869	101	12	field	field	NOUN
aiua-12869	101	13	in	in	ADP
aiua-12869	101	14	which	which	PRON
aiua-12869	101	15	nutraceuticals	nutraceutical	NOUN
aiua-12869	101	16	seem	seem	VERB
aiua-12869	101	17	to	to	PART
aiua-12869	101	18	have	have	VERB
aiua-12869	101	19	convincing	convincing	ADJ
aiua-12869	101	20	possibilities	possibility	NOUN
aiua-12869	101	21	.	.	PUNCT
aiua-12869	102	1	conclusions	conclusion	NOUN
aiua-12869	102	2	both	both	DET
aiua-12869	102	3	nutraceutical	nutraceutical	ADJ
aiua-12869	102	4	complex	complex	NOUN
aiua-12869	102	5	and	and	CCONJ
aiua-12869	102	6	dutasteride	dutasteride	NOUN
aiua-12869	102	7	showed	show	VERB
aiua-12869	102	8	reduction	reduction	NOUN
aiua-12869	102	9	of	of	ADP
aiua-12869	102	10	psa	psa	NOUN
aiua-12869	102	11	values	value	NOUN
aiua-12869	102	12	after	after	ADP
aiua-12869	102	13	6	6	NUM
aiua-12869	102	14	months	month	NOUN
aiua-12869	102	15	of	of	ADP
aiua-12869	102	16	treatment	treatment	NOUN
aiua-12869	102	17	.	.	PUNCT
aiua-12869	103	1	the	the	DET
aiua-12869	103	2	complex	complex	NOUN
aiua-12869	103	3	based	base	VERB
aiua-12869	103	4	on	on	ADP
aiua-12869	103	5	phycocyanin	phycocyanin	ADV
aiua-12869	103	6	,	,	PUNCT
aiua-12869	103	7	pea	pea	NOUN
aiua-12869	103	8	and	and	CCONJ
aiua-12869	103	9	selenium	selenium	NOUN
aiua-12869	103	10	showed	show	VERB
aiua-12869	103	11	a	a	DET
aiua-12869	103	12	statistically	statistically	ADV
aiua-12869	103	13	significant	significant	ADJ
aiua-12869	103	14	improvement	improvement	NOUN
aiua-12869	103	15	in	in	ADP
aiua-12869	103	16	urinary	urinary	ADJ
aiua-12869	103	17	flow	flow	NOUN
aiua-12869	103	18	,	,	PUNCT
aiua-12869	103	19	while	while	SCONJ
aiua-12869	103	20	dutasteride	dutasteride	NOUN
aiua-12869	103	21	acted	act	VERB
aiua-12869	103	22	more	more	ADV
aiua-12869	103	23	on	on	ADP
aiua-12869	103	24	the	the	DET
aiua-12869	103	25	volume	volume	NOUN
aiua-12869	103	26	of	of	ADP
aiua-12869	103	27	the	the	DET
aiua-12869	103	28	prostate	prostate	NOUN
aiua-12869	103	29	.	.	PUNCT
aiua-12869	104	1	however	however	ADV
aiua-12869	104	2	,	,	PUNCT
aiua-12869	104	3	the	the	DET
aiua-12869	104	4	natural	natural	ADJ
aiua-12869	104	5	complex	complex	NOUN
aiua-12869	104	6	is	be	AUX
aiua-12869	104	7	a	a	DET
aiua-12869	104	8	product	product	NOUN
aiua-12869	104	9	with	with	ADP
aiua-12869	104	10	good	good	ADJ
aiua-12869	104	11	efficiency	efficiency	NOUN
aiua-12869	104	12	on	on	ADP
aiua-12869	104	13	the	the	DET
aiua-12869	104	14	phlogistic	phlogistic	ADJ
aiua-12869	104	15	component	component	NOUN
aiua-12869	104	16	and	and	CCONJ
aiua-12869	104	17	does	do	AUX
aiua-12869	104	18	not	not	PART
aiua-12869	104	19	have	have	VERB
aiua-12869	104	20	the	the	DET
aiua-12869	104	21	side	side	NOUN
aiua-12869	104	22	effects	effect	NOUN
aiua-12869	104	23	reported	report	VERB
aiua-12869	104	24	for	for	ADP
aiua-12869	104	25	dutasteride	dutasteride	NOUN
aiua-12869	104	26	(	(	PUNCT
aiua-12869	104	27	such	such	ADJ
aiua-12869	104	28	as	as	ADP
aiua-12869	104	29	gynecomastia	gynecomastia	NOUN
aiua-12869	104	30	,	,	PUNCT
aiua-12869	104	31	reduced	reduce	VERB
aiua-12869	104	32	libido	libido	NOUN
aiua-12869	104	33	)	)	PUNCT
aiua-12869	104	34	.	.	PUNCT
aiua-12869	105	1	therefore	therefore	ADV
aiua-12869	105	2	,	,	PUNCT
aiua-12869	105	3	we	we	PRON
aiua-12869	105	4	believe	believe	VERB
aiua-12869	105	5	it	it	PRON
aiua-12869	105	6	can	can	AUX
aiua-12869	105	7	be	be	AUX
aiua-12869	105	8	used	use	VERB
aiua-12869	105	9	by	by	ADP
aiua-12869	105	10	a	a	DET
aiua-12869	105	11	large	large	ADJ
aiua-12869	105	12	part	part	NOUN
aiua-12869	105	13	of	of	ADP
aiua-12869	105	14	the	the	DET
aiua-12869	105	15	bph	bph	NOUN
aiua-12869	105	16	population	population	NOUN
aiua-12869	105	17	,	,	PUNCT
aiua-12869	105	18	in	in	ADP
aiua-12869	105	19	order	order	NOUN
aiua-12869	105	20	to	to	PART
aiua-12869	105	21	reduce	reduce	VERB
aiua-12869	105	22	luts	luts	PROPN
aiua-12869	105	23	and	and	CCONJ
aiua-12869	105	24	psa	psa	VERB
aiua-12869	105	25	and	and	CCONJ
aiua-12869	105	26	improve	improve	VERB
aiua-12869	105	27	urinary	urinary	ADJ
aiua-12869	105	28	flow	flow	NOUN
aiua-12869	105	29	,	,	PUNCT
aiua-12869	105	30	without	without	ADP
aiua-12869	105	31	side	side	NOUN
aiua-12869	105	32	effects	effect	NOUN
aiua-12869	105	33	.	.	PUNCT
aiua-12869	106	1	acknowledgements	acknowledgement	NOUN
aiua-12869	106	2	first	first	ADV
aiua-12869	106	3	of	of	ADP
aiua-12869	106	4	all	all	PRON
aiua-12869	106	5	,	,	PUNCT
aiua-12869	106	6	we	we	PRON
aiua-12869	106	7	thank	thank	VERB
aiua-12869	106	8	the	the	DET
aiua-12869	106	9	patients	patient	NOUN
aiua-12869	106	10	who	who	PRON
aiua-12869	106	11	participated	participate	VERB
aiua-12869	106	12	giving	give	VERB
aiua-12869	106	13	us	we	PRON
aiua-12869	106	14	the	the	DET
aiua-12869	106	15	possibility	possibility	NOUN
aiua-12869	106	16	to	to	PART
aiua-12869	106	17	observe	observe	VERB
aiua-12869	106	18	and	and	CCONJ
aiua-12869	106	19	analyze	analyze	VERB
aiua-12869	106	20	the	the	DET
aiua-12869	106	21	effects	effect	NOUN
aiua-12869	106	22	of	of	ADP
aiua-12869	106	23	the	the	DET
aiua-12869	106	24	therapies	therapy	NOUN
aiua-12869	106	25	.	.	PUNCT
aiua-12869	107	1	we	we	PRON
aiua-12869	107	2	are	be	AUX
aiua-12869	107	3	grateful	grateful	ADJ
aiua-12869	107	4	to	to	ADP
aiua-12869	107	5	all	all	DET
aiua-12869	107	6	the	the	DET
aiua-12869	107	7	staff	staff	NOUN
aiua-12869	107	8	of	of	ADP
aiua-12869	107	9	our	our	PRON
aiua-12869	107	10	institute	institute	NOUN
aiua-12869	107	11	for	for	ADP
aiua-12869	107	12	the	the	DET
aiua-12869	107	13	support	support	NOUN
aiua-12869	107	14	in	in	ADP
aiua-12869	107	15	the	the	DET
aiua-12869	107	16	successful	successful	ADJ
aiua-12869	107	17	completion	completion	NOUN
aiua-12869	107	18	of	of	ADP
aiua-12869	107	19	this	this	DET
aiua-12869	107	20	study	study	NOUN
aiua-12869	107	21	.	.	PUNCT
aiua-12869	108	1	of	of	ADV
aiua-12869	108	2	course	course	ADV
aiua-12869	108	3	we	we	PRON
aiua-12869	108	4	appreciate	appreciate	VERB
aiua-12869	108	5	who	who	PRON
aiua-12869	108	6	provide	provide	VERB
aiua-12869	108	7	financial	financial	ADJ
aiua-12869	108	8	support	support	NOUN
aiua-12869	108	9	to	to	PART
aiua-12869	108	10	publish	publish	VERB
aiua-12869	108	11	this	this	DET
aiua-12869	108	12	manuscript	manuscript	NOUN
aiua-12869	108	13	.	.	PUNCT
aiua-12869	109	1	declaration	declaration	NOUN
aiua-12869	109	2	the	the	DET
aiua-12869	109	3	introduction	introduction	NOUN
aiua-12869	109	4	of	of	ADP
aiua-12869	109	5	ficoxpea	ficoxpea	NOUN
aiua-12869	109	6	®	®	NOUN
aiua-12869	109	7	in	in	ADP
aiua-12869	109	8	the	the	DET
aiua-12869	109	9	commerce	commerce	NOUN
aiua-12869	109	10	was	be	AUX
aiua-12869	109	11	ethically	ethically	ADV
aiua-12869	109	12	approved	approve	VERB
aiua-12869	109	13	and	and	CCONJ
aiua-12869	109	14	officially	officially	ADV
aiua-12869	109	15	notified	notify	VERB
aiua-12869	109	16	at	at	ADP
aiua-12869	109	17	the	the	DET
aiua-12869	109	18	italian	italian	ADJ
aiua-12869	109	19	ministry	ministry	PROPN
aiua-12869	109	20	of	of	ADP
aiua-12869	109	21	health	health	PROPN
aiua-12869	109	22	on	on	ADP
aiua-12869	109	23	16th	16th	ADJ
aiua-12869	109	24	october	october	PROPN
aiua-12869	109	25	2020	2020	NUM
aiua-12869	109	26	.	.	PUNCT
aiua-12869	110	1	all	all	DET
aiua-12869	110	2	patients	patient	NOUN
aiua-12869	110	3	followed	follow	VERB
aiua-12869	110	4	by	by	ADP
aiua-12869	110	5	us	we	PRON
aiua-12869	110	6	accepted	accept	VERB
aiua-12869	110	7	anonymous	anonymous	ADJ
aiua-12869	110	8	data	datum	NOUN
aiua-12869	110	9	collection	collection	NOUN
aiua-12869	110	10	and	and	CCONJ
aiua-12869	110	11	agreed	agree	VERB
aiua-12869	110	12	on	on	ADP
aiua-12869	110	13	its	its	PRON
aiua-12869	110	14	possible	possible	ADJ
aiua-12869	110	15	use	use	NOUN
aiua-12869	110	16	for	for	ADP
aiua-12869	110	17	scientific	scientific	ADJ
aiua-12869	110	18	purposes	purpose	NOUN
aiua-12869	110	19	.	.	PUNCT
aiua-12869	111	1	references	reference	NOUN
aiua-12869	111	2	1	1	NUM
aiua-12869	111	3	.	.	PUNCT
aiua-12869	111	4	gbd	gbd	NOUN
aiua-12869	111	5	2019	2019	NUM
aiua-12869	111	6	benign	benign	ADJ
aiua-12869	111	7	prostatic	prostatic	ADJ
aiua-12869	111	8	hyperplasia	hyperplasia	NOUN
aiua-12869	111	9	collaborators	collaborator	NOUN
aiua-12869	111	10	.	.	PUNCT
aiua-12869	112	1	the	the	DET
aiua-12869	112	2	global	global	ADJ
aiua-12869	112	3	,	,	PUNCT
aiua-12869	112	4	regional	regional	ADJ
aiua-12869	112	5	,	,	PUNCT
aiua-12869	112	6	and	and	CCONJ
aiua-12869	112	7	national	national	ADJ
aiua-12869	112	8	burden	burden	NOUN
aiua-12869	112	9	of	of	ADP
aiua-12869	112	10	benign	benign	ADJ
aiua-12869	112	11	prostatic	prostatic	ADJ
aiua-12869	112	12	hyperplasia	hyperplasia	NOUN
aiua-12869	112	13	in	in	ADP
aiua-12869	112	14	204	204	NUM
aiua-12869	112	15	countries	country	NOUN
aiua-12869	112	16	and	and	CCONJ
aiua-12869	112	17	territories	territory	NOUN
aiua-12869	112	18	from	from	ADP
aiua-12869	112	19	2000	2000	NUM
aiua-12869	112	20	to	to	ADP
aiua-12869	112	21	2019	2019	NUM
aiua-12869	112	22	:	:	PUNCT
aiua-12869	112	23	a	a	DET
aiua-12869	112	24	systematic	systematic	ADJ
aiua-12869	112	25	analysis	analysis	NOUN
aiua-12869	112	26	for	for	ADP
aiua-12869	112	27	the	the	DET
aiua-12869	112	28	global	global	ADJ
aiua-12869	112	29	burden	burden	NOUN
aiua-12869	112	30	of	of	ADP
aiua-12869	112	31	disease	disease	NOUN
aiua-12869	112	32	study	study	NOUN
aiua-12869	112	33	2019	2019	NUM
aiua-12869	112	34	.	.	PUNCT
aiua-12869	113	1	lancet	lancet	VERB
aiua-12869	113	2	healthy	healthy	ADJ
aiua-12869	113	3	longev	longev	NOUN
aiua-12869	113	4	.	.	PUNCT
aiua-12869	113	5	2022	2022	NUM
aiua-12869	113	6	;	;	PUNCT
aiua-12869	113	7	3	3	NUM
aiua-12869	113	8	:	:	PUNCT
aiua-12869	113	9	e754	e754	PROPN
aiua-12869	113	10	-	-	PUNCT
aiua-12869	113	11	e776	e776	PROPN
aiua-12869	113	12	.	.	PUNCT
aiua-12869	114	1	archivio	archivio	NOUN
aiua-12869	114	2	italiano	italiano	PROPN
aiua-12869	114	3	di	di	PROPN
aiua-12869	114	4	urologia	urologia	PROPN
aiua-12869	114	5	e	e	PROPN
aiua-12869	114	6	andrologia	andrologia	NOUN
aiua-12869	114	7	2024	2024	NUM
aiua-12869	114	8	;	;	PUNCT
aiua-12869	114	9	96(3):12869	96(3):12869	NUM
aiua-12869	114	10	5	5	NUM
aiua-12869	114	11	phytochemicals	phytochemical	NOUN
aiua-12869	114	12	versus	versus	ADP
aiua-12869	114	13	dutasteride	dutasteride	NOUN
aiua-12869	114	14	for	for	ADP
aiua-12869	114	15	luts	luts	PROPN
aiua-12869	114	16	due	due	ADP
aiua-12869	114	17	to	to	ADP
aiua-12869	114	18	bph	bph	NOUN
aiua-12869	114	19	2	2	NUM
aiua-12869	114	20	.	.	NOUN
aiua-12869	114	21	blankstein	blankstein	PROPN
aiua-12869	114	22	u	u	PROPN
aiua-12869	114	23	,	,	PUNCT
aiua-12869	114	24	van	van	PROPN
aiua-12869	114	25	asseldonk	asseldonk	PROPN
aiua-12869	114	26	b	b	PROPN
aiua-12869	114	27	,	,	PUNCT
aiua-12869	114	28	elterman	elterman	ADJ
aiua-12869	114	29	ds	ds	PROPN
aiua-12869	114	30	.	.	PROPN
aiua-12869	114	31	bph	bph	NOUN
aiua-12869	114	32	update	update	NOUN
aiua-12869	114	33	:	:	PUNCT
aiua-12869	114	34	medical	medical	ADJ
aiua-12869	114	35	versus	versus	ADP
aiua-12869	114	36	interventional	interventional	ADJ
aiua-12869	114	37	management	management	NOUN
aiua-12869	114	38	.	.	PUNCT
aiua-12869	115	1	can	can	AUX
aiua-12869	115	2	j	j	PROPN
aiua-12869	115	3	urol	urol	PROPN
aiua-12869	115	4	.	.	PROPN
aiua-12869	116	1	2016	2016	NUM
aiua-12869	116	2	;	;	PUNCT
aiua-12869	116	3	23(suppl	23(suppl	NUM
aiua-12869	116	4	1):10	1):10	NUM
aiua-12869	116	5	-	-	SYM
aiua-12869	116	6	5	5	NUM
aiua-12869	116	7	.	.	NOUN
aiua-12869	116	8	3	3	X
aiua-12869	116	9	.	.	X
aiua-12869	117	1	van	van	PROPN
aiua-12869	117	2	asseldonk	asseldonk	PROPN
aiua-12869	117	3	b	b	PROPN
aiua-12869	117	4	,	,	PUNCT
aiua-12869	117	5	barkin	barkin	PROPN
aiua-12869	117	6	j	j	PROPN
aiua-12869	117	7	,	,	PUNCT
aiua-12869	117	8	elterman	elterman	NOUN
aiua-12869	117	9	ds	ds	PROPN
aiua-12869	117	10	.	.	PROPN
aiua-12869	117	11	medical	medical	ADJ
aiua-12869	117	12	therapy	therapy	NOUN
aiua-12869	117	13	for	for	ADP
aiua-12869	117	14	benign	benign	ADJ
aiua-12869	117	15	prostatic	prostatic	ADJ
aiua-12869	117	16	hyperplasia	hyperplasia	NOUN
aiua-12869	117	17	:	:	PUNCT
aiua-12869	117	18	a	a	DET
aiua-12869	117	19	review	review	NOUN
aiua-12869	117	20	.	.	PUNCT
aiua-12869	118	1	can	can	AUX
aiua-12869	118	2	j	j	PROPN
aiua-12869	118	3	urol	urol	PROPN
aiua-12869	118	4	.	.	PUNCT
aiua-12869	119	1	2015	2015	NUM
aiua-12869	119	2	;	;	PUNCT
aiua-12869	119	3	22	22	NUM
aiua-12869	119	4	suppl	suppl	ADJ
aiua-12869	119	5	1:7	1:7	NUM
aiua-12869	119	6	-	-	SYM
aiua-12869	119	7	17	17	NUM
aiua-12869	119	8	.	.	PUNCT
aiua-12869	120	1	4	4	NUM
aiua-12869	120	2	.	.	X
aiua-12869	120	3	alcaraz	alcaraz	PROPN
aiua-12869	120	4	a	a	PRON
aiua-12869	120	5	,	,	PUNCT
aiua-12869	120	6	rodríguez	rodríguez	NOUN
aiua-12869	120	7	-	-	PUNCT
aiua-12869	120	8	antolín	antolín	NOUN
aiua-12869	120	9	a	a	PRON
aiua-12869	120	10	,	,	PUNCT
aiua-12869	120	11	carballido	carballido	NOUN
aiua-12869	120	12	-	-	PUNCT
aiua-12869	120	13	rodríguez	rodríguez	NOUN
aiua-12869	120	14	j	j	PROPN
aiua-12869	120	15	,	,	PUNCT
aiua-12869	120	16	et	et	PROPN
aiua-12869	120	17	al	al	PROPN
aiua-12869	120	18	.	.	PROPN
aiua-12869	120	19	efficacy	efficacy	NOUN
aiua-12869	120	20	and	and	CCONJ
aiua-12869	120	21	tolerability	tolerability	NOUN
aiua-12869	120	22	of	of	ADP
aiua-12869	120	23	the	the	DET
aiua-12869	120	24	hexanic	hexanic	ADJ
aiua-12869	120	25	extract	extract	NOUN
aiua-12869	120	26	of	of	ADP
aiua-12869	120	27	serenoa	serenoa	ADJ
aiua-12869	120	28	repens	repen	NOUN
aiua-12869	120	29	compared	compare	VERB
aiua-12869	120	30	to	to	PART
aiua-12869	120	31	tamsulosin	tamsulosin	VERB
aiua-12869	120	32	in	in	ADP
aiua-12869	120	33	moderate	moderate	ADJ
aiua-12869	120	34	-	-	PUNCT
aiua-12869	120	35	severe	severe	ADJ
aiua-12869	120	36	luts	luts	PROPN
aiua-12869	120	37	-	-	PUNCT
aiua-12869	120	38	bph	bph	NOUN
aiua-12869	120	39	patients	patient	NOUN
aiua-12869	120	40	.	.	PUNCT
aiua-12869	121	1	sci	sci	PROPN
aiua-12869	121	2	rep	rep	PROPN
aiua-12869	121	3	.	.	PROPN
aiua-12869	121	4	2021	2021	NUM
aiua-12869	121	5	;	;	PUNCT
aiua-12869	121	6	11:19401	11:19401	X
aiua-12869	121	7	.	.	NOUN
aiua-12869	121	8	5	5	NUM
aiua-12869	121	9	.	.	X
aiua-12869	121	10	cai	cai	PROPN
aiua-12869	121	11	t	t	PROPN
aiua-12869	121	12	,	,	PUNCT
aiua-12869	121	13	cui	cui	VERB
aiua-12869	121	14	y	y	PROPN
aiua-12869	121	15	,	,	PUNCT
aiua-12869	121	16	yu	yu	PROPN
aiua-12869	121	17	s	s	PROPN
aiua-12869	121	18	,	,	PUNCT
aiua-12869	121	19	et	et	PROPN
aiua-12869	121	20	al	al	PROPN
aiua-12869	121	21	.	.	PROPN
aiua-12869	121	22	comparison	comparison	NOUN
aiua-12869	121	23	of	of	ADP
aiua-12869	121	24	serenoa	serenoa	PROPN
aiua-12869	121	25	repens	repen	NOUN
aiua-12869	121	26	with	with	ADP
aiua-12869	121	27	tamsulosin	tamsulosin	NOUN
aiua-12869	121	28	in	in	ADP
aiua-12869	121	29	the	the	DET
aiua-12869	121	30	treatment	treatment	NOUN
aiua-12869	121	31	of	of	ADP
aiua-12869	121	32	benign	benign	ADJ
aiua-12869	121	33	prostatic	prostatic	ADJ
aiua-12869	121	34	hyperplasia	hyperplasia	NOUN
aiua-12869	121	35	:	:	PUNCT
aiua-12869	121	36	a	a	DET
aiua-12869	121	37	systematic	systematic	ADJ
aiua-12869	121	38	review	review	NOUN
aiua-12869	121	39	and	and	CCONJ
aiua-12869	121	40	meta	meta	ADJ
aiua-12869	121	41	-	-	PUNCT
aiua-12869	121	42	analysis	analysis	NOUN
aiua-12869	121	43	.	.	PUNCT
aiua-12869	122	1	am	be	AUX
aiua-12869	122	2	j	j	PROPN
aiua-12869	122	3	mens	mens	PROPN
aiua-12869	122	4	health	health	NOUN
aiua-12869	122	5	.	.	PUNCT
aiua-12869	123	1	2020	2020	NUM
aiua-12869	123	2	;	;	PUNCT
aiua-12869	123	3	14:1557988320905407	14:1557988320905407	X
aiua-12869	123	4	.	.	NOUN
aiua-12869	123	5	6	6	NUM
aiua-12869	123	6	.	.	X
aiua-12869	124	1	alcaraz	alcaraz	PROPN
aiua-12869	124	2	a	a	PRON
aiua-12869	124	3	,	,	PUNCT
aiua-12869	124	4	rodríguez	rodríguez	NOUN
aiua-12869	124	5	-	-	PUNCT
aiua-12869	124	6	antolín	antolín	NOUN
aiua-12869	124	7	a	a	PRON
aiua-12869	124	8	,	,	PUNCT
aiua-12869	124	9	carballido	carballido	NOUN
aiua-12869	124	10	-	-	PUNCT
aiua-12869	124	11	rodríguez	rodríguez	NOUN
aiua-12869	124	12	j	j	PROPN
aiua-12869	124	13	,	,	PUNCT
aiua-12869	124	14	et	et	PROPN
aiua-12869	124	15	al	al	PROPN
aiua-12869	124	16	.	.	PUNCT
aiua-12869	125	1	the	the	DET
aiua-12869	125	2	qualiprost	qualiprost	NOUN
aiua-12869	125	3	study	study	NOUN
aiua-12869	125	4	group	group	NOUN
aiua-12869	125	5	obo	obo	PROPN
aiua-12869	125	6	.	.	PUNCT
aiua-12869	126	1	clinical	clinical	ADJ
aiua-12869	126	2	benefit	benefit	NOUN
aiua-12869	126	3	of	of	ADP
aiua-12869	126	4	tamsulosin	tamsulosin	NOUN
aiua-12869	126	5	and	and	CCONJ
aiua-12869	126	6	the	the	DET
aiua-12869	126	7	hexanic	hexanic	ADJ
aiua-12869	126	8	extract	extract	NOUN
aiua-12869	126	9	of	of	ADP
aiua-12869	126	10	serenoa	serenoa	ADJ
aiua-12869	126	11	repens	repen	NOUN
aiua-12869	126	12	,	,	PUNCT
aiua-12869	126	13	in	in	ADP
aiua-12869	126	14	combination	combination	NOUN
aiua-12869	126	15	or	or	CCONJ
aiua-12869	126	16	as	as	ADP
aiua-12869	126	17	monotherapy	monotherapy	NOUN
aiua-12869	126	18	,	,	PUNCT
aiua-12869	126	19	in	in	ADP
aiua-12869	126	20	patients	patient	NOUN
aiua-12869	126	21	with	with	ADP
aiua-12869	126	22	moderate	moderate	ADJ
aiua-12869	126	23	/	/	SYM
aiua-12869	126	24	severe	severe	ADJ
aiua-12869	126	25	luts	luts	PROPN
aiua-12869	126	26	-	-	PUNCT
aiua-12869	126	27	bph	bph	NOUN
aiua-12869	126	28	:	:	PUNCT
aiua-12869	126	29	a	a	DET
aiua-12869	126	30	subset	subset	ADJ
aiua-12869	126	31	analysis	analysis	NOUN
aiua-12869	126	32	of	of	ADP
aiua-12869	126	33	the	the	DET
aiua-12869	126	34	qualiprost	qualiprost	NOUN
aiua-12869	126	35	study	study	NOUN
aiua-12869	126	36	.	.	PUNCT
aiua-12869	127	1	j	j	PROPN
aiua-12869	127	2	clin	clin	PROPN
aiua-12869	127	3	med	med	PROPN
aiua-12869	127	4	.	.	PUNCT
aiua-12869	127	5	2020	2020	NUM
aiua-12869	127	6	;	;	PUNCT
aiua-12869	128	1	9:2909	9:2909	X
aiua-12869	128	2	.	.	NOUN
aiua-12869	128	3	7	7	NUM
aiua-12869	128	4	.	.	X
aiua-12869	128	5	cicero	cicero	PROPN
aiua-12869	128	6	afg	afg	PROPN
aiua-12869	128	7	,	,	PUNCT
aiua-12869	128	8	allkanjari	allkanjari	ADJ
aiua-12869	128	9	o	o	NOUN
aiua-12869	128	10	,	,	PUNCT
aiua-12869	128	11	busetto	busetto	PROPN
aiua-12869	128	12	gm	gm	PROPN
aiua-12869	128	13	,	,	PUNCT
aiua-12869	128	14	et	et	PROPN
aiua-12869	128	15	al	al	PROPN
aiua-12869	128	16	.	.	PROPN
aiua-12869	128	17	nutraceutical	nutraceutical	ADJ
aiua-12869	128	18	treatment	treatment	NOUN
aiua-12869	128	19	and	and	CCONJ
aiua-12869	128	20	prevention	prevention	NOUN
aiua-12869	128	21	of	of	ADP
aiua-12869	128	22	benign	benign	ADJ
aiua-12869	128	23	prostatic	prostatic	ADJ
aiua-12869	128	24	hyperplasia	hyperplasia	NOUN
aiua-12869	128	25	and	and	CCONJ
aiua-12869	128	26	prostate	prostate	NOUN
aiua-12869	128	27	cancer	cancer	NOUN
aiua-12869	128	28	.	.	PUNCT
aiua-12869	129	1	arch	arch	PROPN
aiua-12869	129	2	ital	ital	PROPN
aiua-12869	129	3	urol	urol	PROPN
aiua-12869	129	4	androl	androl	PROPN
aiua-12869	129	5	.	.	PROPN
aiua-12869	129	6	2019	2019	NUM
aiua-12869	129	7	;	;	PUNCT
aiua-12869	129	8	91:139	91:139	NUM
aiua-12869	129	9	8	8	NUM
aiua-12869	129	10	.	.	PUNCT
aiua-12869	130	1	petrosino	petrosino	PROPN
aiua-12869	130	2	s	s	PROPN
aiua-12869	130	3	,	,	PUNCT
aiua-12869	130	4	di	di	NOUN
aiua-12869	130	5	marzo	marzo	NOUN
aiua-12869	130	6	v.	v.	ADP
aiua-12869	130	7	the	the	DET
aiua-12869	130	8	pharmacology	pharmacology	NOUN
aiua-12869	130	9	of	of	ADP
aiua-12869	130	10	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-12869	130	11	and	and	CCONJ
aiua-12869	130	12	first	first	ADJ
aiua-12869	130	13	data	datum	NOUN
aiua-12869	130	14	on	on	ADP
aiua-12869	130	15	the	the	DET
aiua-12869	130	16	therapeutic	therapeutic	ADJ
aiua-12869	130	17	efficacy	efficacy	NOUN
aiua-12869	130	18	of	of	ADP
aiua-12869	130	19	some	some	PRON
aiua-12869	130	20	of	of	ADP
aiua-12869	130	21	its	its	PRON
aiua-12869	130	22	new	new	ADJ
aiua-12869	130	23	formulations	formulation	NOUN
aiua-12869	130	24	.	.	PUNCT
aiua-12869	131	1	br	br	PROPN
aiua-12869	131	2	j	j	PROPN
aiua-12869	131	3	pharmacol	pharmacol	PROPN
aiua-12869	131	4	.	.	PROPN
aiua-12869	132	1	2017	2017	NUM
aiua-12869	132	2	;	;	PUNCT
aiua-12869	132	3	174:1349	174:1349	NUM
aiua-12869	132	4	-	-	SYM
aiua-12869	132	5	1365	1365	NUM
aiua-12869	132	6	.	.	PUNCT
aiua-12869	133	1	9	9	X
aiua-12869	133	2	.	.	X
aiua-12869	133	3	loverme	loverme	PROPN
aiua-12869	133	4	j	j	PROPN
aiua-12869	133	5	,	,	PUNCT
aiua-12869	133	6	russo	russo	PROPN
aiua-12869	133	7	r	r	NOUN
aiua-12869	133	8	,	,	PUNCT
aiua-12869	133	9	la	la	X
aiua-12869	133	10	rana	rana	PROPN
aiua-12869	133	11	g	g	PROPN
aiua-12869	133	12	,	,	PUNCT
aiua-12869	133	13	et	et	PROPN
aiua-12869	133	14	al	al	PROPN
aiua-12869	133	15	.	.	PROPN
aiua-12869	134	1	rapid	rapid	ADJ
aiua-12869	134	2	broad	broad	ADJ
aiua-12869	134	3	-	-	PUNCT
aiua-12869	134	4	spectrum	spectrum	NOUN
aiua-12869	134	5	analgesia	analgesia	NOUN
aiua-12869	134	6	through	through	ADP
aiua-12869	134	7	activation	activation	NOUN
aiua-12869	134	8	of	of	ADP
aiua-12869	134	9	peroxisome	peroxisome	VERB
aiua-12869	134	10	proliferator	proliferator	NOUN
aiua-12869	134	11	-	-	PUNCT
aiua-12869	134	12	activated	activate	VERB
aiua-12869	134	13	receptor	receptor	NOUN
aiua-12869	134	14	-	-	PUNCT
aiua-12869	134	15	alpha	alpha	NOUN
aiua-12869	134	16	.	.	PUNCT
aiua-12869	135	1	j	j	PROPN
aiua-12869	135	2	pharmacol	pharmacol	PROPN
aiua-12869	135	3	exp	exp	NOUN
aiua-12869	135	4	ther	ther	ADV
aiua-12869	135	5	.	.	PUNCT
aiua-12869	136	1	2006	2006	NUM
aiua-12869	136	2	;	;	PUNCT
aiua-12869	136	3	319:1051	319:1051	NUM
aiua-12869	136	4	-	-	SYM
aiua-12869	136	5	61	61	NUM
aiua-12869	136	6	.	.	PUNCT
aiua-12869	137	1	10	10	NUM
aiua-12869	137	2	.	.	PUNCT
aiua-12869	138	1	pessina	pessina	PROPN
aiua-12869	138	2	f	f	PROPN
aiua-12869	138	3	,	,	PUNCT
aiua-12869	138	4	capasso	capasso	ADJ
aiua-12869	138	5	r	r	NOUN
aiua-12869	138	6	,	,	PUNCT
aiua-12869	138	7	borrelli	borrelli	PROPN
aiua-12869	138	8	f	f	X
aiua-12869	138	9	,	,	PUNCT
aiua-12869	138	10	et	et	PROPN
aiua-12869	138	11	al	al	PROPN
aiua-12869	138	12	.	.	PUNCT
aiua-12869	138	13	protective	protective	ADJ
aiua-12869	138	14	effect	effect	NOUN
aiua-12869	138	15	of	of	ADP
aiua-12869	138	16	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-12869	138	17	in	in	ADP
aiua-12869	138	18	a	a	DET
aiua-12869	138	19	rat	rat	NOUN
aiua-12869	138	20	model	model	NOUN
aiua-12869	138	21	of	of	ADP
aiua-12869	138	22	cystitis	cystitis	NOUN
aiua-12869	138	23	.	.	PUNCT
aiua-12869	139	1	j	j	PROPN
aiua-12869	139	2	urol	urol	PROPN
aiua-12869	139	3	.	.	PROPN
aiua-12869	140	1	2015	2015	NUM
aiua-12869	140	2	;	;	PUNCT
aiua-12869	140	3	193:1401	193:1401	NUM
aiua-12869	140	4	-	-	SYM
aiua-12869	140	5	8	8	NUM
aiua-12869	140	6	.	.	NOUN
aiua-12869	141	1	11	11	NUM
aiua-12869	141	2	.	.	X
aiua-12869	142	1	d'amico	d'amico	PROPN
aiua-12869	142	2	r	r	NOUN
aiua-12869	142	3	,	,	PUNCT
aiua-12869	142	4	genovese	genovese	NOUN
aiua-12869	142	5	t	t	PROPN
aiua-12869	142	6	,	,	PUNCT
aiua-12869	142	7	cordaro	cordaro	NOUN
aiua-12869	142	8	m	m	PROPN
aiua-12869	142	9	,	,	PUNCT
aiua-12869	142	10	et	et	PROPN
aiua-12869	142	11	al	al	PROPN
aiua-12869	142	12	.	.	PROPN
aiua-12869	142	13	palmitoylethanolamide/	palmitoylethanolamide/	NUM
aiua-12869	142	14	baicalein	baicalein	PROPN
aiua-12869	142	15	regulates	regulate	VERB
aiua-12869	142	16	the	the	DET
aiua-12869	142	17	androgen	androgen	NOUN
aiua-12869	142	18	receptor	receptor	NOUN
aiua-12869	142	19	signaling	signal	VERB
aiua-12869	142	20	and	and	CCONJ
aiua-12869	142	21	nf	nf	NOUN
aiua-12869	142	22	-	-	PUNCT
aiua-12869	142	23	κb	κb	NOUN
aiua-12869	142	24	/	/	SYM
aiua-12869	142	25	nrf2	nrf2	NOUN
aiua-12869	142	26	pathways	pathway	NOUN
aiua-12869	142	27	in	in	ADP
aiua-12869	142	28	benign	benign	ADJ
aiua-12869	142	29	prostatic	prostatic	ADJ
aiua-12869	142	30	hyperplasia	hyperplasia	NOUN
aiua-12869	142	31	.	.	PUNCT
aiua-12869	143	1	antioxidants	antioxidant	NOUN
aiua-12869	143	2	2021	2021	NUM
aiua-12869	143	3	;	;	PUNCT
aiua-12869	143	4	10:1014	10:1014	NUM
aiua-12869	143	5	.	.	PROPN
aiua-12869	143	6	12	12	NUM
aiua-12869	143	7	.	.	PUNCT
aiua-12869	144	1	bergandi	bergandi	PROPN
aiua-12869	144	2	l	l	NOUN
aiua-12869	144	3	,	,	PUNCT
aiua-12869	144	4	apprato	apprato	PROPN
aiua-12869	144	5	g	g	PROPN
aiua-12869	144	6	,	,	PUNCT
aiua-12869	144	7	silvagno	silvagno	PROPN
aiua-12869	144	8	f.	f.	PROPN
aiua-12869	144	9	antioxidant	antioxidant	PROPN
aiua-12869	144	10	and	and	CCONJ
aiua-12869	144	11	antiinflammatory	antiinflammatory	NOUN
aiua-12869	144	12	activity	activity	NOUN
aiua-12869	144	13	of	of	ADP
aiua-12869	144	14	combined	combined	ADJ
aiua-12869	144	15	phycocyanin	phycocyanin	ADV
aiua-12869	144	16	and	and	CCONJ
aiua-12869	144	17	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-12869	144	18	in	in	ADP
aiua-12869	144	19	human	human	ADJ
aiua-12869	144	20	lung	lung	NOUN
aiua-12869	144	21	and	and	CCONJ
aiua-12869	144	22	prostate	prostate	NOUN
aiua-12869	144	23	epithelial	epithelial	ADJ
aiua-12869	144	24	cells	cell	NOUN
aiua-12869	144	25	.	.	PUNCT
aiua-12869	145	1	antioxidants	antioxidant	NOUN
aiua-12869	145	2	2022	2022	NUM
aiua-12869	145	3	;	;	PUNCT
aiua-12869	145	4	11:201	11:201	NUM
aiua-12869	145	5	.	.	PUNCT
aiua-12869	146	1	13	13	NUM
aiua-12869	146	2	.	.	X
aiua-12869	147	1	cordaro	cordaro	PROPN
aiua-12869	147	2	m	m	PROPN
aiua-12869	147	3	,	,	PUNCT
aiua-12869	147	4	impellizzeri	impellizzeri	ADJ
aiua-12869	147	5	d	d	NOUN
aiua-12869	147	6	,	,	PUNCT
aiua-12869	147	7	siracusa	siracusa	NOUN
aiua-12869	147	8	r	r	NOUN
aiua-12869	147	9	,	,	PUNCT
aiua-12869	147	10	et	et	PROPN
aiua-12869	147	11	al	al	PROPN
aiua-12869	147	12	.	.	PUNCT
aiua-12869	147	13	effects	effect	NOUN
aiua-12869	147	14	of	of	ADP
aiua-12869	147	15	a	a	DET
aiua-12869	147	16	comicronized	comicronized	ADJ
aiua-12869	147	17	composite	composite	NOUN
aiua-12869	147	18	containing	contain	VERB
aiua-12869	147	19	palmitoylethanolamide	palmitoylethanolamide	NOUN
aiua-12869	147	20	and	and	CCONJ
aiua-12869	147	21	polydatin	polydatin	NOUN
aiua-12869	147	22	in	in	ADP
aiua-12869	147	23	an	an	DET
aiua-12869	147	24	experimental	experimental	ADJ
aiua-12869	147	25	model	model	NOUN
aiua-12869	147	26	of	of	ADP
aiua-12869	147	27	benign	benign	ADJ
aiua-12869	147	28	prostatic	prostatic	ADJ
aiua-12869	147	29	hyperplasia	hyperplasia	NOUN
aiua-12869	147	30	.	.	PUNCT
aiua-12869	148	1	toxicol	toxicol	PROPN
aiua-12869	148	2	appl	appl	PROPN
aiua-12869	148	3	pharmacol	pharmacol	PROPN
aiua-12869	148	4	.	.	PROPN
aiua-12869	149	1	2017	2017	NUM
aiua-12869	149	2	;	;	PUNCT
aiua-12869	150	1	329:231	329:231	NUM
aiua-12869	150	2	-	-	SYM
aiua-12869	150	3	240	240	NUM
aiua-12869	150	4	.	.	PUNCT
aiua-12869	150	5	14	14	NUM
aiua-12869	150	6	.	.	PUNCT
aiua-12869	151	1	arias	arias	PROPN
aiua-12869	151	2	-	-	PUNCT
aiua-12869	151	3	chávez	chávez	PROPN
aiua-12869	151	4	dj	dj	NOUN
aiua-12869	151	5	,	,	PUNCT
aiua-12869	151	6	mailloux	mailloux	NOUN
aiua-12869	151	7	-	-	PUNCT
aiua-12869	151	8	salinas	salina	NOUN
aiua-12869	151	9	p	p	NOUN
aiua-12869	151	10	,	,	PUNCT
aiua-12869	151	11	ledesma	ledesma	PROPN
aiua-12869	151	12	aparicio	aparicio	PROPN
aiua-12869	151	13	j	j	PROPN
aiua-12869	151	14	,	,	PUNCT
aiua-12869	151	15	et	et	PROPN
aiua-12869	151	16	al	al	PROPN
aiua-12869	151	17	.	.	PROPN
aiua-12869	151	18	selenium	selenium	NOUN
aiua-12869	151	19	in	in	ADP
aiua-12869	151	20	combination	combination	NOUN
aiua-12869	151	21	with	with	ADP
aiua-12869	151	22	a	a	DET
aiua-12869	151	23	tomato	tomato	NOUN
aiua-12869	151	24	lipid	lipid	NOUN
aiua-12869	151	25	extract	extract	NOUN
aiua-12869	151	26	as	as	ADP
aiua-12869	151	27	a	a	DET
aiua-12869	151	28	therapy	therapy	NOUN
aiua-12869	151	29	for	for	ADP
aiua-12869	151	30	benign	benign	ADJ
aiua-12869	151	31	prostatic	prostatic	ADJ
aiua-12869	151	32	hyperplasia	hyperplasia	NOUN
aiua-12869	151	33	and	and	CCONJ
aiua-12869	151	34	its	its	PRON
aiua-12869	151	35	alterations	alteration	NOUN
aiua-12869	151	36	in	in	ADP
aiua-12869	151	37	rats	rat	NOUN
aiua-12869	151	38	with	with	ADP
aiua-12869	151	39	induced	induced	ADJ
aiua-12869	151	40	bph	bph	NOUN
aiua-12869	151	41	.	.	PUNCT
aiua-12869	152	1	j	j	PROPN
aiua-12869	152	2	cell	cell	PROPN
aiua-12869	152	3	mol	mol	ADP
aiua-12869	152	4	med	med	PROPN
aiua-12869	152	5	.	.	PUNCT
aiua-12869	152	6	2023	2023	NUM
aiua-12869	152	7	;	;	PUNCT
aiua-12869	152	8	27:3147	27:3147	NUM
aiua-12869	152	9	-	-	PUNCT
aiua-12869	152	10	3156	3156	NUM
aiua-12869	152	11	.	.	PUNCT
aiua-12869	153	1	15	15	NUM
aiua-12869	153	2	.	.	PUNCT
aiua-12869	153	3	kok	kok	PROPN
aiua-12869	153	4	de	de	PROPN
aiua-12869	153	5	,	,	PUNCT
aiua-12869	153	6	kiemeney	kiemeney	PROPN
aiua-12869	153	7	la	la	PROPN
aiua-12869	153	8	,	,	PUNCT
aiua-12869	153	9	verhaegh	verhaegh	VERB
aiua-12869	153	10	gw	gw	PROPN
aiua-12869	153	11	,	,	PUNCT
aiua-12869	153	12	et	et	PROPN
aiua-12869	153	13	al	al	PROPN
aiua-12869	153	14	.	.	PUNCT
aiua-12869	154	1	a	a	DET
aiua-12869	154	2	short	short	ADJ
aiua-12869	154	3	-	-	PUNCT
aiua-12869	154	4	term	term	NOUN
aiua-12869	154	5	intervention	intervention	NOUN
aiua-12869	154	6	with	with	ADP
aiua-12869	154	7	selenium	selenium	NOUN
aiua-12869	154	8	affects	affect	VERB
aiua-12869	154	9	expression	expression	NOUN
aiua-12869	154	10	of	of	ADP
aiua-12869	154	11	genes	gene	NOUN
aiua-12869	154	12	implicated	implicate	VERB
aiua-12869	154	13	in	in	ADP
aiua-12869	154	14	the	the	DET
aiua-12869	154	15	epithelial	epithelial	NOUN
aiua-12869	154	16	-	-	PUNCT
aiua-12869	154	17	to	to	ADP
aiua-12869	154	18	-	-	PUNCT
aiua-12869	154	19	mesenchymal	mesenchymal	ADJ
aiua-12869	154	20	transition	transition	NOUN
aiua-12869	154	21	in	in	ADP
aiua-12869	154	22	the	the	DET
aiua-12869	154	23	prostate	prostate	NOUN
aiua-12869	154	24	.	.	PUNCT
aiua-12869	155	1	oncotarget	oncotarget	NOUN
aiua-12869	155	2	.	.	PUNCT
aiua-12869	156	1	2017	2017	NUM
aiua-12869	156	2	;	;	PUNCT
aiua-12869	156	3	8:10565	8:10565	NUM
aiua-12869	156	4	-	-	SYM
aiua-12869	156	5	10579	10579	NUM
aiua-12869	156	6	.	.	PUNCT
aiua-12869	157	1	16	16	NUM
aiua-12869	157	2	.	.	PUNCT
aiua-12869	158	1	traish	traish	PROPN
aiua-12869	158	2	am	be	AUX
aiua-12869	158	3	.	.	PUNCT
aiua-12869	159	1	health	health	NOUN
aiua-12869	159	2	risks	risk	NOUN
aiua-12869	159	3	associated	associate	VERB
aiua-12869	159	4	with	with	ADP
aiua-12869	159	5	long	long	ADJ
aiua-12869	159	6	-	-	PUNCT
aiua-12869	159	7	term	term	NOUN
aiua-12869	159	8	finasteride	finasteride	ADJ
aiua-12869	159	9	and	and	CCONJ
aiua-12869	159	10	dutasteride	dutasteride	NOUN
aiua-12869	159	11	use	use	NOUN
aiua-12869	159	12	:	:	PUNCT
aiua-12869	159	13	it	it	PRON
aiua-12869	159	14	's	be	AUX
aiua-12869	159	15	time	time	NOUN
aiua-12869	159	16	to	to	PART
aiua-12869	159	17	sound	sound	VERB
aiua-12869	159	18	the	the	DET
aiua-12869	159	19	alarm	alarm	NOUN
aiua-12869	159	20	.	.	PUNCT
aiua-12869	160	1	world	world	PROPN
aiua-12869	160	2	j	j	PROPN
aiua-12869	160	3	mens	mens	PROPN
aiua-12869	160	4	health	health	PROPN
aiua-12869	160	5	.	.	PUNCT
aiua-12869	161	1	2020	2020	NUM
aiua-12869	161	2	;	;	PUNCT
aiua-12869	161	3	38:323	38:323	NUM
aiua-12869	161	4	-	-	SYM
aiua-12869	161	5	337	337	NUM
aiua-12869	161	6	17	17	NUM
aiua-12869	161	7	.	.	PUNCT
aiua-12869	162	1	garcia	garcia	PROPN
aiua-12869	162	2	-	-	PUNCT
aiua-12869	162	3	argibay	argibay	PROPN
aiua-12869	162	4	m	m	PROPN
aiua-12869	162	5	,	,	PUNCT
aiua-12869	162	6	hiyoshi	hiyoshi	PROPN
aiua-12869	162	7	a	a	X
aiua-12869	162	8	,	,	PUNCT
aiua-12869	162	9	fall	fall	NOUN
aiua-12869	162	10	k	k	PROPN
aiua-12869	162	11	,	,	PUNCT
aiua-12869	162	12	montgomery	montgomery	PROPN
aiua-12869	162	13	s.	s.	PROPN
aiua-12869	162	14	association	association	PROPN
aiua-12869	162	15	of	of	ADP
aiua-12869	162	16	5α	5α	ADJ
aiua-12869	162	17	-	-	PUNCT
aiua-12869	162	18	reductase	reductase	NOUN
aiua-12869	162	19	inhibitors	inhibitor	NOUN
aiua-12869	162	20	with	with	ADP
aiua-12869	162	21	dementia	dementia	NOUN
aiua-12869	162	22	,	,	PUNCT
aiua-12869	162	23	depression	depression	NOUN
aiua-12869	162	24	,	,	PUNCT
aiua-12869	162	25	and	and	CCONJ
aiua-12869	162	26	suicide	suicide	NOUN
aiua-12869	162	27	.	.	PUNCT
aiua-12869	163	1	jama	jama	PROPN
aiua-12869	163	2	netw	netw	PROPN
aiua-12869	163	3	open	open	ADJ
aiua-12869	163	4	.	.	PUNCT
aiua-12869	164	1	2022	2022	NUM
aiua-12869	164	2	;	;	PUNCT
aiua-12869	164	3	5	5	NUM
aiua-12869	164	4	:	:	PUNCT
aiua-12869	164	5	e2248135	e2248135	VERB
aiua-12869	164	6	.	.	PROPN
aiua-12869	164	7	18	18	NUM
aiua-12869	164	8	.	.	PUNCT
aiua-12869	165	1	ficarra	ficarra	PROPN
aiua-12869	165	2	v	v	NOUN
aiua-12869	165	3	,	,	PUNCT
aiua-12869	165	4	rossanese	rossanese	ADJ
aiua-12869	165	5	m	m	PROPN
aiua-12869	165	6	,	,	PUNCT
aiua-12869	165	7	zazzara	zazzara	PROPN
aiua-12869	165	8	m	m	PROPN
aiua-12869	165	9	,	,	PUNCT
aiua-12869	165	10	et	et	PROPN
aiua-12869	165	11	al	al	PROPN
aiua-12869	165	12	.	.	PUNCT
aiua-12869	166	1	the	the	DET
aiua-12869	166	2	role	role	NOUN
aiua-12869	166	3	of	of	ADP
aiua-12869	166	4	inflammation	inflammation	NOUN
aiua-12869	166	5	in	in	ADP
aiua-12869	166	6	lower	low	ADJ
aiua-12869	166	7	urinary	urinary	ADJ
aiua-12869	166	8	tract	tract	NOUN
aiua-12869	166	9	symptoms	symptom	NOUN
aiua-12869	166	10	(	(	PUNCT
aiua-12869	166	11	luts	luts	PROPN
aiua-12869	166	12	)	)	PUNCT
aiua-12869	166	13	due	due	ADP
aiua-12869	166	14	to	to	ADP
aiua-12869	166	15	benign	benign	ADJ
aiua-12869	166	16	prostatic	prostatic	ADJ
aiua-12869	166	17	hyperplasia	hyperplasia	NOUN
aiua-12869	166	18	(	(	PUNCT
aiua-12869	166	19	bph	bph	NOUN
aiua-12869	166	20	)	)	PUNCT
aiua-12869	166	21	and	and	CCONJ
aiua-12869	166	22	its	its	PRON
aiua-12869	166	23	potential	potential	ADJ
aiua-12869	166	24	impact	impact	NOUN
aiua-12869	166	25	on	on	ADP
aiua-12869	166	26	medical	medical	ADJ
aiua-12869	166	27	therapy	therapy	NOUN
aiua-12869	166	28	.	.	PUNCT
aiua-12869	167	1	curr	curr	PROPN
aiua-12869	167	2	urol	urol	PROPN
aiua-12869	167	3	rep	rep	PROPN
aiua-12869	167	4	.	.	PROPN
aiua-12869	167	5	2014	2014	NUM
aiua-12869	167	6	;	;	PUNCT
aiua-12869	167	7	15:463	15:463	NUM
aiua-12869	167	8	.	.	PROPN
aiua-12869	167	9	19	19	NUM
aiua-12869	167	10	.	.	PUNCT
aiua-12869	167	11	kwon	kwon	PROPN
aiua-12869	167	12	yk	yk	PROPN
aiua-12869	167	13	,	,	PUNCT
aiua-12869	167	14	choe	choe	PROPN
aiua-12869	167	15	ms	ms	PROPN
aiua-12869	167	16	,	,	PUNCT
aiua-12869	167	17	seo	seo	NOUN
aiua-12869	167	18	kw	kw	PROPN
aiua-12869	167	19	,	,	PUNCT
aiua-12869	167	20	et	et	PROPN
aiua-12869	167	21	al	al	PROPN
aiua-12869	167	22	.	.	PUNCT
aiua-12869	168	1	the	the	DET
aiua-12869	168	2	effect	effect	NOUN
aiua-12869	168	3	of	of	ADP
aiua-12869	168	4	intraprostatic	intraprostatic	ADJ
aiua-12869	168	5	chronic	chronic	ADJ
aiua-12869	168	6	inflammation	inflammation	NOUN
aiua-12869	168	7	on	on	ADP
aiua-12869	168	8	benign	benign	ADJ
aiua-12869	168	9	prostatic	prostatic	ADJ
aiua-12869	168	10	hyperplasia	hyperplasia	NOUN
aiua-12869	168	11	treatment	treatment	NOUN
aiua-12869	168	12	.	.	PUNCT
aiua-12869	169	1	korean	korean	PROPN
aiua-12869	169	2	j	j	PROPN
aiua-12869	169	3	urol	urol	PROPN
aiua-12869	169	4	.	.	PUNCT
aiua-12869	170	1	2010	2010	NUM
aiua-12869	170	2	;	;	PUNCT
aiua-12869	170	3	51:266	51:266	NUM
aiua-12869	170	4	-	-	SYM
aiua-12869	170	5	70	70	NUM
aiua-12869	170	6	.	.	PUNCT
aiua-12869	171	1	20	20	NUM
aiua-12869	171	2	.	.	PUNCT
aiua-12869	171	3	kahokehr	kahokehr	NOUN
aiua-12869	171	4	a	a	PRON
aiua-12869	171	5	,	,	PUNCT
aiua-12869	171	6	vather	vather	NOUN
aiua-12869	171	7	r	r	NOUN
aiua-12869	171	8	,	,	PUNCT
aiua-12869	171	9	nixon	nixon	PROPN
aiua-12869	171	10	a	a	PROPN
aiua-12869	171	11	,	,	PUNCT
aiua-12869	171	12	hill	hill	PROPN
aiua-12869	171	13	ag	ag	PROPN
aiua-12869	171	14	.	.	PROPN
aiua-12869	172	1	non	non	ADJ
aiua-12869	172	2	-	-	ADJ
aiua-12869	172	3	steroidal	steroidal	ADJ
aiua-12869	172	4	antiinflammatory	antiinflammatory	NOUN
aiua-12869	172	5	drugs	drug	NOUN
aiua-12869	172	6	for	for	ADP
aiua-12869	172	7	lower	low	ADJ
aiua-12869	172	8	urinary	urinary	ADJ
aiua-12869	172	9	tract	tract	NOUN
aiua-12869	172	10	symptoms	symptom	NOUN
aiua-12869	172	11	in	in	ADP
aiua-12869	172	12	benign	benign	ADJ
aiua-12869	172	13	prostatic	prostatic	ADJ
aiua-12869	172	14	hyperplasia	hyperplasia	NOUN
aiua-12869	172	15	:	:	PUNCT
aiua-12869	172	16	systematic	systematic	ADJ
aiua-12869	172	17	review	review	NOUN
aiua-12869	172	18	and	and	CCONJ
aiua-12869	172	19	meta	meta	NOUN
aiua-12869	172	20	-	-	PUNCT
aiua-12869	172	21	analysis	analysis	NOUN
aiua-12869	172	22	of	of	ADP
aiua-12869	172	23	randomized	randomized	ADJ
aiua-12869	172	24	controlled	control	VERB
aiua-12869	172	25	trials	trial	NOUN
aiua-12869	172	26	.	.	PUNCT
aiua-12869	173	1	bju	bju	NOUN
aiua-12869	173	2	int	int	PROPN
aiua-12869	173	3	.	.	PUNCT
aiua-12869	174	1	2013	2013	NUM
aiua-12869	174	2	;	;	PUNCT
aiua-12869	174	3	111:304	111:304	NUM
aiua-12869	174	4	-	-	SYM
aiua-12869	174	5	11	11	NUM
aiua-12869	174	6	.	.	PUNCT
aiua-12869	175	1	correspondence	correspondence	NOUN
aiua-12869	175	2	giuseppe	giuseppe	PROPN
aiua-12869	175	3	saitta	saitta	PROPN
aiua-12869	175	4	,	,	PUNCT
aiua-12869	175	5	md	md	PROPN
aiua-12869	175	6	(	(	PUNCT
aiua-12869	175	7	corresponding	correspond	VERB
aiua-12869	175	8	author	author	NOUN
aiua-12869	175	9	)	)	PUNCT
aiua-12869	175	10	gsaitta@hotmail.it	gsaitta@hotmail.it	PROPN
aiua-12869	175	11	iccs	iccs	VERB
aiua-12869	175	12	istituto	istituto	PROPN
aiua-12869	175	13	clinico	clinico	PROPN
aiua-12869	175	14	città	città	PROPN
aiua-12869	175	15	studi	studi	PROPN
aiua-12869	175	16	,	,	PUNCT
aiua-12869	175	17	milan	milan	PROPN
aiua-12869	175	18	(	(	PUNCT
aiua-12869	175	19	italy	italy	PROPN
aiua-12869	175	20	)	)	PUNCT
aiua-12869	175	21	viale	viale	PROPN
aiua-12869	175	22	sabotino	sabotino	NOUN
aiua-12869	175	23	19	19	NUM
aiua-12869	175	24	,	,	PUNCT
aiua-12869	175	25	20135	20135	NUM
aiua-12869	175	26	,	,	PUNCT
aiua-12869	175	27	milan	milan	PROPN
aiua-12869	175	28	(	(	PUNCT
aiua-12869	175	29	italy	italy	PROPN
aiua-12869	175	30	)	)	PUNCT
aiua-12869	175	31	franco	franco	PROPN
aiua-12869	175	32	a	a	DET
aiua-12869	175	33	mantovani	mantovani	PROPN
aiua-12869	175	34	,	,	PUNCT
aiua-12869	175	35	md	md	PROPN
aiua-12869	175	36	mantovanifranco@yahoo.it	mantovanifranco@yahoo.it	PROPN
aiua-12869	175	37	benedetto	benedetto	PROPN
aiua-12869	175	38	calabrese	calabrese	PROPN
aiua-12869	175	39	,	,	PUNCT
aiua-12869	175	40	md	md	PROPN
aiua-12869	175	41	calabrese.benedetto98@gmail.com	calabrese.benedetto98@gmail.com	PROPN
aiua-12869	175	42	camilla	camilla	PROPN
aiua-12869	175	43	aliboni	aliboni	PROPN
aiua-12869	175	44	,	,	PUNCT
aiua-12869	175	45	md	md	PROPN
aiua-12869	175	46	camilla.aliboni@gmail.com	camilla.aliboni@gmail.com	PROPN
aiua-12869	175	47	giuseppe	giuseppe	PROPN
aiua-12869	175	48	di	di	PROPN
aiua-12869	175	49	paola	paola	PROPN
aiua-12869	175	50	,	,	PUNCT
aiua-12869	175	51	md	md	PROPN
aiua-12869	175	52	giuseppe.dipaola@ic-cittastudi.it	giuseppe.dipaola@ic-cittastudi.it	X
aiua-12869	175	53	attilio	attilio	NOUN
aiua-12869	175	54	l	l	PROPN
aiua-12869	175	55	meazza	meazza	PROPN
aiua-12869	175	56	,	,	PUNCT
aiua-12869	175	57	md	md	PROPN
aiua-12869	175	58	attilio.meazza@ic-cittastudi.it	attilio.meazza@ic-cittastudi.it	PROPN
aiua-12869	175	59	mauro	mauro	PROPN
aiua-12869	175	60	seveso	seveso	PROPN
aiua-12869	175	61	,	,	PUNCT
aiua-12869	175	62	md	md	PROPN
aiua-12869	175	63	mauro.seveso@ic-cittastudi.it	mauro.seveso@ic-cittastudi.it	PART
aiua-12869	175	64	iccs	iccs	VERB
aiua-12869	175	65	istituto	istituto	PROPN
aiua-12869	175	66	clinico	clinico	PROPN
aiua-12869	175	67	città	città	PROPN
aiua-12869	175	68	studi	studi	PROPN
aiua-12869	175	69	,	,	PUNCT
aiua-12869	175	70	milan	milan	PROPN
aiua-12869	175	71	(	(	PUNCT
aiua-12869	175	72	italy	italy	PROPN
aiua-12869	175	73	)	)	PUNCT
aiua-12869	175	74	conflict	conflict	NOUN
aiua-12869	175	75	of	of	ADP
aiua-12869	175	76	interest	interest	NOUN
aiua-12869	175	77	:	:	PUNCT
aiua-12869	175	78	the	the	DET
aiua-12869	175	79	authors	author	NOUN
aiua-12869	175	80	declare	declare	VERB
aiua-12869	175	81	no	no	DET
aiua-12869	175	82	potential	potential	ADJ
aiua-12869	175	83	conflict	conflict	NOUN
aiua-12869	175	84	of	of	ADP
aiua-12869	175	85	interest	interest	NOUN
aiua-12869	175	86	.	.	PUNCT